,M229-DDR-1,M229-DTPPy-2,M229-MRDDR4-1,M238-DTPP-2,M395-RDDR-1
NAKAMURA_CANCER_MICROENVIRONMENT_UP,0.0185466978612332,-0.108371013538931,-0.0478510093475288,0.192652929790402,-0.376892221689503
NAKAMURA_CANCER_MICROENVIRONMENT_DN,-0.16849618255653,-0.0930305585010404,0.297840065446575,-0.594481659016849,0.232269721203757
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,-0.254849305940162,0.273323298290105,0.169119572779569,-0.652030944927183,0.0561395199833045
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,-0.546088315591784,0.0661434692170381,0.167574651234977,0.335685095478669,-0.129325789716826
WINTER_HYPOXIA_UP,0.0205310518504054,0.284226728654534,0.0432860611661144,-0.143031471989827,-0.532928241037028
WINTER_HYPOXIA_DN,-0.196073143407626,0.0302469613011394,0.46543946164572,-0.281671449267978,-0.21684337977236
PARENT_MTOR_SIGNALING_UP,-0.134360192433551,0.186177156439524,0.15811763104711,-0.319585765643595,-0.304570310657151
PARENT_MTOR_SIGNALING_DN,-0.378876996789486,-0.0316888928003285,0.516439028522587,-0.430752771937315,0.174336420452149
PYEON_HPV_POSITIVE_TUMORS_UP,-0.0136921205416135,-0.0998424729433932,0.16244626240548,-0.426879554325553,-0.0850577300527598
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,-0.196062002016783,0.213208527961472,-0.0415299350383586,-0.118580808325535,-0.342527257081436
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,-0.0708676981856199,0.103210830817043,-0.0696866614874482,-0.249443198677885,-0.115537451596497
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,-0.264781038078743,0.000733167377116789,0.0757009182889844,0.0793121820141387,-0.210503572200805
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,-0.0288984754113782,0.129504606507328,-0.0701159358750098,-0.263126159942767,-0.25791617926218
LU_TUMOR_VASCULATURE_UP,-0.222621129100032,0.00526632901651844,0.235522896854106,-0.142781178436133,-0.386228277361679
KORKOLA_EMBRYONAL_CARCINOMA_UP,-0.169552682831731,-0.305416533682064,0.227267766435599,-0.0125856032331039,-0.147506897504549
KORKOLA_YOLK_SAC_TUMOR_UP,0.0333312839990721,0.261614590835372,0.0510558946321863,-0.161852134440069,-0.50078961502411
KORKOLA_SEMINOMA_UP,-0.0569781225088524,-0.345047185395239,0.149607310721066,0.0731334173873781,-0.261249845773868
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,0.315643412977428,-0.00160234392582639,-0.0247101038915081,-0.236991497286578,-0.293841259471585
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,-0.0470401557997379,0.203110952559777,0.105670098551154,-0.164255177053079,-0.437656683857073
HOLLMANN_APOPTOSIS_VIA_CD40_UP,-0.139375177269201,0.0840813870862091,0.13857086737715,-0.243750577564807,-0.110003758288423
HOLLMANN_APOPTOSIS_VIA_CD40_DN,-0.016951859739907,0.0675611113870641,-0.00705681379239093,-0.22496289336181,-0.265606619577118
LIU_PROSTATE_CANCER_UP,-0.0843179741272135,0.0746326612780538,0.00949584945828513,-0.178556094697806,-0.161886661345483
LIU_PROSTATE_CANCER_DN,-0.294721301363149,0.0824840618928452,0.129944590049115,-0.145890460917715,-0.104332790029161
LIU_SOX4_TARGETS_UP,-0.109970431232037,0.00631291420020647,-0.00831003435425967,-0.145757308656186,-0.217018994218168
LIU_SOX4_TARGETS_DN,0.0653350470780622,0.141451960979429,-0.0895375130943746,-0.255505928612211,-0.422540073637646
ONKEN_UVEAL_MELANOMA_UP,-0.15885937836184,0.0996500340356997,0.0334958247146289,-0.313841272883477,-0.207533411869735
ONKEN_UVEAL_MELANOMA_DN,-0.066508381608811,-0.0528378371738836,0.213749280202309,-0.363480325465591,-0.120608186838382
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,-0.053041027481209,0.330259489012541,-0.191516591419878,-0.189019828172998,-0.305141987816362
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,-0.131123247748858,-0.211588851750417,0.0501181555051359,0.020516617931628,-0.116593146276929
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,-0.323763612179663,-0.00194516117931509,-0.0749395349302302,0.12681443113571,-0.176286962367419
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,-0.183152836621157,0.0278971725529667,0.171009207132786,-0.362569223226982,-0.0476346885616701
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,-0.227737738799657,-0.0832501546757653,0.0673760223223332,-0.337769731040509,-0.0684997132960453
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,-0.613894308684354,-0.428175888188756,-0.0954593745887301,0.317226635766398,0.671946036272789
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,-0.269207125607218,0.43473562355126,-0.184664647389322,-0.245236737555531,-0.152017812354164
FRASOR_TAMOXIFEN_RESPONSE_UP,0.166791434194915,0.288158541929631,-0.060373595791935,-0.312741378500998,-0.35953431102685
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,0.0598760806620852,0.292210319815728,0.00794636671807204,-0.251053697873369,-0.310105752304811
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,-0.113097416875488,0.0265654094159911,0.0564671290768927,-0.230038892404205,-0.095364150087215
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,-0.224175190003842,0.289027188680041,0.242812432150214,-0.365179411699316,-0.163115329698112
WATANABE_COLON_CANCER_MSI_VS_MSS_UP,-0.0366890200011776,0.0790092567574664,-0.140014469782486,-0.542739061749022,-0.0888655893401548
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,-0.0823652388155064,-0.0326154740255852,0.327669928507931,-0.295044525165487,0.00205848960906216
KOBAYASHI_EGFR_SIGNALING_6HR_DN,-0.433175792736752,0.625155735854442,-0.555178942422305,0.307726155826057,-0.571607320494568
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.0695885815842999,0.313536840460005,0.0503643178629434,-0.400549869994088,-0.482675000883528
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,-0.0223695617263714,0.0947526677205279,0.101179506307229,-0.30357533545216,-0.137957882038942
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,-0.0932947480408023,0.161939169509542,0.0403375755070346,-0.27899078830665,-0.218682980356697
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,-0.0692356582379514,-0.0080900849840414,-0.332543786981577,-0.232749388885301,0.114366575838092
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,-0.194779879743144,0.0435430104426352,-0.0164144519270628,-0.0487418278640954,-0.192595615108747
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,-0.154077628124587,0.200156099778165,0.0090712879342679,-0.49319954365463,-0.18081804255469
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,0.123448128394179,-0.293242344054804,-0.0325253467668257,-0.516011468768844,0.235098782627671
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,-0.103942349878894,0.309631159455624,0.263374264204062,-0.524681035814251,-0.173385621480185
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,-0.247111050870854,0.0519488687699499,0.189057693459795,-0.332399247246603,-0.123492232818587
IGARASHI_ATF4_TARGETS_DN,-0.0930442447635726,-0.171787470753028,0.176693212125498,-0.423474811753131,0.14880415368439
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,-0.00293574311807959,0.167867855025547,0.135704167137398,-0.217257331209092,-0.281991432505281
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,-0.113534153133887,0.00454550165546488,0.097636704164278,-0.431721386163378,-0.0808261561346268
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,0.0136050187387877,-0.0140246345517355,0.194139806569842,-0.357717616871953,-0.279983307109701
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,-0.226876283885588,0.133342750568924,-0.137260238852782,0.0544611985668347,-0.314779848585651
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,-0.206462333935868,-0.123804019424908,0.0214491355788863,-0.181244272713855,-0.040519641169586
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,-0.1530460740763,-0.127900214126045,0.224839231115685,-0.313457314626963,0.0921679806475128
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,-0.155522380294054,0.0783973221397253,0.282291389589621,-0.461509980507508,-0.0688508288359229
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,-0.256145437444695,-0.0188701618065619,0.244597344147228,-0.421342633585473,0.0401409834787572
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,-0.11505445409544,0.299895827885973,0.283256827728902,-0.409773439600268,-0.0919388478724153
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,-0.0943392215869563,0.137091754239077,0.0916977942955458,-0.483415355132994,-0.0760206145474722
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,-0.617428946434769,-0.358109511546124,0.201681438309191,0.214942837287762,-0.114771903815715
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,-0.236548953631106,0.0310649411487819,0.168309151755273,-0.19568458119598,-0.0715030880684552
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,-0.387050284911711,-0.0347559795414555,0.102069063652868,-0.171749178322074,-0.0270531203807374
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,-0.317681999023772,-0.0284742787605854,0.277312446847524,-0.190046016295474,-0.0647059621997393
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.201253548268196,0.160598362969212,0.432369210940492,-0.554342598001189,-0.11172608823487
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,-0.466457248771787,0.0793254959730389,0.11043986119584,0.204913853738583,-0.262982945877231
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,-0.116365040274942,0.0889273827035355,0.158508834571444,-0.344605826501499,0.0543510814603468
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,-0.039316619945083,-0.0151538987437001,0.258502749603308,-0.431544923205719,0.0564296506274344
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,-0.443314257965947,-0.0594053070681307,-0.0797464286495794,0.242406115061209,-0.197924326695896
CHANDRAN_METASTASIS_TOP50_DN,-0.24006251824851,-0.124117463835282,-0.325611685626576,0.212963394738648,-0.16974696878184
WILCOX_RESPONSE_TO_PROGESTERONE_UP,-0.0887764886204209,0.154117757280553,0.280631790415934,-0.4324832243496,-0.105893599404053
WILCOX_RESPONSE_TO_PROGESTERONE_DN,-0.311503370008336,-0.0941338498869845,-0.319897020669029,0.284389637027679,-0.152750709146475
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,-0.0462146061564971,0.0808004629643192,-0.0165703031833442,-0.172079118499026,-0.14525978405857
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,-0.087109705639506,0.159278234460442,0.0387572287833529,-0.28034136428349,-0.172055394740121
GARY_CD5_TARGETS_UP,-0.0561385310731762,0.128072649970496,-0.0731904855991787,-0.220343413059772,-0.2596785141874
GARY_CD5_TARGETS_DN,0.0351204128233038,-0.00811636516457098,0.0275902048720185,-0.438541330574,-0.164293392870985
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,-0.19567212938873,0.217698263276922,0.178193731633769,-0.214830313874805,-0.193106835687628
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,-0.205903059707975,0.164631056265275,-0.0121794151347705,-0.321902209788032,-0.13035722501755
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.215412709877458,0.0427267071760567,-0.085718121978736,-0.149169862065701,-0.491372136027859
HOOI_ST7_TARGETS_UP,-0.00372712649617865,0.24563259246149,0.0150450076481191,-0.188913169934255,-0.337776631835232
HOOI_ST7_TARGETS_DN,-0.223882720737397,0.0593400057042552,0.216308341858791,-0.360062292412445,-0.0950108920675296
PRAMOONJAGO_SOX4_TARGETS_UP,0.0169972963665646,0.511013638474317,-0.312571971190441,0.0205395136873945,-0.59166628805147
PRAMOONJAGO_SOX4_TARGETS_DN,0.253326324680258,0.338870865928786,-0.0919713915318835,-0.458647178661396,-0.477104205006214
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.171625706623804,0.0679653841565367,0.122616685526738,-0.439682127017439,-0.253980877894323
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.0272764465250879,0.140108277619114,0.0769106597787276,-0.447594657644977,-0.0665746137837956
PIEPOLI_LGI1_TARGETS_UP,-0.417060053098334,-0.347525099786899,-0.133055189792465,0.292283141759458,0.21603738603402
PIEPOLI_LGI1_TARGETS_DN,0.073437620430148,0.193223247051197,0.490171545702623,-0.360907062074109,0.01827047768907
THUM_SYSTOLIC_HEART_FAILURE_UP,-0.203688027941792,0.0589998508084658,0.0777452475164605,-0.273142460691944,0.0556369551252918
THUM_SYSTOLIC_HEART_FAILURE_DN,-0.0374603636704718,-0.0276307153854732,0.173553644807484,-0.369369046028393,-0.101790933183198
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,-0.00975994778811148,-0.132464239994432,0.0552078958278246,-0.0941508614058037,-0.117058604537749
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,-0.138234892423069,0.155311150202426,0.174878461476532,-0.371377602721813,-0.274425360094543
CORRE_MULTIPLE_MYELOMA_UP,-0.217052691199994,0.0633207894452009,0.180862834039205,-0.0833273541282258,-0.149734485693998
CORRE_MULTIPLE_MYELOMA_DN,-0.308628595624024,-0.147624920540916,0.0994512133307037,-0.189171671531402,0.0905166327612648
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,-0.127086589798596,0.207510080957067,0.0477066842986705,-0.196229682602598,-0.285167029463203
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,-0.178442511879967,0.116764419173861,0.347104503240816,-0.475355442359235,-0.100036954669803
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP,0.0261597171047198,-0.0609166538473113,0.119841068378413,-0.421122455571727,-0.207195609629011
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN,-0.00132149768975282,0.139763335872086,-0.00868954714825707,-0.194943702227915,-0.203866616152824
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.152747480692724,-0.257453079407509,-0.275404842505408,0.026162317392782,-0.215162178339065
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,-0.153911228212554,0.155992676908265,0.0871822462792867,-0.285017710626396,-0.211601677860151
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,-0.217283233312459,0.105142461809687,0.335281286137908,-0.342756199307292,-0.201215348584087
LIU_CMYB_TARGETS_UP,0.183919339389678,-0.0711619405301049,0.0940068881777048,-0.204241250482325,-0.460403719135771
LIU_VMYB_TARGETS_UP,0.0710070881651256,0.0867138060427473,0.0158428916346287,-0.306682723219946,-0.416379075030966
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,-0.378384765786481,0.272713703507335,0.0141948729120902,0.0148208760059768,0.060311538211782
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,-0.205887689681238,0.0563315697934829,0.10039156996183,-0.32492784560621,-0.0855125683263787
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,-0.0228634438327973,0.185148543009862,-0.00857392395316431,-0.194671254773352,-0.295589597137306
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,-0.0822891800413828,0.145881085849211,0.10342545785629,-0.362055289358861,-0.172600924978823
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,-0.264848224977189,0.0491692891177182,-0.0864947092047222,0.039520933020038,-0.306886482048322
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,-0.0128607518633094,0.246101758239865,0.0825204851953705,-0.349271996811556,-0.218574540176193
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,-0.463430154617357,-0.224511205029212,0.107921717185124,0.463882784788418,-0.29315533827362
DOANE_BREAST_CANCER_CLASSES_UP,-0.00966508687110396,0.0947111403184226,0.34120952078587,-0.348953559375822,-0.280388082350019
DOANE_BREAST_CANCER_CLASSES_DN,0.15427015728192,-0.0367916437462053,0.339355352904849,-0.182655869730557,-0.520523794888415
DOANE_RESPONSE_TO_ANDROGEN_UP,-0.109473577856966,0.198728236959032,0.0051172103065717,-0.270454910256341,-0.190429115025469
DOANE_RESPONSE_TO_ANDROGEN_DN,-0.347958344364125,-0.040538416000131,-0.100067039477659,-0.000271043958378514,-0.0884483190119393
DOANE_BREAST_CANCER_ESR1_UP,-0.169224115528137,0.177076897745125,0.163482269547387,-0.365256194853711,-0.090822060493584
DOANE_BREAST_CANCER_ESR1_DN,-0.236459729648394,0.0842990517594743,0.292484794816019,-0.265964934926191,-0.0660761565692723
WANG_RESPONSE_TO_ANDROGEN_UP,-0.126495740493335,-0.660234839864243,-0.118239612036864,-0.11987971509281,0.313926273080406
WANG_RESPONSE_TO_FORSKOLIN_UP,-0.191667181190353,-0.502021006744882,-0.0840265035140495,-0.167750790612138,0.104942871757608
LAIHO_COLORECTAL_CANCER_SERRATED_UP,-0.0129446469041269,0.0512517036335123,0.28459404246182,-0.40016388527063,-0.356189518482106
LAIHO_COLORECTAL_CANCER_SERRATED_DN,-0.404316651340571,0.498072888741385,0.331530099458149,-0.267145076141469,-0.428638276225517
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,0.0709713172709688,-0.15598194378321,-0.142005325519127,-0.358731318970559,-0.0176677702613519
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,-0.0470321072010675,0.0876145536279377,0.252959102205593,-0.339687320244877,-0.179684169849546
ROY_WOUND_BLOOD_VESSEL_UP,-0.461355323325779,-0.0635296934829505,-0.180171369219528,0.197541406553916,0.0108879473791192
ROY_WOUND_BLOOD_VESSEL_DN,-0.366436642198932,0.353825036586604,0.33852193809448,-0.355467285713653,-0.395915869255853
GRABARCZYK_BCL11B_TARGETS_UP,-0.292316344275866,-0.220564593778329,0.231535251365736,-0.191094105334437,0.00870637686230954
GRABARCZYK_BCL11B_TARGETS_DN,-0.144669489689306,-0.0289783904167048,0.0265941910780317,-0.0223097424267837,-0.187925849059486
NEWMAN_ERCC6_TARGETS_UP,0.163929014923769,0.257694423876806,0.250351847161219,-0.600064659178428,-0.108886635544551
NEWMAN_ERCC6_TARGETS_DN,-0.186921987390468,-0.16056124568371,-0.0714530339159249,0.0804358370251307,-0.349384450458886
HORIUCHI_WTAP_TARGETS_UP,-0.269682728343259,0.00671878945756926,0.0950111365334311,-0.145547761250078,-0.0669920834672296
HORIUCHI_WTAP_TARGETS_DN,0.10812756511094,0.0954964683950701,0.162349514605982,-0.528125900247524,-0.26924370738411
GAL_LEUKEMIC_STEM_CELL_UP,-0.320399620725454,0.0313758628654388,0.0962076252461913,-0.266234122184732,0.196877839854648
GAL_LEUKEMIC_STEM_CELL_DN,-0.0881996466025197,0.286604530734359,0.174768949466717,-0.203984138336484,-0.251776777405439
BASAKI_YBX1_TARGETS_UP,-0.0897553127606645,0.42354971187875,-0.0101117982427079,-0.395098911732313,-0.471654928166133
BASAKI_YBX1_TARGETS_DN,-0.0150462275279484,0.0631028283874343,-0.025225379151913,-0.361337463400127,-0.0637099810804577
NOJIMA_SFRP2_TARGETS_UP,0.292539656264295,0.178632520790732,0.0610176295349081,-0.237803594141083,-0.375931758920817
NOJIMA_SFRP2_TARGETS_DN,-0.134398248564522,0.222364989578671,-0.327296209517506,0.355591891249208,-0.410781996144506
WIKMAN_ASBESTOS_LUNG_CANCER_DN,-0.35344629553973,0.129074888419147,0.304952716887342,-0.246441776803186,0.00480050798540149
RODRIGUES_DCC_TARGETS_DN,-0.1888194047443,-0.163963732729382,-0.244793438984016,-0.0534669271744592,0.0318914173078675
RODRIGUES_NTN1_TARGETS_DN,-0.000643513662956646,0.0227064387442812,0.15048232474818,-0.147624989761402,-0.356607417982134
WANG_LMO4_TARGETS_UP,0.0363310460123993,-0.0520312687045964,0.0821589204009192,-0.328683816141397,-0.192296064324827
WANG_LMO4_TARGETS_DN,0.0989887245816655,-0.0531426697817199,0.0809884146766656,-0.366305208572768,-0.19390243726178
WANG_CLIM2_TARGETS_UP,-0.184808546279847,0.231304978187452,0.14922369713697,-0.220579003779703,-0.375657373648922
WANG_CLIM2_TARGETS_DN,0.028305283860526,0.13210149308473,-0.0484711811657418,-0.384254143932014,-0.247884598062656
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,-0.298498903435887,0.125747828688667,-0.0253046553503468,-0.0536587106977838,-0.223435087361097
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.0624434736438085,0.307313084701048,0.217720911127938,-0.375207907141477,-0.292280204650264
VECCHI_GASTRIC_CANCER_EARLY_UP,-0.0532639745268121,0.238070897057171,0.147716559503304,-0.314359629739522,-0.363401833951032
VECCHI_GASTRIC_CANCER_EARLY_DN,-0.160604656042041,0.0464908862718465,0.277784425432093,-0.383411790398927,0.100342619981627
BARRIER_COLON_CANCER_RECURRENCE_UP,0.0996440136074814,-0.255426119698381,0.106859122974145,-0.487218631687835,0.0126430971877245
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,-0.159742861679827,0.255466584927488,0.0419232279928084,-0.186268669583353,-0.343420421846612
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,-0.158309541326259,0.10087990216964,0.106517467708912,-0.360386108341051,-0.124484531769687
JAEGER_METASTASIS_UP,0.0935416198466156,0.0276136124548141,0.021165394226857,-0.326755885381247,-0.250253839895377
JAEGER_METASTASIS_DN,-0.161921543886277,0.233806738998417,0.243328420006011,-0.403774182332754,-0.0857226113973194
OSMAN_BLADDER_CANCER_UP,0.103559031629873,-0.0474917463541637,0.135122982436244,-0.373131637476419,-0.130588518789205
OSMAN_BLADDER_CANCER_DN,-0.0308878024957463,0.0779154466436306,0.0138278628675453,-0.371470006331302,-0.185874066672057
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,0.340518387501208,-0.348146802477598,-0.167960408907749,-0.559471885989071,0.259605530368779
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,-0.299482435137939,0.410038076321053,-0.0272911639261694,-0.261549320522185,-0.369402876129584
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,0.35014907431375,-0.449312770513228,0.130094475415973,-0.372656955506541,-0.0843132874890511
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,-0.181241841374635,0.361243136809614,-0.0871107360299257,-0.426766766054966,-0.310553940775864
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,-0.280998176999602,0.235638041465584,-0.0306036472168199,-0.0633638620774416,-0.157892768294619
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,0.0220151391603342,0.0629123259819757,-0.0254596868268026,-0.362389448748469,-0.165268658600275
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,0.173859875960665,-0.069537470921968,-0.0846887448635329,-0.390440022065317,-0.0397306057473166
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,0.0499292814154411,0.141674642056229,-0.0346997297073066,-0.393726377634577,-0.207369171502236
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,0.103831857463087,0.220922343557542,-0.00173476805239936,-0.433146458389868,-0.478204186653112
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,-0.0799507632822338,0.198427721245457,-0.553282034224301,-0.136091928012171,-0.181352478084803
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,-0.505594535618322,0.246561110038723,0.325780151753287,-0.32262173600682,-0.341722791114373
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,-0.380435681701375,0.141555020990057,-0.110541417752441,0.137547347058487,-0.119062417811761
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,-0.41268891546111,0.0161343431017706,0.0293905233694964,-0.13763549732852,-0.0531897280120347
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,-0.124772282929777,0.159803048554414,0.0940543485999626,-0.333654781626057,-0.184431024864999
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,-0.115792764324925,-0.119185490871695,-0.0410317792933551,-0.153175260966442,-0.138437951758351
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,0.267582543599253,-0.290850609944969,-0.073245715293588,-0.440063669453614,-0.0780815011772973
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,-0.138314332458317,-0.0313524972626863,0.234522962991242,-0.101333478637358,-0.263592840313039
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,-0.142649231536713,0.129794644530608,0.256824454271482,-0.469368732621105,0.202290712805425
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.0570832551975371,0.0991953244749371,0.0935149196578871,-0.338482612060272,-0.141397962291925
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,-0.192441271857402,0.155780917710221,0.112118313443442,-0.232421125899447,-0.198938789095311
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,-0.274118099400826,-0.0448358241215214,0.511058414360027,-0.28860452155763,0.151072516642915
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,-0.175128232934834,0.197433972544244,-0.051774742407565,-0.159694148222341,-0.040444635396375
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,-0.0906043121176415,-0.0113350420435852,0.264966926812301,-0.297036796163794,0.0588374182873223
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,-0.242875295838716,0.226415658173465,0.0338403523637504,-0.180243584119601,-0.0979199523903443
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,-0.105828611345025,0.116606236181588,0.253653779997808,-0.300628715056851,-0.145649491547764
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,-0.219291388986375,0.24239708762033,-0.00685848891055252,-0.079595302271767,-0.145846679322581
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,-0.131961135441628,0.0678245489009908,0.266834867757337,-0.369706330861132,-0.0421706169685319
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,-0.229153846827785,0.427708570336073,-0.0562675517832573,-0.120411397362833,-0.20756448253054
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,-0.200760930240668,0.172148508195005,-0.369088506167277,-0.308823900385367,0.0288642815877962
BILBAN_B_CLL_LPL_UP,-0.0799328943648535,0.195488857776452,0.0881157476677119,-0.224261211003268,-0.246984570698657
BILBAN_B_CLL_LPL_DN,0.0668467319470656,0.0671311396094049,-0.199230281598084,-0.148098087848869,-0.00477404869728243
HOEBEKE_LYMPHOID_STEM_CELL_UP,-0.398292080337787,-0.0102310333326575,0.225535225445066,-0.309292089380163,-0.158274836839872
HOEBEKE_LYMPHOID_STEM_CELL_DN,0.151870930306415,-0.00413248441471839,0.0749011068089212,-0.268003561245608,-0.383569366923572
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,-0.221625099832088,0.0431553009233104,0.197897392819284,-0.230925583719765,0.0481707894452605
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.125376468322874,0.322215458067801,0.113489645605059,-0.365336952767823,-0.129322719994491
AKL_HTLV1_INFECTION_UP,-0.0608474379114818,-0.0250841491308437,-0.035485247319704,0.1327390850122,-0.579763877172944
AKL_HTLV1_INFECTION_DN,-0.172050870249056,0.0268525077442827,0.300844334066467,-0.538322489026792,0.0263379833537255
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,-0.0811806262654694,0.248584680115465,0.0361828929959931,-0.313560497144355,-0.154988134132551
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.0608777685018244,-0.00760006079211425,0.029513902575474,-0.433296885369212,-0.156989498403423
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,-0.0110421363984866,0.0479305893426916,0.0238351926310051,-0.36744951093034,-0.111821036333486
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,-0.303965817290132,0.227336301272626,0.197177473800655,-0.337703225322441,-0.0555422833498774
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,0.0285346475146398,0.297625463009774,0.210076704647792,-0.561113605020719,-0.14279360977712
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,-0.314494594968083,-0.127572053132115,0.316522935868187,-0.321033328085998,0.134836122116223
MULLIGHAN_MLL_SIGNATURE_1_UP,-0.0747853365210016,0.127277027541666,-0.0715230161082174,-0.249794314560681,-0.155307778611238
MULLIGHAN_MLL_SIGNATURE_1_DN,-0.220310684239272,0.0935626699450473,0.223541900809611,-0.267184812238461,-0.144884680189732
MULLIGHAN_MLL_SIGNATURE_2_UP,-0.0209038127628637,0.153102897163191,-0.0391554132632874,-0.301595537896996,-0.223374520615399
MULLIGHAN_MLL_SIGNATURE_2_DN,-0.0755775794034297,0.121342060242496,0.223460773411867,-0.289083434212229,-0.208056585064493
MULLIGHAN_NPM1_SIGNATURE_3_UP,-0.0598899286675896,0.0805597491219823,0.0360530380393361,-0.307553562897157,-0.188261884287997
MULLIGHAN_NPM1_SIGNATURE_3_DN,-0.275532177654929,0.15754539830155,0.175184357461918,-0.24822552301484,-0.112363034572963
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,-0.400226105464818,0.102032499676162,0.151304071362741,0.203682411734612,-0.198933965799652
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,-0.0504240204914269,-0.156125422514538,0.207831502607364,-0.118252313090626,-0.125427025082939
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,-0.106325595706403,0.163355464678107,-0.0173458462233523,-0.0822035786881209,-0.151929889897287
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,-0.100051190173701,-0.0214833198877837,-0.0146382121148966,-0.0995896753325312,-0.239794523366946
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,-0.0900852714858516,-0.205604050553127,0.339754199276957,-0.131440731045462,-0.376443785105476
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,-0.0921518207285967,0.239175711808825,0.00709668173760294,-0.265051648306312,-0.36882329620191
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,0.0147880596757179,0.205913293030943,-0.177103210662013,-0.356376178077995,0.155781108479864
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,-0.0642542184966672,0.057206808536327,-0.0162353053413797,-0.129283429684158,-0.170512256945899
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,-0.376102412938753,-0.118829760896767,0.124296214118695,0.0124051475421763,-0.115872059842184
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,-0.167584209524378,-0.119697316174881,0.143547133889726,-0.137281010323299,-0.140441440247338
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,0.134473176440427,0.185680016246746,-0.236907523769337,-0.130661025970667,-0.165474037496064
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,-0.540338212586518,-0.215752131929598,0.0599433233597505,0.0707575596773345,0.0356031709003869
DITTMER_PTHLH_TARGETS_UP,-0.0707841428247701,-0.167582757249343,0.0605180762976747,-0.0361116817254194,-0.37723625554106
DITTMER_PTHLH_TARGETS_DN,-0.21947634571532,0.0215741427487843,-0.0335596277712652,0.0219167783349732,-0.335162576250506
UDAYAKUMAR_MED1_TARGETS_UP,-0.0253490548722099,-0.426890499315708,0.140461452163021,-0.252213809459594,-0.0362086202479675
UDAYAKUMAR_MED1_TARGETS_DN,-0.101437029141557,0.0774044405063734,-0.171193915228938,-0.0179640959722782,-0.352907294875501
ODONNELL_TFRC_TARGETS_UP,-0.0533041919143137,0.212215214770142,0.107175086544449,-0.261901404828852,-0.214253770620009
ODONNELL_TFRC_TARGETS_DN,-0.0746708771220339,0.256780713412299,0.270275403524168,-0.525259130629457,-0.133955815692132
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,0.139321561035692,0.0811709214749717,0.176695044828373,-0.28757669987493,-0.135634968841536
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,0.0906744758162575,0.326307971545281,0.119298127105371,-0.662489087265848,-0.203530715499117
SENESE_HDAC1_TARGETS_UP,-0.0958653979414181,0.218707538112823,0.0333245084659369,-0.358353413250098,-0.223359309441909
SENESE_HDAC1_TARGETS_DN,-0.127376560844572,-0.0619432618852331,-0.0408917621126485,-0.0148914899583162,-0.185617070819999
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,-0.155083459867454,0.309433676516328,0.0309024096528949,-0.267684003718755,-0.285303106905607
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,-0.0484410254208965,-0.228725955943129,-0.0695852156609275,-0.00912311664210702,-0.120962094927567
SENESE_HDAC2_TARGETS_UP,-0.246127325065187,0.304255358897893,0.0805531755182142,-0.424468823001484,-0.267583700078008
SENESE_HDAC2_TARGETS_DN,-0.0954586774566347,-0.216899612015226,-0.203770124497379,0.124270764353666,0.00762411427589652
SENESE_HDAC3_TARGETS_UP,-0.153718233316104,0.0355628886325678,0.0803586619595936,-0.314089996554473,-0.00702155863632672
SENESE_HDAC3_TARGETS_DN,0.0368083227651834,0.0381263239219613,0.0558855156381313,-0.246658527956614,-0.226944996088486
LEE_NEURAL_CREST_STEM_CELL_UP,-0.370797777552247,-0.10666872542529,0.15892171861602,-0.0505490252419594,0.036430567967368
LEE_NEURAL_CREST_STEM_CELL_DN,-0.107737814562896,0.0416687557912516,-0.0469742238505191,-0.246806909886153,0.13770916859054
HUMMEL_BURKITTS_LYMPHOMA_UP,0.158456131635949,-0.185619707690653,0.000993168748066153,-0.323564159664095,0.0599262889486447
TIEN_INTESTINE_PROBIOTICS_2HR_UP,-0.190577537080623,0.429031253738987,0.428770767028329,-0.487319168799605,-0.547076580048911
TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.126549959331668,0.136714955931917,-0.091258565287318,-0.225469640447573,-0.415884874535584
TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.201646808567622,-0.0316606041949789,0.35351520758718,-0.460929377816462,-0.329369168190863
TIEN_INTESTINE_PROBIOTICS_6HR_DN,-0.0280113300927602,-0.0247753557675039,0.0451271373969905,-0.196624569765117,-0.288840485320086
TIEN_INTESTINE_PROBIOTICS_24HR_UP,0.0338673968348747,0.0674999607627454,0.0147288634838545,-0.357197895500358,-0.282675137363008
TIEN_INTESTINE_PROBIOTICS_24HR_DN,0.127681291223421,0.0786825527227744,-0.0270863575772084,-0.428495625951909,-0.22462811697113
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,-0.171379599512954,0.153749588025844,0.230133461115527,-0.332369359256967,-0.145801054442984
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,-0.241457619239418,0.201350021026636,0.10602870602753,-0.389162992240085,-0.0251154437258227
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,-0.119517823657313,0.254266676862702,0.192116016556232,-0.277555635755888,-0.210012879805471
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,-0.160315334177043,-0.00650724796417171,-0.0480918143510178,0.0134426569778004,-0.278820149486651
SABATES_COLORECTAL_ADENOMA_SIZE_UP,-0.267039828122059,0.0266799661058333,-0.284576866415651,-0.181262870655307,0.163525347247549
SABATES_COLORECTAL_ADENOMA_UP,0.0363643652789549,0.237551842567438,0.176528335799107,-0.325179423848028,-0.27291183770175
SABATES_COLORECTAL_ADENOMA_DN,-0.191232122265161,0.0698052136772432,0.29939487128188,-0.315150330252842,-0.0274479830262404
SCIBETTA_KDM5B_TARGETS_DN,0.286286650474801,-0.114588886265795,-0.0102788611198786,-0.362358224229666,-0.252436311187757
NAGASHIMA_NRG1_SIGNALING_UP,-0.348938037292771,0.444228563533658,-0.236168531093347,-0.00863636455839148,-0.407652145971085
NAGASHIMA_NRG1_SIGNALING_DN,-0.327503235311888,-0.102701207882651,0.398503435225708,-0.0210239302046324,-0.242568101557496
NAGASHIMA_EGF_SIGNALING_UP,-0.413976333116141,0.531778091742391,-0.182433807475875,0.230002427326723,-0.58469542049362
KIM_WT1_TARGETS_UP,-0.356017011405088,0.339628190446308,-0.11883589368524,0.0533883084330588,-0.348658334110815
KIM_WT1_TARGETS_DN,0.0226948632609639,0.0399547771151334,0.126692392407886,-0.391263433874242,-0.322079132780422
KIM_WT1_TARGETS_8HR_UP,-0.311689502940034,0.266667017366608,-0.0763847139270727,-0.0423832265657189,-0.239608175715866
KIM_WT1_TARGETS_8HR_DN,-0.0206084490655574,0.0468947871389094,-0.0481238044829297,-0.0773144547536573,-0.32947672603749
KIM_WT1_TARGETS_12HR_UP,-0.263548185214543,0.0709995487935885,-0.0877904452339347,-0.0321177318445178,-0.179450795435473
KIM_WT1_TARGETS_12HR_DN,-0.0725459422342576,0.303954226906577,-0.206515450281794,0.0149260208548486,-0.443605812257121
ELVIDGE_HYPOXIA_UP,0.0125935814164237,0.279551425208022,-0.136613338728047,-0.0956629470275737,-0.455069237277339
ELVIDGE_HYPOXIA_DN,-0.198372387338816,0.0691331245969621,0.0914584738445832,-0.390889765190662,-0.223691430870027
ELVIDGE_HYPOXIA_BY_DMOG_UP,-0.0158340398013198,0.231147230311047,-0.122854707696012,-0.130068156376612,-0.385996457557484
ELVIDGE_HYPOXIA_BY_DMOG_DN,-0.0979188798769848,0.327175703552152,-0.0217203998031577,-0.443037816622028,-0.250024475210089
ELVIDGE_HIF1A_TARGETS_UP,-0.118348934703587,0.0166981574065888,-0.0418273818078096,-0.349085359509591,-0.141517563078372
ELVIDGE_HIF1A_TARGETS_DN,-0.15034367704634,0.32235298937544,-0.135289803841032,-0.0154801725826335,-0.455093289080341
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,-0.0636063179753452,0.202576953380277,-0.147815404166137,-0.158486551898018,-0.400454569825166
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,0.0155676121371612,0.170926999505634,-0.110576524888422,-0.0052912814454967,-0.502527227911921
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,-0.0658585924811223,-0.00879360096502335,0.231464384430885,-0.445483245231014,-0.0739285991165299
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,-0.0659665078740928,0.0315270393470844,0.186870804083845,-0.22039254235422,-0.036540217240904
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,-0.457079628828842,-0.0124863717879384,-0.105607045616601,0.0827029545503248,0.118090279928677
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,0.318820472928573,-0.107733974315498,0.0755452827892559,0.0433125940172909,-0.184530113017498
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,0.139827452769474,-0.0955808268098128,0.442627896647133,-0.485874854816585,0.135396275119507
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,-0.00889348998169415,0.203831405682701,-0.113470298892086,-0.295310014434493,-0.0118050652965595
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,-0.274469882812525,-0.0940726589316013,0.28932443979747,-0.387898822654514,0.321935325662205
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.137660077302503,0.243015109465045,0.0310374760712115,-0.268227879754065,-0.00569321433190251
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,0.0252352959508912,0.277624175640316,0.15616244912174,-0.420172161321866,-0.328811994396619
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,-0.287901670174945,0.0133915393640561,0.282101289085151,-0.299961678243289,0.176500288194168
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,-0.301071745469198,0.274389313185029,0.208036606263487,-0.325532216392049,-0.0565252619395255
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.00464282763157114,0.296985560191213,0.0457985927653522,-0.525706220857155,-0.20726360104216
BIDUS_METASTASIS_UP,0.173285319832151,-0.0820144623096773,0.230526551649953,-0.548732851181166,-0.208954776931409
BIDUS_METASTASIS_DN,-0.204494922550636,0.243952344080684,-0.0435207763032337,-0.0301738332789064,-0.302629370046427
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,-0.0166753475258163,0.220933475981613,0.0431467382921931,-0.307004804170688,-0.27495984050048
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,-0.185988907354831,-0.253234166836151,0.206907648689166,-0.21063122964054,-0.0576251659598743
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.131718746802139,0.0295673792324152,0.253383228990675,-0.404934760129222,-0.251149210978388
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,-0.0542427711049528,-0.00870490067942653,0.237297506336968,-0.360897145366029,-0.136634945077941
MAYBURD_RESPONSE_TO_L663536_UP,0.240055626103781,0.0635406276902445,0.0130067461972843,-0.38129748596685,-0.411957367612994
MAYBURD_RESPONSE_TO_L663536_DN,0.274358045391102,-0.22564327931682,-0.0322877227825864,-0.518219888675984,0.173077251866895
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,0.26416473591831,-0.394736904181071,0.339243703696241,-0.507720249098686,-0.230732210451757
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,0.11833188360185,0.0673743844507866,0.00174147071950312,-0.435130735489502,-0.248478005912535
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,-0.163669146413902,0.0141134456713885,0.0527867920503497,-0.329626415490664,-0.0636061396628603
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,0.085106655424612,0.0963999771583607,0.0910157346044986,-0.400004377269479,-0.281844261814482
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,-0.130985742384175,-0.154535523724776,0.126636924401685,-0.346335616682864,0.0483194252800811
RODRIGUES_THYROID_CARCINOMA_UP,-0.276499693139832,0.186541343365648,0.421207854080397,-0.448294780916653,-0.189017849059686
RODRIGUES_THYROID_CARCINOMA_DN,-0.279154113973306,0.21402834821047,0.00249427845570568,-0.0578075129830134,-0.373823350664606
GOZGIT_ESR1_TARGETS_UP,0.0270936234600034,0.134910652357357,0.00492513827832713,-0.18428503223948,-0.23709359058897
GOZGIT_ESR1_TARGETS_DN,-0.198696150375577,0.133985369542157,0.111200265608562,-0.274834387356538,-0.0894983416044273
HAHTOLA_SEZARY_SYNDROM_UP,0.146044215860087,0.042996956934316,0.0425706735760684,-0.271676729918717,-0.157356354551715
HAHTOLA_SEZARY_SYNDROM_DN,-0.109376122066299,-0.0351395464661348,0.467678579254186,-0.16936062532912,-0.265298617413965
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,-0.144407295487795,-0.12575676339778,0.166395140861027,-0.201986907360748,-0.166355263860806
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,-0.0425253293425597,-0.0887805017506449,0.162132035763953,-0.367007833323847,-0.189554483496959
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,-0.119690171856738,0.334881909784561,-0.0829837021802647,-0.235874534055389,-0.366848604852593
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,0.0597878818764471,-0.169316328453511,0.313520472609846,-0.440526976241376,-0.121337986891616
PROVENZANI_METASTASIS_UP,0.0483068480373495,0.0373039675771185,0.0375836737153746,-0.21030104278627,-0.127003149607813
PROVENZANI_METASTASIS_DN,-0.0658324684012558,0.100722018888935,-0.05281301706254,0.00101530655592558,-0.443494064390269
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,0.167300084889743,0.110015037737703,0.186978856887651,-0.473751114814822,-0.14694234880584
LIU_CDX2_TARGETS_UP,-0.157654609938591,0.0862910302372362,0.162970164688202,-0.333137823548822,0.0289664953684507
COLDREN_GEFITINIB_RESISTANCE_UP,-0.206076855495043,0.210703921265974,0.115772001338569,-0.215779218039143,-0.488445410937641
COLDREN_GEFITINIB_RESISTANCE_DN,-0.162632731699338,0.177481044970117,0.0789749710550999,-0.426752637791916,0.0233873275900476
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,-0.0290531888706818,-0.0283259383402545,-0.196606908547264,-0.0815423208482246,-0.229679023638609
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,-0.025520202341652,0.129544361646374,-0.130452012331737,-0.230275776018074,-0.262554193517727
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,-0.0722947210635426,-0.229191475221627,-0.192680553054897,0.0419094654546734,-0.167372331472344
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.0382476560311608,0.400423112363318,-0.180043995825758,-0.386165979335385,-0.380714654556207
CHOW_RASSF1_TARGETS_UP,0.12191971824374,-0.406028226486345,0.566467027402563,-0.221589579805796,-0.226634518422805
ENK_UV_RESPONSE_EPIDERMIS_UP,-0.174316662492611,0.357216007993015,-0.00390997986316477,-0.230993968003326,-0.359970797733364
ENK_UV_RESPONSE_EPIDERMIS_DN,-0.159147394626644,0.108929432122391,0.0902267570711158,-0.239886678923923,-0.209532234995818
ENK_UV_RESPONSE_KERATINOCYTE_UP,-0.0868257652961037,0.207660925421908,-0.129940781557133,-2.34690046629349e-05,-0.380096189229362
ENK_UV_RESPONSE_KERATINOCYTE_DN,-0.0928688175512915,-0.0159170388703983,0.0138755496499779,-0.363401020101071,-0.095572152656195
LANDIS_BREAST_CANCER_PROGRESSION_UP,0.343631850934179,-0.0204234126669576,-0.138846084309101,-0.419039704783416,-0.318043623121417
LANDIS_BREAST_CANCER_PROGRESSION_DN,-0.216897744249163,-0.286147021587915,0.181974576700359,0.0431914891564783,-0.262854795581525
GESERICK_TERT_TARGETS_DN,0.0406471530298073,0.155241681060236,-0.486255443337026,0.168495191008201,-0.160284665361703
LAU_APOPTOSIS_CDKN2A_UP,0.221124287095921,0.157744178513782,-0.281700463146939,-0.166190480417087,-0.399509640107215
DELYS_THYROID_CANCER_UP,-0.101202066482793,0.227580760205344,-0.0334624970788333,-0.101876071642947,-0.195367674626184
DELYS_THYROID_CANCER_DN,-0.266020792259422,-0.0282923706061952,0.244193417244528,-0.3658095276116,0.075332238842517
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,0.0510094692588607,0.154412535978223,-0.211468629678313,0.017977645031742,-0.355555948049724
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,-0.280005165907596,0.325316877750628,-0.0656322964580223,0.0787017128901987,-0.338758654291785
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,-0.13459260051822,-0.0175967020318357,-0.151689227498077,-0.182563200782305,0.0468145913701801
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,-0.0649035340856296,-0.357840804534185,-0.128328328904918,0.302499998698207,-0.276706329324633
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,-0.00942655878592427,-0.156856728624827,-0.167638648667333,-0.143991327277789,0.0954061561960967
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,-0.121320447641856,0.0304510998796983,-0.210747174817633,0.0812401455470865,-0.170681704696487
CASTELLANO_NRAS_TARGETS_UP,-0.155322211288158,-0.296329624342895,-0.166564717431337,0.0883991771747546,-0.0556130056276653
CHEBOTAEV_GR_TARGETS_UP,-0.21953222974985,-0.159987283484152,0.113231452940397,-0.194014918085217,-0.00999779142424415
CHEBOTAEV_GR_TARGETS_DN,-0.0880904996620755,-0.0531816808654693,0.264972087207569,-0.228362599299948,-0.162571016271791
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,0.0125440367748855,0.22336365838903,-0.0974569621832064,-0.0287113105986684,-0.33332889885329
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,-0.280105638150922,0.0424700722061568,-0.199467997305969,0.204747980949363,-0.377405900617945
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,-0.124614768722922,0.201933739689848,-0.0475982522683132,0.358838563853808,-0.570467448030639
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,0.282469218573066,-0.306830778007895,0.23445813895519,-0.495951391868994,-0.202377910681385
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,-0.227736642230394,0.0996947999838617,0.0578812328436884,-0.243516022012492,-0.0912682611974029
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,0.0627501491000759,0.0561322419610108,0.177598280045063,-0.445759974261747,-0.227917139282233
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,0.115848040522027,-0.00772017778254083,0.0881678530924488,-0.393610572083457,-0.235366105566799
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,-0.134625172140828,0.034816752955571,0.148907250503039,-0.251054259764683,-0.1573378841035
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,-0.359019009548695,-0.0390371898467246,-0.238713893935968,0.276794125721862,-0.279767333746997
NADERI_BREAST_CANCER_PROGNOSIS_UP,0.167189397035393,0.123752561993197,0.269453467024341,-0.542118136859007,-0.21833742988269
NADERI_BREAST_CANCER_PROGNOSIS_DN,-0.233147583692553,0.270302350949708,-0.141353651806028,0.114934175889553,-0.384488943826467
MARKEY_RB1_CHRONIC_LOF_UP,-0.121101687363566,0.280854785847491,0.109656306226051,-0.344093218446781,-0.213217381911465
MARKEY_RB1_CHRONIC_LOF_DN,0.0374731039949493,-0.139679761335944,0.0714525652616646,0.025055125895242,-0.0565477560976841
MARKEY_RB1_ACUTE_LOF_UP,0.0482630863129067,0.0193771527652729,-0.0141103576129715,-0.28748930592469,-0.146946182267369
MARKEY_RB1_ACUTE_LOF_DN,0.00440248460825129,0.199634141689627,0.0650959008756188,-0.145846609674383,-0.212165418907353
CHIN_BREAST_CANCER_COPY_NUMBER_UP,-0.0521721494484592,0.142202175690778,-0.198784902208181,-0.036852360931504,-0.247994815429864
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,-0.0915243778260595,0.108908089876115,0.0192896092792558,-0.168319512089663,-0.287318958051785
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,0.0146404615505536,0.126518084551547,-0.00789130551788234,-0.236189305155081,-0.266286430060806
VANHARANTA_UTERINE_FIBROID_UP,-0.537173750845392,-0.136244996750619,-0.139082575679576,0.23909884374237,0.0815270670053612
VANHARANTA_UTERINE_FIBROID_DN,-0.280761239073324,0.333551205984339,0.0907095216989519,-0.11801569794218,-0.273221193113055
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,0.25283863856968,-0.143222385792329,-0.0250170139989278,-0.256570673260516,-0.478141454314832
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,-0.31688673110469,-0.378555168414282,0.474726882472193,-0.521272612374514,0.374149856073634
LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.108503548092094,-0.095029510527196,-0.0282579344594134,-0.310927283714831,-0.0353854949485282
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,0.212530498564627,-0.290945500579075,-0.43315634135272,-0.119585397241988,0.130990794327211
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,0.0782304932052287,-0.148748587851017,0.280856710902794,-0.542661752222813,-0.134988681228036
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,-0.0844097177616884,0.123943296980457,0.0359378906639873,-0.255885161268025,-0.21886467908013
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,-0.181495878567569,0.107639261389646,-0.0618278309208091,-0.169385068230677,-0.160933975532763
ODONNELL_METASTASIS_UP,-0.302715265064151,0.152177615894282,0.405872310531253,-0.462476583181998,-0.0602495601019828
ODONNELL_METASTASIS_DN,-0.249391511364834,0.276639363879924,0.234948971882662,-0.417154636929845,0.116876297214109
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,-0.0693974482593014,0.00382558716469172,-0.000983518475528106,-0.0271195365212606,-0.293741641799401
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,0.0228847155631386,0.159930175897329,-0.00248995478468672,-0.147293425284365,-0.350285833964162
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,-0.00924066589875244,0.167773294195667,0.00943077711118556,-0.265930025856276,-0.311887401359885
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,-0.097952504213191,0.106645531931467,-0.0393474280212661,-0.375659204140168,-0.122873286186449
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.00235214834960937,0.155995222364384,-0.100990149444157,-0.363967962456345,-0.0154572320016261
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,-0.0999860983259689,-0.308417320374976,-0.0387026611463851,-0.130892390167754,0.178712437669517
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,-0.10554268100418,-0.054238139946034,0.5596007764438,-0.398828455568489,-0.400857141214893
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,-0.240454636350255,-0.0496650383096838,0.0731521670253037,-0.250972666643931,-0.103645950579796
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,-0.172793785333207,-0.0236439166869341,0.277123927312287,-0.233592058208848,-0.00788719999940918
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,-0.238181103958013,-0.176863887926958,0.0369524887024042,-0.0277265623260316,-0.101699109544155
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,-0.274450048102616,0.0420762762575958,-0.145819731425079,0.214220617028529,-0.236684783601665
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,-0.0842067167708254,0.145611043853309,-0.0804289992679382,-0.281124901073372,-0.0416879582665061
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,0.0141197113572031,0.263330604373228,0.248028703040436,-0.350614837100937,-0.356877139114531
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,-0.198686360430644,0.118993295737649,0.182659920488173,-0.354491136133926,0.00756621078331057
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,-0.292266623113998,0.466425296091217,0.0141736958736592,-0.237060828784302,-0.39538122082308
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,-0.328606408780072,0.0237656492308961,0.440847073082178,-0.0606610622463665,-0.412226092625489
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,-0.0208171561824456,0.521110169617497,0.153035658256179,-0.264665684372625,-0.496194691263355
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,-0.321254815009533,0.265193550781956,-0.0129900428892121,-0.0682404598109635,-0.297813688586862
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.420990727335028,-0.116130009360993,0.158879573515561,-0.488015245473968,-0.336205879711829
LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.165054924753584,-0.182627665682896,-0.232365375244952,-0.163042855364281,-0.0307630706037916
LANDIS_ERBB2_BREAST_TUMORS_324_DN,0.014701879781464,-0.0802723254684516,-0.00948764988909198,-0.0740135438835008,-0.243499005826536
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,-0.24120083868433,0.404343538923949,0.404762452192727,-0.377587367945384,-0.251189957899008
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,0.158696322221366,0.266877247230092,-0.13799256978938,-0.161663096094726,-0.630871907420416
BARIS_THYROID_CANCER_DN,0.211590121772677,-0.0044802439066243,-0.157514496601162,-0.0833949530928914,-0.334438173367317
BERENJENO_TRANSFORMED_BY_RHOA_UP,-0.0310636201167995,0.25340848363437,-0.146012574529779,-0.299503436508931,-0.300946276198756
BERENJENO_TRANSFORMED_BY_RHOA_DN,-0.187238689602922,-0.17541338521599,-0.110946935191485,0.00299271668838508,-0.103887291743499
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,-0.275502075972088,0.173877676883391,0.31592813363954,-0.473582308516604,-0.0506478890309156
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,-0.142529846946658,-0.0874162151992766,0.320129252391725,0.0187468951804991,0.118199565974797
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,-0.32879260569232,0.403088115494281,0.414780217272569,-0.456710161824076,-0.0271903380912696
KERLEY_RESPONSE_TO_CISPLATIN_UP,-0.0106314504197605,-0.254406527811665,-0.365051900324275,0.200088296609453,-0.0933192368075491
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.0558907460937422,-0.0219679295896119,-0.167524943753295,-0.0372149225070501,-0.190492416489467
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,0.18292996349963,0.234548993966747,0.0206353972455359,-0.512937618911546,-0.407769481838088
TANG_SENESCENCE_TP53_TARGETS_UP,-0.28402144456612,0.233816189072415,-0.193307204950251,-0.209458517417264,-0.018876575141073
TANG_SENESCENCE_TP53_TARGETS_DN,-0.318529845834344,0.321556797856963,0.232870105776713,-0.340201988945386,-0.269514125269426
WANG_BARRETTS_ESOPHAGUS_UP,0.0759052115056451,0.0433237633873487,0.0962190338658912,-0.254576698316124,-0.161124616123345
WANG_BARRETTS_ESOPHAGUS_DN,-0.0173952352084759,0.277834195379166,-0.0303611915052235,-0.204442360804271,-0.224072564718125
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,-0.191964802750326,-0.012356945023333,0.162221777154707,0.0321632858934551,-0.385959205307011
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,0.00323990628123874,0.183198885173075,0.0615830199868961,-0.165608514735627,-0.528489545820987
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,0.380543018814938,0.159636011897946,-0.028871225457439,-0.467596228051562,-0.296952096765736
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,0.0688240574800223,0.106679663309949,0.202036091036947,-0.366948805870712,-0.392394504424847
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,-0.0746102573621424,-0.2122289707436,-0.218571911487475,0.303494665646262,-0.264744781652708
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,-0.332614076248979,0.181130765446933,-0.0797364582091458,-0.21627901504703,-0.0682392409184749
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,-0.0756189294948862,0.19718070937407,-0.0738882254854732,-0.216019753458739,-0.179569984488217
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,-0.245252905966966,-0.193588402978347,0.290165620859214,-0.215943144136018,0.0637575215505479
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,-0.15056331158231,0.123709128947251,-0.0209815838910634,-0.182688728232204,-0.114873681385611
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,-0.144033970558005,0.0320625439725681,0.0336884724643268,-0.17481304640982,-0.186338698379141
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,-0.0570225827609089,0.181196374399432,0.155909733710762,-0.124989094007006,-0.39834779231955
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,-0.342094975543905,-0.0835165628163085,0.0409914064806264,-0.0147742254311253,-0.0764961871055857
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,-0.168292569782997,0.00184672976532924,0.0454389677093452,-0.0654806431736035,-0.152968452497803
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,-0.269149579385352,0.0387169744229735,0.0112438194509377,-0.150314413203167,0.0374913029230616
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,0.0550048298434546,-0.0385169643811202,-0.0311336766839746,0.0727625930230503,-0.208384138006363
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,-0.435509888031618,-0.375525938225831,0.215485933865776,0.133880376417459,0.0486841822189923
LUI_THYROID_CANCER_PAX8_PPARG_UP,-0.387424556982413,0.295484068592865,0.0158192453048964,-0.0283928308175637,-0.303974124321074
LUI_THYROID_CANCER_PAX8_PPARG_DN,-0.259438630624949,0.282912590426204,0.210945995830781,0.0514507593121375,-0.574817242100575
HAMAI_APOPTOSIS_VIA_TRAIL_UP,-0.121973412061787,0.0383152221488943,0.233707929263439,-0.445132863357232,-0.124597004718991
HAMAI_APOPTOSIS_VIA_TRAIL_DN,-0.114603163197037,0.184028015917641,0.0117542742947068,0.0989521202865226,-0.409696407629859
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.364183886189391,0.0588370818931316,-0.378338777525012,-0.316138333743955,-0.420084778810817
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,-0.415309887373932,0.29018623425759,0.280334638008146,-0.330856716681986,-0.151505299475459
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,-0.144402507187476,0.0524736470314127,-0.26681102386303,0.121897311827649,-0.365881729998806
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,-0.264510040617936,-0.0308075475530079,0.336543740473137,-0.192708749081146,-0.328684853501476
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,-0.370714956065651,0.106058918649587,0.0466180131002729,0.258967051657794,-0.227574203866587
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.129850310576111,-0.343669985937364,-0.271717853252635,0.168224228310262,0.1595032608431
LUCAS_HNF4A_TARGETS_UP,-0.153714027281062,-0.0671621777988679,0.258247517065954,-0.248536066888612,-0.121201721662557
ZIRN_TRETINOIN_RESPONSE_UP,0.138844811203246,-0.488685820141421,-0.263145917876987,0.511941266141857,-0.2948084732378
STREICHER_LSM1_TARGETS_UP,-0.200096507889192,0.161998421126849,0.0788144295300908,-0.209102156001658,-0.197979247664734
STREICHER_LSM1_TARGETS_DN,0.399150699904491,0.417785288381168,-0.394330441503159,-0.290762363504531,-0.204575902476901
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.0422276628948041,-0.0931618514425864,0.0398189075161533,0.0271327805914265,-0.371525167366183
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.467233155733555,-0.0998704632621942,-0.491066573617706,0.139819141446658,-0.189562025026143
DARWICHE_SKIN_TUMOR_PROMOTER_UP,-0.00329814586168778,0.0749325522067122,0.112472246937551,-0.255244359291968,-0.170512268690107
DARWICHE_SKIN_TUMOR_PROMOTER_DN,-0.0527561018123291,-0.0157514697476145,0.207183648086161,-0.363288930853404,0.0535667978485019
DARWICHE_PAPILLOMA_RISK_LOW_UP,0.222976809820697,-0.0782357972593213,0.338382606581796,-0.427589593434824,-0.0936640732843113
DARWICHE_PAPILLOMA_RISK_LOW_DN,-0.239746598851476,0.086971781030672,0.0671043152949295,-0.161789089651327,0.00438374787873302
DARWICHE_PAPILLOMA_RISK_HIGH_UP,0.218277773566438,-0.056475713940871,0.279668003177152,-0.439820631838522,-0.100974325307704
DARWICHE_PAPILLOMA_RISK_HIGH_DN,-0.230514268909054,0.0721260927414027,0.107211203293732,-0.175519209876153,0.00516314832223019
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.0217370258471105,-0.0263712680994187,0.147071729617447,-0.381162422339832,-0.0919622104753306
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,-0.111448396027941,0.0852436372673061,0.176202285356586,-0.241488849727035,-0.00860475431085456
MAHADEVAN_IMATINIB_RESISTANCE_UP,-0.144933872676406,-0.0998138295131273,0.289854479113134,-0.0147323220256277,-0.407448799769612
MAHADEVAN_IMATINIB_RESISTANCE_DN,-0.281540409281168,0.319760582298776,0.113611377029384,-0.156207221960205,-0.410018939926761
TOMIDA_METASTASIS_UP,0.500120289664601,0.251085104833763,-0.049978761332389,-0.550237989261349,-0.442151304131424
HWANG_PROSTATE_CANCER_MARKERS,0.0741280426379066,0.520608106643663,-0.225482050273317,-0.194373373524793,-0.258928137024527
HU_ANGIOGENESIS_UP,0.0448224905445954,-0.216547667097327,-0.0103015234831302,-0.02758646613336,-0.170455066418371
HU_ANGIOGENESIS_DN,0.185213394858437,0.11587938303072,0.54834604006289,-0.548092457364087,-0.567860712855829
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,-0.322926250123869,-0.24937091280339,0.244235331924641,-0.346064309245845,0.262197006550903
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,-0.0335928296810887,0.13879928179667,-0.0901529869762276,-0.0135291225618981,-0.585216114792615
DARWICHE_PAPILLOMA_PROGRESSION_RISK,-0.357823340748669,0.2126765871909,0.418096246902233,-0.429117422325402,-0.0744384123444183
OLSSON_E2F3_TARGETS_UP,-0.179564997411547,0.379851522907147,0.0968414190014438,-0.196733482025035,-0.476748951343377
OLSSON_E2F3_TARGETS_DN,0.392797405657457,0.112051828896975,-0.454319528691938,0.00325404730571788,-0.465010064994143
MARKS_HDAC_TARGETS_UP,0.35070440074133,0.163133281063956,-0.488108225617906,-0.286742545883133,-0.2268311875293
CHOI_ATL_STAGE_PREDICTOR,-0.0776977604575784,-0.0374526891402203,0.230712978494183,-0.340100681362429,-0.191149978333058
WONG_ENDMETRIUM_CANCER_UP,-0.0435806494350714,0.377751021501769,0.156432079632501,-0.329100864662201,-0.127732128812331
WONG_ENDMETRIUM_CANCER_DN,-0.374717773607537,-0.0131139595274616,0.307058198137564,-0.000176140628728949,-0.152965734994825
KONG_E2F3_TARGETS,0.192908623137106,0.292377263055403,0.0176726172994062,-0.448022473456825,-0.488341831257005
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,-0.311488434783361,0.137622090542568,0.246560586432506,-0.374176588776769,0.0548245122097534
RIZ_ERYTHROID_DIFFERENTIATION,0.0646574805643145,0.484679909356209,-0.297047081826708,-0.33892680204163,-0.536734049957538
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,-0.114755527618604,0.213311675546027,-0.166001859189172,0.0364501979541993,-0.419590671526343
RIZ_ERYTHROID_DIFFERENTIATION_HBZ,-0.174258180802249,0.275361826517186,0.130195860178659,-0.319897828024337,-0.260499497077313
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,-0.0340124146362697,0.262818823511428,0.325627518565886,-0.473290278517099,-0.476440524270394
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,-0.191005204426129,0.0732235838297123,0.102484450106748,-0.333447291059886,-0.134125614026442
MUELLER_METHYLATED_IN_GLIOBLASTOMA,0.0265620290147523,0.440219092029098,-0.0553063079115865,-0.405785661787435,-0.295278980480003
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,-0.108484704051973,-0.00814300052207562,0.0136115126106801,-0.153538032407907,0.014828875267149
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,-0.500112890256535,-0.420341149595145,0.492159635982983,0.0333210726255873,0.137298952429854
RIZ_ERYTHROID_DIFFERENTIATION_6HR,-0.481907250991225,0.59018221287459,0.178621185249869,-0.182535142114897,-0.230493844150214
RIZ_ERYTHROID_DIFFERENTIATION_12HR,-0.412997091371467,-0.251893672077299,0.236926096900617,0.0384516784632798,0.258201708425723
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,-0.297480004259996,0.236499459634387,0.162027909696155,-0.167809075871348,-0.181128482156739
PEREZ_TP63_TARGETS,-0.24096412826418,0.0450416322204511,0.14060072655442,-0.237615813293737,-0.00471003233353795
PEREZ_TP53_AND_TP63_TARGETS,-0.267022379014527,-0.0463869791369255,0.109173578442519,-0.257995077171508,0.121608791579125
WAKASUGI_HAVE_ZNF143_BINDING_SITES,-0.0848917534967986,0.27200742171843,0.148135992883285,-0.571188367009342,-0.276253615086816
RODRIGUES_NTN1_AND_DCC_TARGETS,-0.124650692183156,0.053319495331728,0.16361907689281,-0.121482235033939,-0.324524663514923
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.112135909384252,-0.133067058923668,-0.187769341219848,-0.130440347959656,-0.0709811039678516
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,-0.34043255376138,0.0268620281839126,0.310961785719337,-0.386776993627675,-0.0134325232830197
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,-0.35185892885949,0.212654883802155,-0.31676897129975,0.372866825707763,-0.418512701877479
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,-0.284328605601118,-0.151631391064047,0.084239559109514,-0.168273777087741,0.207234285115198
APPIERTO_RESPONSE_TO_FENRETINIDE_UP,-0.0340049588344536,0.356506898618484,-0.162189671880166,-0.254400552422425,-0.485509318308876
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,0.402218984510872,0.390828703813351,0.007391468974113,-0.596884548716733,-0.550052129430732
AUNG_GASTRIC_CANCER,-0.294787209890568,0.416322706477091,0.0670446588650239,-0.345840276333474,-0.190226944651102
SANCHEZ_MDM2_TARGETS,-0.410101039892533,0.316346442646662,-0.632775553873587,0.536433405028952,-0.227786123865474
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,-0.197215469466788,-0.00665030927629351,-0.194015765857074,0.0363877337280238,0.0437718634816115
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.0066663145900466,0.117065493766554,0.470540133066429,-0.365038861114263,-0.375337700341653
DUTTA_APOPTOSIS_VIA_NFKB,0.0755343756759896,0.392090480378452,-0.295160559037665,-0.044112854122921,-0.0258716259602986
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.134385400567141,0.491467385326932,0.317268560134057,-0.241097048573612,-0.394824508071711
ROVERSI_GLIOMA_COPY_NUMBER_DN,0.018178640344387,-0.0283271431138584,0.339293010931711,-0.296323504528801,-0.247215745458659
SEIDEN_ONCOGENESIS_BY_MET,0.168591972528015,-0.387876419077364,0.137983656882465,-0.282848386115596,-0.0740544387696784
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,-0.158844136858643,0.110608128236969,-0.20176810873953,0.124923341542581,-0.386567555329518
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,-0.0694850854331452,0.0244939936713697,-0.168448286659616,0.0414453880468311,-0.20398074848476
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,-0.0491501762304566,0.258066959740052,0.306543602754459,-0.459543292909209,-0.363712195850129
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,-0.153489951032507,0.340690506600645,0.184922535678374,-0.302078850264745,-0.356345318982792
ROVERSI_GLIOMA_LOH_REGIONS,-0.0381070382737712,0.135034789848538,0.309504564193525,-0.479773341510006,-0.322764460993816
ROVERSI_GLIOMA_COPY_NUMBER_UP,0.0440913620457,0.180964109810297,0.205268357590115,-0.264056691277895,-0.380407032135711
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,-0.334573865765128,0.173614341225162,-0.0764549605107794,0.383380809745833,-0.20032640112692
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,-0.254725520766886,0.341465928267251,-0.225911799688143,-0.129720038744006,-0.0381991995669987
RASHI_RESPONSE_TO_IONIZING_RADIATION_3,0.00259440843258738,0.247414834987606,-0.0100961100432607,-0.304484969184213,-0.332887169861318
RASHI_RESPONSE_TO_IONIZING_RADIATION_4,0.381100167830502,0.347145431298177,-0.260541816152965,-0.505360467172207,-0.342253870754277
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,-0.0935022355502442,0.131217897627274,0.313373324469642,-0.335833058223048,-0.227462948117822
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,0.0196674699126163,0.288939634151202,-0.0247862410226483,-0.0358087464046859,-0.0672431043284964
AIGNER_ZEB1_TARGETS,-0.0646980812331789,0.206337218715973,-0.236418353897101,-0.0305702117911481,-0.0851175879855369
MARTIN_INTERACT_WITH_HDAC,-0.085696033600706,0.27388213612382,-0.00139358970000517,-0.150196743635276,-0.555316751411241
LASTOWSKA_COAMPLIFIED_WITH_MYCN,-0.32759543940422,-0.127774394102209,0.467477915614916,-0.465741786358935,0.0449138918087124
LI_LUNG_CANCER,-0.086134631529933,0.180048133047864,-0.113591603111227,-0.0641522061059028,-0.276512976386405
LI_AMPLIFIED_IN_LUNG_CANCER,0.053907000464236,0.0223996321916993,-0.056990742642636,-0.0682794412083015,-0.431528101327843
LINDGREN_BLADDER_CANCER_CLUSTER_2B,-0.266091806247491,0.11982105482993,0.0116544365151057,0.00995166662492217,-0.103010787205984
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,-0.476094820781731,0.0624364894558714,-0.152114589939749,0.213625364413356,-0.174666708836633
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,0.27239944063127,0.13263894308621,0.139931541189156,-0.49615425376738,-0.409711747851983
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,-0.304079370964257,0.177020926001827,0.280056557120723,-0.438474525322599,-0.158502152220941
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,-0.455539006177468,0.286932172316398,0.198075514003611,-0.0344290746629534,-0.0559098196307201
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,-0.115377082551252,0.243338867303843,0.245558368605181,-0.136364700632062,-0.56336484009461
MATTIOLI_MGUS_VS_PCL,0.0892404788582835,0.174328147652081,0.0723824589502241,-0.210665402638669,-0.288405519176476
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,0.00955693590420179,0.0872285459395968,0.161943571917196,-0.40802460164501,-0.22310996166332
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,-0.0443974206877713,0.126534035960448,0.101407449324068,-0.439858094487057,-0.137072075626291
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,-0.279308297914332,0.311202629653186,0.166308854172477,-0.394313705511568,-0.126355496870528
LUI_THYROID_CANCER_CLUSTER_1,-0.439235885248424,-0.0997285567761601,-0.323418017660803,0.260914004942831,0.0649537462403198
LUI_THYROID_CANCER_CLUSTER_2,-0.123280964085182,0.138361628901854,0.115801804234879,-0.47478117787965,-0.0576685075760242
LUI_THYROID_CANCER_CLUSTER_4,-0.143983487209089,0.0891016827923423,0.0740810709413691,0.123515013490339,0.198516340172009
LUI_TARGETS_OF_PAX8_PPARG_FUSION,-0.141828216564043,0.354404303778765,0.24419399081493,-0.26909516218427,-0.533606391131138
SCHLOSSER_SERUM_RESPONSE_UP,0.0835658642364783,0.0272537247018598,-0.114960896181551,-0.314435775101993,-0.117451023868233
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,-0.113145887500193,0.444479085311428,-0.146316822027994,-0.10929890886257,-0.493951215035824
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,-0.433712679410562,0.253820888214058,-0.369396472645865,0.51131230831604,-0.426776259541891
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.0418350205699221,0.0554300247459049,0.19248163092269,-0.524535800444758,-0.407008655483904
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,-0.108547825313445,-0.041114802273542,0.4731317442926,-0.23981878085497,-0.413871711615638
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,-0.135635358679544,0.301453596064945,0.0375443579893516,-0.548889889030469,-0.127646309730202
SCHLOSSER_SERUM_RESPONSE_DN,0.0251332937910634,-0.122973551658627,0.0991783941015425,-0.407267001029532,-0.0441933219524281
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,-0.154516673942668,0.13200169391188,0.117942738193933,-0.228653023654114,-0.441685190702381
FARMER_BREAST_CANCER_CLUSTER_1,-0.261542033338439,0.227143496521537,0.310908490967639,-0.23953165077101,-0.268802993376486
FARMER_BREAST_CANCER_CLUSTER_7,0.0551326429273394,-0.332762462633417,0.493486346308095,-0.360481561465768,-0.233758403076539
FARMER_BREAST_CANCER_CLUSTER_2,-0.200669067527263,0.360418982911519,0.289874421707235,-0.566455887905435,-0.315259248451132
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,0.259002416163431,0.355385615795412,0.141017866165551,-0.540047731022565,-0.511827126213485
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,-0.0887417575678892,0.370803995018235,0.143765371120807,-0.302337013128145,-0.440459042097473
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,0.0774520493696195,0.18650263061831,-0.409111312364813,-0.177215719063556,-0.425371203010925
LA_MEN1_TARGETS,0.115259328430389,-0.279681363910342,-0.134606675827847,0.0306811156945143,0.0829096052684843
BOWIE_RESPONSE_TO_TAMOXIFEN,-0.359258972034554,-0.117067384599452,-0.381027775879648,0.505575941202381,-0.100077705020265
AIYAR_COBRA1_TARGETS_UP,0.179449541118451,0.00598851476928439,0.105132839544775,-0.447888556728173,-0.185191916365091
AIYAR_COBRA1_TARGETS_DN,0.249646016101841,0.133948230699177,0.0405464579608954,-0.454461161327243,-0.54700112290303
LI_CISPLATIN_RESISTANCE_DN,-0.18370533383178,0.093780052510583,0.216196208505436,-0.262412914362047,-0.0746292884653863
LI_CISPLATIN_RESISTANCE_UP,-0.402900683375184,-0.181465439928687,0.313297828004823,-0.362040090488262,0.270825441207963
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,-0.517067363805841,-0.112471535290239,-0.0272633745161504,0.0986891745313677,0.0683900506552743
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,-0.114909459580418,-0.156136583552284,-0.0330472397381765,0.0688194945189338,-0.161288538868324
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,-0.137535650971246,0.215248262280852,-0.0400174536061285,-0.0376416904267271,-0.452831771922337
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,-0.239097369695015,0.212853633111327,0.194807764474991,-0.323379391357135,-0.230727869025769
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,-0.21399945874467,-0.168497610329104,-0.00795625181262993,-0.048583128393244,-0.120440681701353
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,-0.212958416302654,0.179183813223664,0.244571017745788,-0.192044440269047,-0.15136745692811
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,-0.109482055988473,0.475711505517745,-0.297589253402656,-0.420405280880886,-0.03719293825974
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,-0.155593349033912,0.389681223439098,-0.0859862108781527,-0.377683810818501,-0.1776901498047
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,-0.172393956902777,0.310260143871761,0.224333073952699,-0.275118619189921,-0.159751551897653
SHI_SPARC_TARGETS_UP,-0.0263264950802585,0.0977494058847241,-0.344691598119446,-0.0452941303985521,-0.340729609522993
DIRMEIER_LMP1_RESPONSE_EARLY,0.152814667903293,0.440963970697603,-0.18556904624261,-0.0146900596092963,-0.387751206587447
EINAV_INTERFERON_SIGNATURE_IN_CANCER,-0.136528269600673,0.464939790198178,-0.413276325623884,0.32172880082179,-0.490770056323775
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,-0.0819374455770814,0.560784654473356,-0.26661394225696,-0.373805187807957,-0.390286635834584
SILIGAN_BOUND_BY_EWS_FLT1_FUSION,-0.339989279371967,0.441893057017659,0.181275008131964,-0.393709649585813,-0.0593631258179539
DAUER_STAT3_TARGETS_UP,-0.0899238831744802,0.312340935659124,-0.272636199612101,0.363998695670537,-0.480679594417154
DAUER_STAT3_TARGETS_DN,-0.339549504514701,0.376528796520683,0.183583663635827,-0.109777566622144,-0.514615666148827
PATIL_LIVER_CANCER,0.0142062370514604,0.111811608678853,-0.0257865605393245,-0.336540748002984,-0.306618752476292
KORKOLA_TERATOMA,-0.105744665731229,0.30928210548428,0.280009906416536,-0.274468562149659,-0.393553040887086
KORKOLA_YOLK_SAC_TUMOR,-0.255445636910894,0.0639452387278371,0.18093128042994,0.0280006917464108,-0.240836498067252
WANG_METHYLATED_IN_BREAST_CANCER,-0.365246043715852,0.468304516302899,-0.461028865397352,0.225825978999757,-0.413774341432349
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,-0.132855206588541,0.0356591450794975,-0.217426255423617,0.0182554331203663,-0.396768252156424
TERAMOTO_OPN_TARGETS_CLUSTER_6,0.145013712730642,-0.136061514221043,0.346872600932442,-0.2545091655691,-0.438787193277137
TERAMOTO_OPN_TARGETS_CLUSTER_7,-0.0522142174977083,0.194135282255122,-0.290089808356458,-0.310388938133166,0.103455247742731
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.0455856572997857,-0.0284326858744748,0.0545292724327542,-0.118991589996947,-0.219857090638101
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,-0.156937046268283,-0.0290036440883635,0.017633396561815,0.00119064003954256,-0.414145096881533
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,0.11256909583354,0.111507602337766,0.122928775262488,-0.430604554321018,-0.262576926370614
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,0.0570038943259773,0.478506468447939,0.0143137108639918,-0.268817505063031,-0.651633477510268
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,-0.306011965625086,0.0789187357528157,-0.104120605946684,0.190386685803533,-0.192221256289014
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,-0.345762332400423,-0.210528409946666,0.132012499427817,0.0551953383329195,-0.10450580378527
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,-0.0534652531372677,0.162463449764852,-0.214089491804459,-0.085912952650445,-0.384783025085899
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,-0.26606274230491,0.164148625294294,0.188936353895391,-0.351846450412277,-0.214911353266727
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,-0.2765691591478,0.159904037530932,0.226691419810876,-0.399630834030662,-0.24107620222464
DIRMEIER_LMP1_RESPONSE_LATE_UP,-0.0998005680893791,0.462062692113787,0.137686813295357,-0.225805234253613,-0.339053343738399
DIRMEIER_LMP1_RESPONSE_LATE_DN,-0.31366796965984,0.290896464730469,0.477264346452648,-0.442198038803956,-0.157913542473948
HEIDENBLAD_AMPLICON_8Q24_UP,0.0974034345825347,0.109235540754109,0.264980529492958,-0.279397731965002,-0.440816387132803
HEIDENBLAD_AMPLICON_8Q24_DN,0.10984155444395,-0.365327487518488,0.181985248145849,-0.255862694087186,-0.220045925201573
HEIDENBLAD_AMPLICON_12P11_12_UP,-0.0879097274678615,0.378756613672331,0.254347125346797,-0.485033675031024,-0.235045625389405
HEIDENBLAD_AMPLICON_12P11_12_DN,-0.043884192854304,0.412120289538363,0.245592770743457,-0.600616867532975,-0.364620359363578
AMUNDSON_RESPONSE_TO_ARSENITE,-0.0203091933364969,0.231782932452803,-0.0875013658501391,-0.244087150845462,-0.222858326367923
YANAGIHARA_ESX1_TARGETS,-0.15137518269268,0.154637689449502,0.0386172908937974,-0.216525002086175,-0.322628400447754
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,-0.179311272238287,0.326576861841886,-0.573247106515203,0.0177823196586571,-0.194786717039359
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,-0.012987959738812,0.260700816765268,-0.456066698822784,-0.0316431728115113,-0.177455068599341
TSUNODA_CISPLATIN_RESISTANCE_DN,0.00394175350084944,0.262856224535586,-0.0304099295498519,-0.147163449768844,-0.31835484982541
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,-0.0544381781173242,0.0628904880900983,-0.161320403585905,-0.0647613415921946,-0.270646408129104
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,-0.322695058647148,-0.0174283305337701,0.247282334682006,-0.277420873849797,0.138748470522715
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,-0.0515406697593399,0.0357765429094336,-0.111890261660613,-0.21798553333501,-0.21721727404583
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,-0.131956850400667,-0.0977478218198003,0.104979269819227,-0.282087323620876,-0.0960882904623412
BORLAK_LIVER_CANCER_EGF_UP,0.147877728312466,-0.0130922646474266,-0.362065222556818,-0.117201997525143,-0.101273641886298
YAN_ESCAPE_FROM_ANOIKIS,-0.192978302399435,0.543156278918806,-0.638129836979129,0.225042522331955,-0.227134362628142
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,-0.241208649885776,0.183722615672106,-0.195939366427815,-0.081563644786945,-0.0970343681587195
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.0862520742920896,0.256434316773058,0.056129633135255,-0.3317523725096,-0.231673169911511
WOOD_EBV_EBNA1_TARGETS_UP,0.140298282147647,0.133315750368364,-0.17150779835812,-0.0278914714575649,-0.36513247305734
WOOD_EBV_EBNA1_TARGETS_DN,-0.0851138414298784,-0.196614709302477,-9.16589374820309e-05,0.397771787244005,-0.29132450291916
MOHANKUMAR_HOXA1_TARGETS_UP,0.0299085781730772,-0.086752581811106,0.16419298713493,-0.378999664508173,-0.236624781138043
MOHANKUMAR_HOXA1_TARGETS_DN,-0.267413630476533,0.160557189145668,0.314535161853369,-0.343557124887205,-0.0650793256547545
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,-0.311431932255544,-0.0347314009735913,0.179878183961156,-0.361622556880019,0.160090802976792
MURATA_VIRULENCE_OF_H_PILORI,-0.392785989486301,0.388142952324959,-0.0469979977636995,0.186705316373986,-0.105553755550882
WANG_HCP_PROSTATE_CANCER,-0.289966676417869,0.181761618035235,-0.34529729559245,0.106728006079781,-0.243982870708983
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,0.076718091975676,-0.400198445428005,-0.161910465986286,0.213193629480895,-0.302570488714833
MAINA_VHL_TARGETS_DN,-0.284787833763813,0.292597747093052,-0.422201739490522,0.0543925645870685,-0.364491074317282
GRUETZMANN_PANCREATIC_CANCER_UP,-4.10285843271962e-07,0.070644548241188,-0.0657945219080949,-0.0788210474256584,-0.381853142469772
GRUETZMANN_PANCREATIC_CANCER_DN,-0.0488350321252815,-0.0503197877027024,0.151349366476521,-0.334443360776059,-0.00404219837241518
JAZAG_TGFB1_SIGNALING_UP,-0.168880857071707,0.283304774559161,0.305545254518888,-0.445805706617173,-0.163087023889141
JAZAG_TGFB1_SIGNALING_DN,-0.36209866087053,0.20884286182136,0.159651951887652,-0.0026218754114074,-0.26894921802895
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,-0.00654341088841695,0.459015417269386,0.20884824591397,-0.448672698633749,-0.506177121424188
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,-0.0530569634399994,0.170579255637994,0.275369353619527,-0.0841813688761003,-0.30804210407024
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,-0.282860875331106,0.0905503522700656,0.438397189363788,-0.342495239099828,0.0636014379216842
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,-0.272634735468831,-0.176415611300407,0.123557805334528,0.350185541689041,-0.425989857418137
SIMBULAN_UV_RESPONSE_NORMAL_DN,0.285112991847538,0.278325231903769,-0.13258977737521,-0.372516980608409,-0.614539440121082
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,-0.102671626064372,0.196862475472244,-0.374600982253181,-0.059070442970894,-0.446919803440641
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,-0.0783463768872769,0.0245035585778458,-0.165379269203852,-0.109306648561827,-0.213010191523258
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,-0.361913122976324,0.292756974261326,0.31268289789482,-0.140951674617164,-0.354981188663983
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,-0.240258617596684,-0.164324898513242,-0.364678392476372,0.55786090291139,-0.352170098425046
KIM_MYC_AMPLIFICATION_TARGETS_UP,-0.042788207052963,-0.0568526177362195,0.327731796478198,-0.458598040202087,-0.0763089578589304
KIM_MYC_AMPLIFICATION_TARGETS_DN,-0.0540819598668914,0.161656860266446,0.243610536680831,-0.310099609052693,-0.24979810914818
KIM_MYCN_AMPLIFICATION_TARGETS_UP,-0.250539475742058,-0.250400058342302,0.440574984050678,-0.428849492743824,0.142039006698894
KIM_MYCN_AMPLIFICATION_TARGETS_DN,-0.0782885407378449,0.00838250860905695,0.248971089308948,-0.333765492628351,-0.346435451742143
KIM_MYCL1_AMPLIFICATION_TARGETS_UP,-0.101133463139744,0.318608794499704,-0.0476996895286867,-0.20131562647898,-0.0820209871506938
TSAI_RESPONSE_TO_IONIZING_RADIATION,0.0502575916124568,0.0583791409322411,0.0784032784329698,-0.144691551727388,-0.391669422202659
YANG_BREAST_CANCER_ESR1_UP,-0.0207695139949742,0.146310033564463,0.227252958077305,-0.502755726052408,0.00644188777699023
YANG_BREAST_CANCER_ESR1_DN,0.177076449111731,0.345688122244159,0.126055149447809,-0.672020929152676,0.0171926002548339
YANG_BREAST_CANCER_ESR1_LASER_UP,-0.189761997957853,0.11301142411521,-0.190346509310795,-0.0204569699352486,-0.118897799279233
YANG_BREAST_CANCER_ESR1_LASER_DN,-0.375156701208175,0.0914424390717642,0.369855519211842,-0.466331481516874,-0.0617926913233158
YANG_BREAST_CANCER_ESR1_BULK_DN,-0.588252559347404,0.388365685080352,-0.0397115054525231,-0.367547693278157,0.0833463496942403
WANG_RESPONSE_TO_BEXAROTENE_UP,-0.214519380864242,0.226327351961043,0.148925227686554,-0.310044486653197,0.0889349579271373
WANG_RESPONSE_TO_BEXAROTENE_DN,0.0833127313521387,0.190971518605907,0.540801067880865,-0.47475269685499,-0.332480647635312
HOWLIN_PUBERTAL_MAMMARY_GLAND,-0.323194866828547,0.0780733853753595,0.0373617148304396,-0.101504660592964,0.226437218487357
HATADA_METHYLATED_IN_LUNG_CANCER_UP,-0.137518961877023,0.193444080619629,0.0163452193947258,-0.194387463647413,-0.219813139529513
HATADA_METHYLATED_IN_LUNG_CANCER_DN,-0.124073578075377,0.153349118028515,0.403038319189103,-0.390410925060603,-0.263966789246369
FURUKAWA_DUSP6_TARGETS_PCI35_UP,0.0635547392790069,0.167128638300119,0.0197068989732004,-0.0805331403455151,-0.175764239865643
FURUKAWA_DUSP6_TARGETS_PCI35_DN,-0.218720311936173,0.317299380138935,0.217958893763748,-0.501330937542109,-0.299743055886198
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,-0.0994200393637034,0.195386368565573,0.0153102533159831,-0.0630306633954081,-0.35611404535939
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,-0.111230819544642,0.0612844027245311,0.188136134463516,-0.273989815054412,-0.206405036998113
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,-0.226273519383003,0.146137585643011,0.0542490193002845,-0.0598623970902144,-0.239198881520387
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,-0.0913323200696111,0.159682378565976,0.158713787814415,-0.41856093057272,-0.0155423108402638
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,-0.178547698451099,0.186872425269686,0.317088798574131,-0.280829552941426,-0.235382081004415
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,-0.175676296809278,0.531551247498604,-0.0355445558910598,-0.401072251215166,-0.407983903817256
LIEN_BREAST_CARCINOMA_METAPLASTIC,-0.507433441233494,-0.365066992715629,-0.0506664674488455,0.365568362045663,-0.128142499934379
TOMLINS_PROSTATE_CANCER_UP,0.0046125877002442,0.067950584790212,0.253066394292135,-0.399704982138456,-0.242802939048095
TOMLINS_PROSTATE_CANCER_DN,-0.367574034836424,0.241981774309955,0.00339176503875865,-0.446549261579988,-0.00877219201414206
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,0.015159157207967,-0.0932411535198836,-0.0668085919877562,-0.123071295091159,0.0335092654504142
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,0.0927878868779117,-0.00369419277424615,0.251540958923382,-0.456761136570276,-0.250314414101162
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,0.106005449491877,-0.0115906264504199,0.238099247716881,-0.465032530415821,-0.195517410081972
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,-0.0595093169748729,-0.255696281838195,0.00674152958656984,-0.113879437307454,-0.232990608105336
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,-0.229648616753356,0.491287755818568,-0.0638402950962262,-0.388585289111408,-0.301244353992253
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,0.0444601062420317,0.205368774685212,-0.037823586833261,-0.230333745823052,-0.367763739591947
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.0405011529218209,-0.103573464699548,0.172794448501168,-0.4233374541987,-0.232231368192618
HUI_MAPK14_TARGETS_UP,-0.417242134661023,-0.00695364446243429,0.184352329656866,-0.185224918107997,-0.10258663942011
THEODOROU_MAMMARY_TUMORIGENESIS,-0.0590945852549968,0.186170426006552,0.147793576568415,-0.40235752277378,-0.0206340668605128
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.0454662223165433,0.327876618392845,-0.130916935035868,-0.255051755325422,-0.54453854402578
PUJANA_XPRSS_INT_NETWORK,0.00506224757925217,0.162270196353873,0.0777314996510211,-0.326783117678384,-0.492663989109521
PUJANA_BRCA2_PCC_NETWORK,-0.0733548214888981,0.169688823546678,0.0717988364853161,-0.467595345688696,-0.231506979751046
PUJANA_CHEK2_PCC_NETWORK,0.139463203275069,0.102788393065546,0.0945342358520978,-0.483937545756292,-0.289431793032536
PUJANA_BRCA_CENTERED_NETWORK,-0.0833526470181447,0.225595682869672,-0.052463034283484,-0.430403953385135,-0.393843375610147
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,-0.335658738254155,0.0274378723773293,0.400072909753178,-0.0442249049093255,-0.0531851022763801
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,-0.064798250616912,-0.110480425573602,0.138874969625054,-0.123956190313622,0.0589638500032761
KHETCHOUMIAN_TRIM24_TARGETS_UP,-0.214248784229415,-0.024817699531409,-0.224273022742952,0.287978173109952,-0.363495703268979
OHM_METHYLATED_IN_ADULT_CANCERS,-0.0496414012585175,-0.137531980100584,-0.189758057749174,-0.024139614889172,-0.0956387346628589
ALCALA_APOPTOSIS,-0.0722695073462728,0.0432783941018532,0.055436465941379,-0.123112248929952,-0.426638188983206
COWLING_MYCN_TARGETS,-0.397427525232628,0.283532253164171,0.159053595628706,0.0874456438938664,-0.428947306880636
FALVELLA_SMOKERS_WITH_LUNG_CANCER,-0.0564576763330093,0.286745655997574,0.269350501420807,-0.279531204793876,-0.41856665509913
KAUFFMANN_MELANOMA_RELAPSE_UP,-0.0491229071526225,0.200146032863751,0.237319237926224,-0.600509110859276,-0.337943970157029
WILLIAMS_ESR1_TARGETS_UP,0.216389849383003,0.382559936560803,-0.163885730476881,-0.372204353999862,-0.447512637058754
WILLIAMS_ESR2_TARGETS_UP,-0.470588694637559,-0.0864617203864844,0.586486782429938,0.00433073785534269,-0.0959125023842758
GROSS_ELK3_TARGETS_UP,0.0404672780606922,-0.168380463535563,-0.039505763400586,0.114253678756939,-0.370740202420015
GROSS_ELK3_TARGETS_DN,0.0893077629333241,0.308104790442828,0.0411221483612832,-0.424730036690804,-0.338372073018334
GROSS_HYPOXIA_VIA_ELK3_UP,-0.0223144020418539,-0.0610575518309588,-0.116594567431311,-0.0337816641542618,-0.35782464309338
GROSS_HYPOXIA_VIA_ELK3_DN,-0.111414603853639,0.21017327789412,-0.154035875022063,-0.0755977154534004,-0.310308521279413
GROSS_HIF1A_TARGETS_DN,0.00394486639589448,0.0889154795718191,-0.205156236466912,-0.17233035113599,-0.219002661985802
GROSS_HYPOXIA_VIA_HIF1A_UP,-0.323250724687842,0.17065262168977,-0.013813733807481,-0.495060452809307,-0.0421232654434441
GROSS_HYPOXIA_VIA_HIF1A_DN,-0.0957045704006307,-0.060284715482908,0.0099932947417502,-0.0677091296761832,-0.234822576310435
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,0.310721751456444,0.208381289576868,-0.354686273807583,-0.0243809075816783,-0.440670140146477
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,0.0217822763410298,0.203799961805384,-0.234303208283124,-0.0466487231203305,-0.470752590279174
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,-0.156436549106451,0.126503014799019,0.0343259603027999,-0.179627138149151,-0.120971597676091
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,0.0227803726090122,-0.0228973891967261,0.0873900702408458,-0.298896404782041,-0.319679235194788
NUYTTEN_NIPP1_TARGETS_UP,-0.155905355169457,0.172067942356212,0.113173680119496,-0.348015213992022,-0.17368700353188
NUYTTEN_NIPP1_TARGETS_DN,0.0071565012853724,-0.0134333443164325,0.00720055325469957,-0.360309408964271,-0.19376183857806
NUYTTEN_EZH2_TARGETS_UP,-0.123185329740154,0.0626901872467662,0.0477149135021393,-0.282703382241005,-0.175130088964658
NUYTTEN_EZH2_TARGETS_DN,-0.0672477650887458,0.0642114582139906,0.135365402439297,-0.407370425263233,-0.210925792035663
INGRAM_SHH_TARGETS_UP,-0.172094576984285,-0.0834197442949927,-0.0751556840655958,-0.0722996047967677,-0.121801466330941
INGRAM_SHH_TARGETS_DN,-0.236314709680496,0.0123902876193124,0.227093521174192,-0.117087791534397,-0.322305061991117
MARTIN_NFKB_TARGETS_UP,-0.287786066865191,0.264382161980307,0.26958427387607,-0.267060838894277,0.0728887529146234
MARTIN_VIRAL_GPCR_SIGNALING_UP,-0.154865052507099,0.163174873661535,-0.0133608273849769,-0.233362628279079,0.061816604547784
MARTIN_VIRAL_GPCR_SIGNALING_DN,-0.175279052042544,-0.172805091337829,0.301336338757386,-0.273793702001954,0.0948453089800678
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,-0.0841722801445742,0.15352950707922,0.114131597673323,-0.350174036054136,-0.274191540633916
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,-0.10580204067446,0.0822253656507295,-0.10292572176656,-0.119667499392961,-0.20677805586073
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,-0.104786745806492,0.220679484222649,0.185332862650107,-0.474815322088102,-0.332894809556195
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,-0.0753178926848167,0.17580336557764,-0.0375723019921502,-0.0518897736387748,-0.414994399380154
NAKAYAMA_FRA2_TARGETS,0.0594658816375762,-0.234479210346294,-0.337823989178678,-0.0955633946061502,0.0722093305810112
LOPEZ_MBD_TARGETS,0.0602617388285779,0.106223041509839,-0.0538177037666003,-0.209052714820042,-0.321968482388589
ROPERO_HDAC2_TARGETS,-0.154039109222563,0.195849493622565,0.273903433241369,-0.170463106105572,-0.2399567369764
LIU_LIVER_CANCER,0.258593124191857,-0.0205376691663396,-0.372835621471932,-0.0375351039537456,-0.145821041898093
LIU_NASOPHARYNGEAL_CARCINOMA,-0.0551046329632455,0.100165328297736,0.298177115729491,-0.247716614547272,-0.32055399423587
LIU_COMMON_CANCER_GENES,-0.148908249200117,0.0245661351314813,0.27686555205251,-0.480999965045401,-0.128128300422108
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,-0.0127432326209568,0.117941276433714,-0.116733618808191,-0.110711956200325,-0.339418939775915
WEI_MIR34A_TARGETS,-0.010339534414291,0.045958401868083,0.233540038694546,-0.43224233268504,-0.132763561584366
WEI_MYCN_TARGETS_WITH_E_BOX,-0.0485536637453155,0.130437754406478,0.174905487545567,-0.438543078433755,-0.208834837031488
LIAO_HAVE_SOX4_BINDING_SITES,0.132908995550633,0.108118568494532,-0.0161064613276358,-0.493220113725563,-0.330797735051085
LIAO_METASTASIS,-0.0871312465581076,0.259273376509446,-0.0242991679818067,-0.282036208052181,-0.338234779098566
TONG_INTERACT_WITH_PTTG1,0.518913765586148,0.0815579391853064,-0.0110341560474433,-0.39705226313932,-0.594552580901658
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,0.0794398319902789,0.408697356531993,-0.419899717613873,-0.274041933482992,-0.185534431168524
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,-0.143884048740878,-0.303942312850692,0.229497885519117,-0.370035876088329,0.290969354244161
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,0.410037431272275,-0.257230103530621,-0.00582724374250099,-0.0458790341804531,-0.629821328155701
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,-0.372039153234627,0.553041851460051,0.238188959658598,-0.605739623659199,-0.271642320206022
GOUYER_TATI_TARGETS_DN,-0.177504939165291,0.000861725889197612,-0.277059256983632,0.300721235177238,-0.111301361322237
CAFFAREL_RESPONSE_TO_THC_UP,-0.365914894877098,0.395261243691828,0.219332436147237,-0.428247500395146,-0.369043993596711
CAFFAREL_RESPONSE_TO_THC_DN,0.32666571128418,-0.0345984256305598,-0.357700279112985,0.104915411604293,-0.474746740466728
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.0763723963042172,0.0467585243471074,0.0638369698589181,-0.46175720237831,-0.321719374912688
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,0.243361467368419,-0.133615776331534,-0.00552611161734537,-0.190043730943802,-0.315090479688314
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.101292793792842,-0.0788693554011621,0.307883330780101,-0.521558708020136,-0.126371512809815
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.0304946891813977,0.155758659476845,0.174709285770482,-0.488661308383927,-0.223611738745573
WOTTON_RUNX_TARGETS_UP,0.0169331623676443,-0.240848286600538,-0.484701798195272,0.365768691916112,0.106662887661732
WOTTON_RUNX_TARGETS_DN,-0.489318855185738,-0.207452398647844,0.354019643944817,0.199516591613333,-0.188338854221608
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,-0.133004549927968,0.0823022501771284,0.0429806995753704,-0.0863441390117517,-0.257009919480118
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,-0.0112531412681063,0.284912396709787,0.118405943545306,-0.422413752666261,-0.300152445753953
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,-0.165293246652728,-0.0972298122817706,0.0687520716581783,-0.446788268300137,0.150103396242548
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,0.0198924799528575,0.119445207673791,-0.0392265768876504,-0.133881755128081,-0.342976528059275
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,-0.222455246501348,-0.114973473870971,0.0962686297569251,-0.478517047849217,0.222740288382346
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,-0.0205261186000543,0.453120329069243,-0.066181971644745,-0.0738854495254579,-0.325029270391595
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,-0.0492542186924866,-0.0396927369011013,0.0576525231545385,-0.197364770823472,-0.23635237749067
RICKMAN_METASTASIS_UP,-0.0961666253267365,-0.116754555622959,0.0940979164638277,-0.463969462045399,0.148917322419807
RICKMAN_METASTASIS_DN,-0.114956365568927,0.377623700020479,-0.141841361407227,-0.110977919914644,-0.381631706993154
FRIDMAN_SENESCENCE_UP,-0.342733410376092,0.179106406464108,-0.368236382541721,0.422970281273677,-0.516074188235495
FRIDMAN_IMMORTALIZATION_DN,-0.225359032210832,-0.290311110390526,-0.302710363513447,0.69735040759382,-0.536405285369584
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,0.00566567216156344,0.0609031734141573,0.260168913699226,-0.472436752215995,-0.0459661109617829
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,-0.207367553749098,-0.00117089316779662,0.0909340957823808,-0.153270219835724,-0.137365476822192
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,-0.165738769463617,-0.0748446746981024,0.125292672198936,-0.26587893105401,0.00663299359014941
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.105419080127072,-0.0144097615568047,0.234900377825756,0.0409028667202687,-0.490749970836488
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,-0.0804487469593306,0.0500538253170336,0.167122024678702,-0.381474239536008,-0.0966759955622299
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,-0.231811578853299,0.0997079496063854,0.184580776262682,-0.264324161023384,-0.061567744458031
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,-0.0162396407417432,-0.168330516689394,-0.13666140032211,-0.327860406357143,-0.088580223672397
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,-0.319767032444477,0.338651392424961,-0.0955441440974305,-0.0359507207141433,-0.287599169172368
KOYAMA_SEMA3B_TARGETS_UP,-0.27129285656476,0.156539202899699,0.0339089575949994,-0.233866509603473,-0.11494031450713
KOYAMA_SEMA3B_TARGETS_DN,-0.176083796921609,-0.0285416971566253,0.00960937643811918,-0.114786235397374,-0.122979900492205
RICKMAN_HEAD_AND_NECK_CANCER_A,-0.24009663267162,-0.168125795724398,0.302390656262505,-0.320720393170641,0.216423949134599
RICKMAN_HEAD_AND_NECK_CANCER_B,-0.32119127664711,0.278621131699434,0.0962537386693743,-0.124938353567113,-0.0549823632976124
RICKMAN_HEAD_AND_NECK_CANCER_C,-0.0606437431732381,0.217614197993679,0.319395619205514,-0.217497247756247,-0.170543518990537
RICKMAN_HEAD_AND_NECK_CANCER_D,0.0757718408548223,0.10573994992363,0.276778390752758,-0.458271095896597,0.101416179789214
RICKMAN_HEAD_AND_NECK_CANCER_E,-0.173551510820405,0.31138281302641,0.403340757575418,-0.489217605549479,-0.076114514123827
RICKMAN_HEAD_AND_NECK_CANCER_F,-0.188496248090361,0.0302651481321279,0.432355530462266,-0.130245748059605,-0.178049758382235
WU_CELL_MIGRATION,-0.0688658617346324,0.222450899259258,-0.0177302073691609,-0.121837404019486,-0.435668863218462
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,0.325427886890105,-0.435506676785879,-0.16534307642688,-0.049910479848304,0.0387791441011981
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,-0.123039240712099,-0.248063072155756,0.086848756658506,-0.0788120982105763,-0.226508386969177
BALDWIN_PRKCI_TARGETS_UP,0.363895021267504,-0.4474655508386,-0.12002530175964,-0.344947501093087,0.0079807747265723
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,-0.263512077765255,-0.357974247148978,-0.0647769389531903,0.260830658661926,-0.135788184391906
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.0827330701140967,0.16388381084216,-0.0656223590485968,-0.267223830921875,-0.297349377852559
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,-0.09121812156005,0.183022179635863,0.218307017174103,-0.470703936850668,-0.243311399232547
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,0.0172682790791622,-0.0743622497866492,0.116195838877101,-0.304347823119254,-0.0243836255212231
BENPORATH_ES_1,-0.0826730100249967,0.22010049157341,0.168157249160767,-0.406935463945045,-0.255395732942131
BENPORATH_ES_2,-0.0333755344277429,0.249044929489307,0.341107520274524,-0.453412445804556,-0.320816547897847
BENPORATH_NANOG_TARGETS,-0.0908137252997826,0.0281376136180004,0.0900941365153054,-0.295488614352486,-0.230182113548469
BENPORATH_OCT4_TARGETS,-0.167575703781861,-0.0457243558260018,0.138759120547719,-0.218880289590316,-0.141560559472441
BENPORATH_SOX2_TARGETS,-0.128733874023824,0.039213777093302,0.110106476447841,-0.308084819141232,-0.201154411284219
BENPORATH_NOS_TARGETS,-0.214404722256686,-0.0148622118300418,0.247215896673806,-0.243541731287728,-0.169983958571224
BENPORATH_PRC2_TARGETS,-0.188656611105027,0.171395730800181,0.215158123270365,-0.278900581684009,-0.0781441965813538
BENPORATH_MYC_TARGETS_WITH_EBOX,0.178095553843756,0.055750937328769,-0.0548804783610864,-0.23188837259565,-0.307168732427339
BENPORATH_MYC_MAX_TARGETS,0.0667088412127464,0.111508075584662,0.068247517450741,-0.362990654017385,-0.265193007757904
BENPORATH_CYCLING_GENES,0.0345930251774276,0.119959749575187,0.0140816682746941,-0.388851838582276,-0.339551395683642
BENPORATH_PROLIFERATION,-0.0844197665156069,0.0995211802740274,0.365554175175654,-0.486490389067706,-0.22237664423087
PETRETTO_CARDIAC_HYPERTROPHY,-0.326111287011308,-0.383297736783205,-0.457022052238672,0.347988016379745,0.108662538873989
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,-0.271776813926312,-0.0378560840411689,0.164697246272225,-0.219132153170034,-0.0823997597419724
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,0.105837961027407,0.032059697818343,0.0754176322359356,-0.305936930042687,-0.278079919629644
STARK_HYPPOCAMPUS_22Q11_DELETION_UP,-0.187053610269579,0.180674309594707,0.0646791113605964,-0.194915556735602,-0.506015137761954
BENPORATH_ES_CORE_NINE_CORRELATED,-0.295862043931229,0.310366386697745,-0.147458047855739,-0.107118446191351,-0.271947253095653
PETRETTO_HEART_MASS_QTL_CIS_UP,-0.125588907800925,0.414321561281824,0.217513674507552,-0.420418859921025,-0.243992013058061
PETRETTO_HEART_MASS_QTL_CIS_DN,-0.358156250329616,0.357171852368089,0.110541417752483,0.184042506253859,-0.265161354797429
AMIT_EGF_RESPONSE_40_HELA,-0.170258988029001,0.357494252362219,-0.0791941459713463,-0.130819910952413,-0.405866243660694
AMIT_EGF_RESPONSE_60_HELA,0.0497641776274101,0.465348306245921,-0.524578072963388,-0.0470942203920704,-0.573040735332518
AMIT_EGF_RESPONSE_120_HELA,-0.0910170842669229,0.360390000226595,-0.0490435284487976,0.101891902375025,-0.425534378526099
AMIT_EGF_RESPONSE_240_HELA,-0.0657150544611466,0.304451194444687,-0.0105530239581854,-0.312508976421601,-0.436386444021284
AMIT_EGF_RESPONSE_480_HELA,-0.14982246316257,0.409155984287425,-0.377993520094922,0.216940820393365,-0.584091619561471
AMIT_EGF_RESPONSE_60_MCF10A,-0.163017111593329,0.439630885736172,-0.133298447062736,0.0332186829096959,-0.285829642549977
AMIT_EGF_RESPONSE_120_MCF10A,-0.266775428509907,0.214796495909118,-0.329602064063506,0.0502453047761499,-0.273532059914507
AMIT_EGF_RESPONSE_480_MCF10A,-0.208012106142117,0.489467903771617,-0.149414380750024,0.104242782217885,-0.557442758764845
AMIT_SERUM_RESPONSE_40_MCF10A,-0.0137921423632282,0.0271518355792481,-0.301442688330075,0.381460098678926,-0.402589397395582
AMIT_SERUM_RESPONSE_60_MCF10A,-0.232444325108989,0.251296821485024,-0.0915140541287198,-0.0918673250761023,-0.187703295310715
AMIT_SERUM_RESPONSE_120_MCF10A,-0.250347175864897,0.28548180999839,0.0822890153383919,-0.00023426182622599,-0.445562122818449
AMIT_SERUM_RESPONSE_240_MCF10A,0.0117501888497225,0.0594637906692182,-0.158686599210788,0.100765736051904,-0.334156079588239
AMIT_SERUM_RESPONSE_480_MCF10A,0.023146769288049,0.0889872572794495,0.222872531234223,-0.0908944731595677,-0.478930627518686
GEORGES_CELL_CYCLE_MIR192_TARGETS,-0.177543720175889,0.188656525826268,0.0218247793723977,-0.480469824689699,-0.0822574527590179
GEORGES_TARGETS_OF_MIR192_AND_MIR215,-0.0430744813843489,-0.11331899061083,0.227242151436611,-0.471165981548019,-0.0212085265922476
SHEN_SMARCA2_TARGETS_UP,-0.000785400907864192,-0.195475837490272,0.255818663326383,-0.491220051740581,-0.0640298423532001
SHEN_SMARCA2_TARGETS_DN,0.0375096421290634,0.23123439549942,0.280907972095456,-0.38817180993855,-0.253275703365205
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,-0.0131562684867156,0.26862559816118,0.0571870155708195,-0.371906477697452,-0.245479459637323
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,-0.0400828802008071,0.0418361265054956,0.00788587444256014,-0.404052988158023,0.211089760198469
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,-0.51519608508315,0.535384888759865,-0.343493736040465,0.367132819530907,-0.699604672262512
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.115410864552264,0.313090738916402,-0.240258076981654,0.040722550148182,-0.563629807461483
JEON_SMAD6_TARGETS_UP,-0.283829797179129,0.0724242816028522,0.102930799266067,0.335216908727434,-0.445779744344512
JEON_SMAD6_TARGETS_DN,0.019507954578139,-0.271414008629027,0.0804162424631807,-0.446779484697524,0.187107991268859
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,-0.175051969073135,-0.099462051557122,-0.145148345203519,0.0794936532164841,-0.225651076934341
SUNG_METASTASIS_STROMA_UP,-0.122140038448498,-0.198087043128722,-0.202381745102823,0.0342350508822725,-0.260419632310415
SUNG_METASTASIS_STROMA_DN,0.0457155355514941,0.179118220478917,-0.0256789048512976,-0.347902660513846,-0.266893203708908
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,0.146050515377062,0.320026562202488,0.0510660880671682,-0.00638927393683586,-0.478844423306097
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,-0.476679315363815,-0.334963642622193,-0.0154200376240061,-0.101329015387134,0.4178259339409
SHIN_B_CELL_LYMPHOMA_CLUSTER_5,0.46420381515585,0.506381848282491,-0.529933607344301,-0.29234070108089,-0.351157785434375
SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.0478433681780143,0.317183120299809,-0.240606012975885,-0.013333955240792,-0.247703671654547
SHIN_B_CELL_LYMPHOMA_CLUSTER_9,-0.168552208176268,-0.121522373627245,0.421578269128698,0.0497130159369298,-0.0784909646686998
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,-0.164661891112859,0.322918485798081,0.140305951387546,-0.275952314472427,-0.287157192053936
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,-0.244223605611981,0.153401290215662,0.0605920334265261,-0.35801916176029,-0.157588347627132
MORI_PRE_BI_LYMPHOCYTE_UP,0.00376471656485045,0.177128313223775,0.00953143394348271,-0.318830994719214,-0.255064541292581
MORI_PRE_BI_LYMPHOCYTE_DN,-0.24960997717455,-0.190639491640816,0.332046907448289,-0.40874865787399,0.249037910327703
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,0.0040348613266451,0.0467684505096952,0.0828964144348199,-0.130535354316154,-0.405895694606629
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,-0.146306194964267,0.278869845439,0.0518988131693519,-0.453106128381923,-0.0391165031269519
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,-0.0601128532528629,-0.0633790113408988,0.0392845072365934,-0.185964933576763,-0.0264044020094282
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,-0.253265108481367,0.412407902245806,0.0956200066406208,-0.23634876850186,-0.281069754670492
MORI_IMMATURE_B_LYMPHOCYTE_UP,-0.229636282354622,0.0691967973519492,-0.0254378894517809,-0.551303536328907,0.315785086834043
MORI_IMMATURE_B_LYMPHOCYTE_DN,0.0901920957557245,0.0890111562220056,0.0169005283366424,-0.31604178485985,-0.241691925754468
MORI_MATURE_B_LYMPHOCYTE_UP,-0.205935733174745,0.173993767485168,0.185857402845726,-0.318068110069008,-0.279255886007429
MORI_MATURE_B_LYMPHOCYTE_DN,-0.33032359137167,0.260798285048096,0.0610695826030025,-0.331445168103885,-0.0395298148644588
MORI_PLASMA_CELL_UP,0.0206378215887554,-0.14204531753596,0.181956641864199,-0.387240655414747,-0.00561999286495857
MORI_PLASMA_CELL_DN,-0.369611081997394,0.23603194575756,-0.241383883415372,0.100279739518579,0.0678860166509545
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,-0.0766372124091081,-0.0312531439935326,0.182924313135966,-0.370244073117576,-0.100876022037469
COLLIS_PRKDC_SUBSTRATES,-0.459721277653922,0.397433071792775,-0.49712483815249,0.0896684884430529,-0.421885791124049
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,0.104223539347641,0.0799181814967806,-0.207459472438585,-0.188994934953002,-0.164663102310439
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,-0.128498991939379,-0.0120175461381356,0.340634797687,-0.325764005095703,-0.175788163534695
KAUFFMANN_DNA_REPAIR_GENES,-0.158876451636707,0.309272484309421,0.160026887238686,-0.410033575276221,-0.318929590192108
KAUFFMANN_DNA_REPLICATION_GENES,-0.264915261688539,0.319318979164336,0.101116983606767,-0.371433962871693,-0.326843058192136
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,-0.32365855120627,0.290653067923865,-0.361015160246697,0.341337522383049,-0.183715552551109
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,0.360542359886447,0.26037789816655,-0.403746618173501,0.0634016479431496,-0.431877024097875
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,-0.138368004353406,0.147988858431574,-0.569854970710205,0.104245245598182,0.137099280497133
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,-0.306241113367532,0.0924388115446983,0.461151193705701,-0.391197963197843,-0.377474184105507
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,-0.0422304768555797,0.262833846211441,0.489595412601755,-0.561218969331981,-0.139938835451206
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,-0.322307358862772,-0.0189322814700622,0.386648215782309,-0.477440344358685,0.0716240006517337
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,-0.195082723621088,0.37805609949593,-0.0127290313788888,-0.187660802998892,-0.376505392948251
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,-0.322679614829787,0.310321792557988,0.137041734320514,0.0357145527024875,-0.371486915630393
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,-0.344355681608795,0.0432492449752475,-0.0751898449119093,-0.239406966305364,0.412600022240022
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,-0.0871433290192049,0.263743613708003,0.321601231838956,-0.348669516837367,-0.591394377339458
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,-0.521823076943451,-0.312459990450133,-0.150718980006712,-0.00379214070981648,0.323118559381992
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,0.136229405704132,0.0661656872910105,-0.172396875790298,0.0978484783357679,-0.338141798112635
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,0.0548518466211719,0.350869290045471,0.156792258876846,-0.0908160858387842,-0.588355443314818
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,0.249678488375447,-0.107207605420121,0.203842773169241,-0.274034839991607,-0.185975126582077
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,-0.0754210960254795,0.445217419880886,0.337766002193631,-0.452239288523943,-0.469250996979737
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,-0.458478179812525,-0.658336288330299,0.66264042492615,-0.34451713769673,0.495925204534172
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,0.281464142592419,-0.237799669264957,0.0547841682295934,-0.35886940698916,-0.0435447406469299
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,-0.408004003011181,-0.121996742298118,-0.616816114081953,0.0196311856259896,0.501436445026101
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,-0.280150634729918,0.253971580496415,0.408906207146972,-0.363652233618516,-0.379411408074573
WHITEHURST_PACLITAXEL_SENSITIVITY,0.327211068516668,0.069278538217097,0.277047683080392,-0.549992585024446,0.00403088288339212
JI_METASTASIS_REPRESSED_BY_STK11,0.103764075070867,0.166634672818833,0.252385640606047,-0.498596167586155,-0.14662702072475
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.0219261224085741,0.270775298708167,-0.103121966323386,-0.18007047027461,-0.260235686138994
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,-0.255166221098723,-0.010676400949218,-0.0327241320726422,-0.388083837136529,-0.0106824827012638
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,-0.135461210372535,0.312948851489202,0.191249907558596,-0.450688111900152,-0.154007746469714
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,0.117594160910143,-0.231109573257753,-0.117909836887512,-0.27065099815182,-0.0394429349646326
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,-0.436784899538666,-0.0598765906463721,0.417848826228853,-0.219705212746293,-0.0478590216481135
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,-0.0132208602290915,-0.179827569149749,0.0478192146708764,-0.425286400994088,-0.0200485688192685
ONDER_CDH1_TARGETS_2_UP,-0.214678538271544,-0.2164718051819,-0.153528290157361,0.215092626307245,-0.280391588166219
ONDER_CDH1_TARGETS_2_DN,-0.139136267775501,0.293006964803428,0.202788231266542,-0.383249416037539,-0.169737589172805
ONDER_CDH1_TARGETS_1_UP,-0.102417331075236,-0.0155634920417258,-0.168164178065477,-0.0906667786181558,-0.0524704705701286
ONDER_CDH1_TARGETS_1_DN,0.090736776122283,0.222092154414071,0.0353580592560424,-0.318291219383607,-0.273734611469496
ONDER_CDH1_TARGETS_3_DN,0.0466934082735882,0.0755870291197299,0.179631433562235,-0.204787908505204,-0.178700071691818
ONDER_CDH1_SIGNALING_VIA_CTNNB1,-0.303368898222332,0.238485466690739,-0.204683359465191,0.17056863405379,-0.357743081492346
CERVERA_SDHB_TARGETS_2,-0.322851420102252,0.0457634622744979,0.264666103151407,-0.280478372529701,0.0594371361046727
ROZANOV_MMP14_TARGETS_SUBSET,-0.307568671957245,-0.214467439916811,-0.375977171599997,0.26644035730241,-0.410542580732073
ROZANOV_MMP14_TARGETS_UP,-0.0965753307555388,-0.0975607285726633,-0.0110034960394748,-0.0113859729264119,-0.141314093112516
ROZANOV_MMP14_TARGETS_DN,-0.449446445603476,-0.0346343784832316,0.307638740170102,-0.164577669729386,0.166449904093261
LANDEMAINE_LUNG_METASTASIS,-0.291451786398058,-0.238218797177731,0.413441108901888,-0.52418295500719,0.344163260554919
CERVERA_SDHB_TARGETS_1_UP,-0.120100177780241,0.149448373628244,-0.0628568879764824,-0.0671372962089405,-0.167859870471224
CERVERA_SDHB_TARGETS_1_DN,-0.352717302757709,0.300064171750553,0.232514902698352,-0.170225705933532,-0.131593891801656
LE_EGR2_TARGETS_DN,-0.328864999314503,0.0542151271408598,0.0151317519414927,-0.25021222720659,0.218784284610097
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,-0.274534420700364,0.160813466202184,-0.264549441260815,-0.033271723970699,0.0231670867322094
KENNY_CTNNB1_TARGETS_UP,-0.157523307694986,0.439084508340381,-0.300647618834451,-0.207261017197633,-0.382241729442726
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,0.452322309386398,0.192892316164215,0.296914053673416,-0.457910731686067,-0.5143663446079
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,0.374030005783611,-0.236406857340518,-0.0868776635172956,-0.267185146396012,-0.28526091862832
BYSTROEM_CORRELATED_WITH_IL5_DN,0.0151603215815066,0.153147513026729,0.231731648999164,-0.414297897960138,-0.223869479189633
SWEET_KRAS_TARGETS_DN,-0.149943439849387,0.308388713580884,0.237242082280374,-0.0125856232019466,-0.540262396499853
SHEPARD_CRUSH_AND_BURN_MUTANT_UP,-0.0755833194605882,0.0619555968622548,-0.125123028577239,0.0862958517995059,-0.269268744125603
ROSS_AML_WITH_PML_RARA_FUSION,-0.26366573398672,-0.0118222628241313,0.355812598500299,-0.130729093967065,-0.311174164725055
LEI_HOXC8_TARGETS_UP,-0.405704127441525,0.000247697029983562,-0.231265543732409,0.483350000134853,0.014235532862384
LEE_LIVER_CANCER_CIPROFIBRATE_DN,-0.108536440299424,0.240685936620002,0.454784611343647,-0.385041951518337,-0.249400310085423
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,-0.233381947527828,0.112348057099692,0.114516063296818,-0.254821941132847,0.0646707129399222
STANELLE_E2F1_TARGETS,-0.205199945427292,0.584849103323157,-0.281739872877995,-0.15432495251595,-0.504499280586019
SHIPP_DLBCL_CURED_VS_FATAL_DN,-0.0661082982905218,0.190842775341843,-0.303822185356784,-0.277445072492556,-0.394336313494113
UEDA_CENTRAL_CLOCK,0.156092332314175,-0.30980044130461,-0.0430353918800452,-0.20474425296824,0.070686395070615
HOUSTIS_ROS,0.0613332445563069,0.176418093245605,0.10755771025643,-0.0498205547161328,-0.55715918162765
BASSO_B_LYMPHOCYTE_NETWORK,0.129625067147319,0.160784288847069,-0.0896499309750988,-0.43097975327355,-0.348939940310489
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,0.0490909050716827,-0.146834084006987,0.0229851321694669,-0.31861753493406,0.0272154413554907
LEI_HOXC8_TARGETS_DN,-0.0347653062274386,0.136464986748549,-0.268872701563053,-0.326410487870137,0.128978844303014
CHESLER_BRAIN_QTL_CIS,-0.0539212378169756,-0.210621667685755,-0.0122653764990389,-0.287761932821187,-0.0639194004804579
ROSS_AML_WITH_CBFB_MYH11_FUSION,-0.0625379026665318,0.0153219265024329,-0.118944099842847,-0.0410604642216535,-0.152303195830271
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,0.0130116485735333,0.122527285355053,0.525123719803636,-0.549198225901816,-0.212216790098722
FERRANDO_TAL1_NEIGHBORS,0.356559636886087,0.289964910406661,0.245361858241324,-0.458463154763645,-0.0554067988902444
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,0.00901250524283773,0.162181281153229,0.00814434734470643,-0.282351857644074,-0.352530586283139
LEE_LIVER_CANCER_MYC_TGFA_DN,-0.137283777022381,0.198939497282368,0.24456318586686,-0.322789158314511,-0.118966338979893
GOLDRATH_HOMEOSTATIC_PROLIFERATION,0.0252721141321243,-0.164239933981754,0.134305284026897,-0.396045586130652,0.0295006613174134
GNATENKO_PLATELET_SIGNATURE,-0.0308387165008925,-0.19028316674542,-0.122283455419301,0.111946596083136,-0.246733935400304
KIM_GERMINAL_CENTER_T_HELPER_UP,-0.055438795685066,-0.438643251154794,0.314488582947175,-0.288301864678875,0.119371546850967
SHEPARD_BMYB_MORPHOLINO_DN,-0.0814474767635157,0.115928583007664,0.177507322693552,-0.231909225886898,-0.279262812723661
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.158238414514826,-0.311386294706484,0.0296205347384493,-0.515251616316958,0.193443913546217
LEE_LIVER_CANCER_ACOX1_DN,0.0484215553266788,0.171610699668345,0.219712899544262,-0.251230117560139,-0.279401807460941
SMITH_TERT_TARGETS_UP,-0.118213193314992,0.328598473681705,-0.271067042736397,-0.212323998550345,-0.28188729693528
LEE_LIVER_CANCER_MYC_UP,-0.165738829484119,0.325646517454883,-0.0366797714058603,-0.220399319465798,-0.238189214286003
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,-0.212164841564922,0.0848487981076251,-0.0301878213115412,0.210382455990341,-0.351335550957584
DER_IFN_ALPHA_RESPONSE_UP,-0.0831991945496114,0.304970931517486,-0.310045087431976,0.0367468156939766,-0.407779008921927
KANNAN_TP53_TARGETS_UP,0.208427915339491,0.315237169941168,-0.268283979760802,-0.138189847119498,-0.400504404867266
WELCH_GATA1_TARGETS,0.511417532441236,0.134019635840784,-0.286075418122846,-0.251978012566635,-0.469968567090453
FRASOR_RESPONSE_TO_ESTRADIOL_UP,-0.300658923398091,-0.0208485223083724,0.373050993808721,-0.33650700835923,-0.0521814440065969
LEE_LIVER_CANCER_MYC_TGFA_UP,0.145524287613265,0.362761809979739,0.0246931419099955,-0.434573084254391,-0.345781415007857
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,-0.14357651349358,-0.109384436857085,-0.182406137892615,-0.402541117515531,0.128118478101957
DORSAM_HOXA9_TARGETS_UP,0.191119020011542,0.12574847506045,-0.324418400879454,-0.561135387232341,-0.0712502300092722
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,-0.307228871180093,-0.189079546101631,0.277869793014973,-0.162953377238891,0.210845480067403
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,-0.0616098964891691,0.402253095900526,-0.0380737679578591,-0.218605939385241,-0.14949584555548
SHEPARD_BMYB_TARGETS,-0.102697514129038,0.144537115482053,0.22550376551449,-0.451452047261045,-0.175566788640722
KANNAN_TP53_TARGETS_DN,-0.389533944148487,0.107162564092267,0.264061013195983,-0.35818553446369,0.180928082419047
SANA_TNF_SIGNALING_DN,-0.0204925382541455,0.207222056657763,0.145233916750224,-0.340983310071449,-0.241413209997455
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,-0.0139532604714665,0.121369723690644,0.082364281592501,-0.111977520223348,-0.285301911539162
KENNY_CTNNB1_TARGETS_DN,-0.0780890602869922,-0.294302408702305,0.431939087771966,-0.0231168884718522,-0.457157062847839
BECKER_TAMOXIFEN_RESISTANCE_UP,0.0736470569818991,-0.203908471409661,-0.388024604260368,0.282364994067201,-0.0627844827864042
SHEPARD_CRUSH_AND_BURN_MUTANT_DN,-0.0104278337342144,0.161106977743639,0.135937165637383,-0.372799008823309,-0.258139391034902
RADAEVA_RESPONSE_TO_IFNA1_UP,-0.328026524847046,0.189338342288285,-0.383540149669797,0.118662950571382,-0.0534556789420196
PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.0645639867643173,0.304586494287225,0.00728831881010189,-0.295196520501949,-0.553863027067521
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,-0.370278021553339,0.0531680410392119,-0.181654756336295,0.0411983781438078,0.10830676219015
YAGI_AML_RELAPSE_PROGNOSIS,0.259804792933953,0.291546114194858,-0.380564355928865,-0.235881746334867,-0.4662773897947
SHIPP_DLBCL_CURED_VS_FATAL_UP,-0.193547683502879,0.463567513258777,0.145082530430124,-0.24241954597381,-0.364803081828803
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,-0.183190285263583,0.306047094513409,0.248085407123703,-0.306383742647614,-0.20860807033885
LEE_LIVER_CANCER_ACOX1_UP,-0.0929990024881135,0.133129470307773,-0.0941531960748324,0.0344878360561157,-0.148581919154173
UEDA_PERIFERAL_CLOCK,-0.0962727025843393,-0.00962264872061186,-0.101633349863699,-0.0834258896378719,-0.146151923062005
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,-0.0965226245862996,-0.342974808312889,-0.0185218644352467,-0.163097183847991,0.0897352880528832
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.00560185204604438,0.0540365759085246,0.43153257275944,-0.500729992206124,-0.148268220417889
WIELAND_UP_BY_HBV_INFECTION,-0.166568905510164,0.191803346640734,-0.0542614445702508,-0.249830109872112,0.00885441404431581
SHEPARD_BMYB_MORPHOLINO_UP,-0.028961713432479,0.0639853804038139,-0.103245270457114,-0.172032825893538,-0.200752405561874
GOLUB_ALL_VS_AML_DN,0.435814686929296,-0.322172802661163,-0.267252519443297,0.142234664639754,0.0472005548485362
DER_IFN_BETA_RESPONSE_UP,-0.0642234688927064,0.264569445014838,-0.373123026767852,0.0563346276399446,-0.468145065469862
MANALO_HYPOXIA_DN,0.0168904992283418,0.265833079778498,0.064069843402132,-0.496710916141802,-0.380136389115981
CHESLER_BRAIN_HIGHEST_EXPRESSION,-0.0722200590057537,-0.053656861687717,0.00836935579540787,-0.0562884158530723,-0.275159971892189
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,-0.11547864543113,0.450925641038207,-0.0475726687598279,-0.439080137729767,-0.267878762128178
LEE_LIVER_CANCER_MYC_E2F1_DN,-0.0452472081260551,0.0106203532979873,0.317610447092649,-0.375966721663645,-0.185166238311631
BYSTROEM_CORRELATED_WITH_IL5_UP,0.284498805104488,-0.127292622773571,0.00309393543104877,-0.348092796894014,-0.359357760163648
NELSON_RESPONSE_TO_ANDROGEN_UP,0.206097291132592,-0.349307917831742,-0.0303439561905589,-0.16136342732393,-0.226313192280349
LIN_APC_TARGETS,0.0791046264006811,0.24521230998354,-0.229660953728453,0.249975899238192,-0.462614587397394
VANTVEER_BREAST_CANCER_METASTASIS_DN,-0.254834418242719,0.186281228078,0.16747433557677,-0.36117237712173,-0.188989854865018
BROCKE_APOPTOSIS_REVERSED_BY_IL6,0.0440952045973529,0.0983071058530662,0.00294466279545955,-0.165326013914731,-0.362500373437402
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,-0.0521750511620206,0.242845182955672,-0.0916006772876844,-0.181172456185789,-0.399026584558787
FRASOR_RESPONSE_TO_ESTRADIOL_DN,-0.0683916290570188,0.287702591823937,0.134136606823383,-0.215131619434203,-0.441962913572636
CHEOK_RESPONSE_TO_HD_MTX_DN,0.169803388882247,0.440048986316644,0.238639570985117,-0.730759693259726,-0.496915646541661
TENEDINI_MEGAKARYOCYTE_MARKERS,-0.142132673004327,0.172345309842213,-0.148038934577586,-0.158012568742746,-0.355157602502026
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,0.184859894257414,0.0779367800526157,-0.00107657485372381,-0.473432456150743,-0.318251402808006
SMITH_LIVER_CANCER,0.392231694515244,-0.438812062631132,0.0237256743973155,-0.44821178141551,0.113477861408369
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,-0.0193533761986832,-0.0993312437705871,-0.252635053342791,0.195613062735571,-0.29973439635395
ROSS_AML_WITH_MLL_FUSIONS,0.148147037611425,0.214404906188815,0.0547461928267166,-0.349580171286795,-0.295370727508311
LEE_LIVER_CANCER_MYC_E2F1_UP,-0.19710648139231,0.297753482415197,-0.136975733434676,-0.234734963958165,-0.0859517767856988
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,0.00682245312043969,-0.32176217711948,0.495629860097993,-0.556329656041707,-0.0769537667690618
LE_EGR2_TARGETS_UP,-0.259583915228016,-0.0579222365033772,-0.0390825766960938,-0.308462742910132,-0.0777971058990658
FERNANDEZ_BOUND_BY_MYC,0.0613781772886734,-0.0192799652659114,-0.0140290592220186,-0.220685770804457,-0.249021484909139
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.0365028563029141,0.105184167394687,-0.107126470835447,-0.148532362042123,-0.376429365720828
ROSS_AML_OF_FAB_M7_TYPE,-0.0772783109896517,-0.0581855699334598,0.221206125156161,-0.325127278333852,-0.201484499670964
MOOTHA_VOXPHOS,0.324065882180804,-0.283159981295458,0.298342305502135,-0.565707723616817,-0.292973598348977
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.142407430866892,0.125721449258986,-0.494781557448726,-0.287918747651351,-0.0278409460410853
SANA_RESPONSE_TO_IFNG_UP,-0.355058882132011,0.482802973571432,-0.120008219505406,-0.1334014845081,-0.386510524130543
SANA_TNF_SIGNALING_UP,0.00435891725358706,0.292401213862913,-0.0520146545711763,-0.095507848863482,-0.431950168635323
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,0.0687327935653707,-0.00939923979293145,0.0282454021905,0.0212960174412109,-0.426017600961831
SCHUHMACHER_MYC_TARGETS_UP,0.0725540160906778,-0.0463427025597641,0.0543331584966107,-0.4121623037751,-0.227868780755368
SWEET_KRAS_TARGETS_UP,-0.42002305261341,-0.374522116599018,-0.132847962204735,0.308122054206795,-0.191893914087642
CHEOK_RESPONSE_TO_HD_MTX_UP,0.0821250571558833,-0.297314889286116,0.274684896309174,-0.198718175388797,0.22270282405375
OKUMURA_INFLAMMATORY_RESPONSE_LPS,-0.19999457519435,0.154117294000779,0.039141496829469,-0.207970979312213,-0.131199675782282
SMITH_TERT_TARGETS_DN,-0.0140644591023808,-0.0417131311857336,0.0815603031524219,-0.28898816395899,-0.0704127311307302
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,-0.148922437490159,-0.135314217645017,0.4097920036827,-0.46026792100799,0.117916412808043
LEE_LIVER_CANCER_DENA_DN,-0.0812197874319298,0.121995642560955,0.46226955632569,-0.518001079363285,0.0167249610732304
SANA_RESPONSE_TO_IFNG_DN,0.0983672584320464,-0.12677960981846,0.327747763540871,-0.337185241433267,-0.360635181492315
LEE_LIVER_CANCER_MYC_DN,-0.00785296166311743,0.284088368310093,0.358830123774803,-0.334434086552987,-0.38222620012744
LEE_LIVER_CANCER_CIPROFIBRATE_UP,-0.112714881764075,0.137794080239326,0.0331499857804981,-0.109045664262216,-0.158307602085959
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,0.175746612291543,-0.361233362324861,0.23810357408859,-0.00200650987446099,-0.224973517000129
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.356735673787925,0.335163462698822,0.171278576682862,-0.520704651315224,-0.719461757909656
LU_IL4_SIGNALING,-0.133841829558243,0.0638822255939021,-0.0647300638915687,-0.090899334555,-0.071002019097516
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,-0.150754210968906,0.12202890159601,0.178731199248554,-0.307801354955777,-0.182237051754172
FERRANDO_LYL1_NEIGHBORS,0.323576833645045,0.139005791774477,0.12949674053273,-0.0530004356221783,-0.242130976337322
VANTVEER_BREAST_CANCER_METASTASIS_UP,-0.045401576135655,0.246489332579087,0.220376274627075,-0.515517493364297,-0.202918806453218
COLLER_MYC_TARGETS_UP,0.573051655715068,0.146026579746767,0.315014060714308,-0.627817306194933,-0.482154697707914
MANALO_HYPOXIA_UP,-0.259050407173774,0.0455621160479446,-0.0780435343990747,-0.0277676479365325,-0.262073299993005
REN_BOUND_BY_E2F,0.0530787116794391,0.234560493241724,0.284913448234753,-0.478121820774309,-0.43042550186185
DORSAM_HOXA9_TARGETS_DN,0.103566815424819,0.293027221867978,0.323247932253014,-0.477655884383181,-0.271211178593318
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,-0.0264756242739733,-0.0870313251909651,0.240328012555286,-0.425650482559828,-0.124096925549179
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,0.220135194862716,0.335110878998563,-0.216675000285677,-0.208321251178458,-0.622141301355734
BECKER_TAMOXIFEN_RESISTANCE_DN,-0.146349689357984,-0.125457494780046,0.264975965979884,-0.208553481838982,-0.114318097995995
PEART_HDAC_PROLIFERATION_CLUSTER_DN,-0.0151660918777688,0.300882097794059,0.0701781912638334,-0.380697929475555,-0.274317062458847
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.242524316127354,0.180701807360799,-0.0299247109704142,-0.3302126985859,-0.360890859401103
SASAKI_ADULT_T_CELL_LEUKEMIA,-0.13104226289354,0.0750374720583205,0.0716779129754831,-0.33328309861624,-0.156161523760245
LEE_LIVER_CANCER_E2F1_DN,-0.0456319171825301,0.194293965277217,0.317587574610536,-0.491135175780651,-0.145730056474974
LEE_LIVER_CANCER_DENA_UP,0.100858245538321,0.080167285264844,-0.157495532969321,-0.137330123224802,-0.118499835949472
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,-0.546347567522856,0.181063488932497,-0.405799572111138,0.345533123592431,-0.470233695616363
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,0.195502297376957,0.189796577686115,0.201302502842463,-0.506294070131954,-0.297759935021097
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.0457070130953492,-0.247799650685791,0.148010882789547,-0.334489630871365,-0.258215536796497
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,-0.0182574487065653,-0.0695180666900259,0.13440758578539,-0.302700609770604,-0.155961427000968
GOLDRATH_IMMUNE_MEMORY,-0.17711859411394,-0.053548897279187,-0.101047086804575,-0.28075215865664,0.120083467306408
LEE_LIVER_CANCER_E2F1_UP,-0.00726490165120566,0.260409515140588,-0.239095788274776,-0.226143886949547,-0.115880611984422
ROSS_AML_WITH_AML1_ETO_FUSION,-0.300906823464359,0.125212065055766,-0.0137675428591564,-0.192876696901799,0.0586184694917945
BHATTACHARYA_EMBRYONIC_STEM_CELL,0.26466486475472,0.233368195578578,0.0621406289065727,-0.430659509066549,-0.48137066243564
DER_IFN_GAMMA_RESPONSE_UP,-0.102455523126929,0.388873533563567,-0.328484647971552,0.0552942908657013,-0.430029432873245
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,-0.128377902589831,0.10225391890503,-0.0288470716832603,-0.0453466905552047,-0.214411396952588
ZHAN_MULTIPLE_MYELOMA_CD1_UP,-0.0223302075262321,0.350076935403714,0.0898168984146058,-0.375455171144896,-0.287127054837854
ABBUD_LIF_SIGNALING_1_DN,-0.238860837066598,-0.0918307093633969,0.452537526470046,-0.485780306756101,-0.11751493107843
SANSOM_APC_TARGETS_UP,-0.143664415253028,0.219250213963419,0.150803669827133,-0.293506705527538,-0.185181859918009
NAKAJIMA_EOSINOPHIL,0.0829909320019753,0.124003447028946,-0.144179236158447,-0.323203072258794,0.17288482259748
BROWN_MYELOID_CELL_DEVELOPMENT_UP,0.0852757095599591,0.118596947920555,0.0376025364727296,-0.216787987706016,-0.263868132797195
NADLER_OBESITY_UP,-0.0382026778794403,0.20944021904423,-0.267174701379646,0.170647120923,-0.39136212547373
SANSOM_APC_TARGETS_DN,-0.0822385949830239,0.157371246131576,0.158086831363735,-0.352387066680485,-0.177203792449189
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,-0.0473584578554905,0.238070240093845,-0.18563679741821,-0.225201231796979,-0.206511537285985
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,-0.0506881828855068,0.164586695078915,-0.222070081691292,-0.082886195935544,-0.335960914227326
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,-0.378837373480162,0.0120568179149041,0.313560515264194,-0.256307576537343,-0.0727439194118668
MA_MYELOID_DIFFERENTIATION_DN,0.0538851779407465,-0.209090362838279,0.119350435965381,-0.0893755782414282,-0.31716803008619
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.105017593918774,0.208700911064564,-0.220973083722098,0.0386396826827115,-0.256063190302605
VERNELL_RETINOBLASTOMA_PATHWAY_DN,-0.0287355025359304,-0.533967396325055,-0.251911708621426,0.317099402491085,-0.220811744230664
CROMER_METASTASIS_UP,-0.168852731326885,-0.105496830252934,-0.0150375233657237,-0.33831076080193,0.199915861403505
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,-0.163202882273996,0.172586907836563,0.17927977979233,-0.302198742909939,-0.18287634434623
GUO_HEX_TARGETS_UP,-0.389442969975195,-0.034458261852855,0.197088825613919,-0.255799126897328,0.116068308058973
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,-0.282405450171566,0.258159257954905,0.587663440757067,-0.385540327195829,-0.326155692399777
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,-0.194251642954717,0.0180732934379154,0.066922848788924,-0.260978149508821,0.023300637395953
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,-0.345270430517128,-0.0275033632335632,0.0523560805505476,-0.234959729399748,-0.0217282084130903
STOSSI_RESPONSE_TO_ESTRADIOL,-0.005297167725066,0.332270278743433,0.00958317737974133,-0.433073568838258,-0.119338414899976
YU_MYC_TARGETS_UP,0.100955841838765,0.177721094426677,0.0983689545734588,-0.662060508836636,0.0272932116556692
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,-0.140341722391468,-0.00410641907826004,0.196336455423223,-0.356234378679845,-0.226818790917832
PARK_HSC_MARKERS,-0.152336897449018,0.0258816198031882,0.342911698596691,-0.25405866977458,-0.134040495369192
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.113677415289475,0.360743808661618,-0.0569897826211949,0.0131338948146003,-0.521551656136369
HOFMANN_CELL_LYMPHOMA_DN,-0.100186108571407,0.287000355810257,0.121869221090624,-0.436308287949597,-0.0760960168807735
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,0.0172523632024529,0.359261077258148,-0.140122023352072,-0.305288595206355,-0.336962874955474
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,-0.146997749531321,0.102582771571908,0.226603288016177,-0.273254843846199,-0.223774834810685
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,-0.0783794469614227,0.149622649431348,0.192218710306663,-0.454530526524485,-0.148561391065801
STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.362956821255732,0.280700053489969,0.0895824136441096,-0.360691779216195,-0.540474735059964
HASLINGER_B_CLL_WITH_13Q14_DELETION,0.0741130430304319,-0.513722587647312,-0.133831888040402,0.157224006385168,-0.0361595834878314
HOFMANN_CELL_LYMPHOMA_UP,-0.110798293691389,0.356911464551455,-0.326394479322459,-0.0408217924389725,-0.424721135853921
GUO_HEX_TARGETS_DN,-0.0990801356929657,0.171577654866908,0.0660236438500123,-0.500877715718623,0.0886464560250966
HSIAO_LIVER_SPECIFIC_GENES,0.0287231793213495,0.29844137595276,0.236486720275271,-0.391973628422521,-0.293763464919292
GILDEA_METASTASIS,-0.558822415138616,0.237122142177786,-0.175548039785315,0.542287979960037,-0.383785459265217
ZHAN_MULTIPLE_MYELOMA_SPIKED,-0.527211171812697,0.0695099239764576,0.160465892268276,-0.173102805651065,0.239598772315603
ASTIER_INTEGRIN_SIGNALING,0.0324231121228115,0.131656831667301,0.119033689247059,-0.185233173216741,-0.331333458512074
ZHAN_MULTIPLE_MYELOMA_LB_UP,-0.302428889969491,0.264581430159313,0.327927963196477,-0.330940780259435,-0.234135059198579
LEI_MYB_TARGETS,0.0824152156626669,0.134728816769362,-0.165034461822438,0.00806664946015884,-0.348175345828245
BROWN_MYELOID_CELL_DEVELOPMENT_DN,-0.0706068041080577,-0.0180280809454325,0.210484596000104,-0.368745696055607,-0.113501632067552
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,0.0018564582701337,0.205099560569785,-0.24391987565068,-0.0495666548196284,-0.31526789995494
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,-0.120316628788317,0.195538845123318,0.159785771915346,-0.454712948780386,-0.37406322138881
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,-0.138448984513863,0.225163149339916,-0.000119495320574231,-0.237266987575233,-0.168942836235736
HALMOS_CEBPA_TARGETS_DN,-0.148068186479836,0.272554763962403,0.203450348170951,-0.283024283899483,-0.355265253409852
NADLER_OBESITY_DN,0.277774164102121,-0.19192809027897,0.0517031268798679,0.0589872710523584,-0.371656939948403
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,0.262665060960458,0.107845972672287,0.156407798744186,-0.413398525460832,-0.508250880042558
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,-0.284066675936772,0.17133352561037,0.36456629732965,-0.429978333508363,0.00810809711011123
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,0.0703216173370077,0.126220517955418,-0.242908992972029,-0.202381215995743,-0.238809735063686
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.23634841890852,-0.189344800169385,0.0658565880159547,-0.313984729420075,-0.28332934030813
NADLER_HYPERGLYCEMIA_AT_OBESITY,-0.0610709024984784,0.360438430149142,0.103688551022133,-0.46727676840668,-0.231291731313454
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.186776794773516,-0.141021657289297,-0.487680138918715,-0.136510890941961,-0.0294754596687847
ZHAN_MULTIPLE_MYELOMA_PR_UP,-0.309132431894661,0.285707726205328,0.243957405976889,-0.468421853588756,-0.163295739167264
HALMOS_CEBPA_TARGETS_UP,-0.0269708389468858,0.269520164554968,-0.127821939234139,-0.132631187404724,-0.207416465979962
YU_MYC_TARGETS_DN,-0.190677128157405,0.011569634719903,0.242799665923637,-0.324570644922644,-0.12934982322062
ZHAN_MULTIPLE_MYELOMA_UP,0.0372377540644897,0.146773892170159,-0.152254231456995,-0.177958438670339,-0.45567401567629
LENAOUR_DENDRITIC_CELL_MATURATION_UP,-0.0689608286702179,0.147233278668173,0.120083336558255,-0.182845293622084,-0.143684365303094
TAVOR_CEBPA_TARGETS_DN,-0.29590172472319,0.0995816531445649,0.0299045200336807,0.287902875460635,-0.424605367640856
LENAOUR_DENDRITIC_CELL_MATURATION_DN,-0.120755715709259,0.40947788455218,0.0776084965485789,-0.248567849731118,-0.347085968154491
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,-0.088967092514364,0.179505242728226,0.0257937794225854,-0.40127415706645,-0.294728400073771
HADDAD_B_LYMPHOCYTE_PROGENITOR,-0.0732314674949667,-0.0451257512421501,0.137135865965027,-0.327342904487016,-0.0901806885511816
PARK_HSC_AND_MULTIPOTENT_PROGENITORS,-0.0643975045219397,0.21767017934004,-0.153543198181308,-0.253318032915534,-0.347040987342517
GREENBAUM_E2A_TARGETS_DN,-0.322615684083268,0.342446205993184,0.199733507924314,-0.359066779375142,0.107890628226679
ZHAN_MULTIPLE_MYELOMA_CD2_UP,-0.118934206538628,0.13203544436574,0.157750351674144,-0.280625846020653,-0.144574237824623
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,-0.165670040654104,0.286278998704689,0.202075481456346,-0.277090179807327,-0.259033703591372
ABBUD_LIF_SIGNALING_1_UP,-0.239183040272266,0.0973387240181033,0.322233683232175,0.017320144844172,-0.528522425073639
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,-0.242077572197642,-0.130439909697151,-0.10514648074207,0.499756103336105,-0.476344735850256
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,-0.051370644488052,0.296777890588176,0.246339131788302,-0.34392377462821,-0.343887215439724
GERY_CEBP_TARGETS,0.0352721626164446,0.0555922552119492,-0.165946375957051,-0.185926425420626,-0.0356259141935676
VERHAAK_AML_WITH_NPM1_MUTATED_UP,-0.045242496059327,0.187626078102446,0.146003908888341,-0.264483716464116,-0.13908209540479
KANG_IMMORTALIZED_BY_TERT_UP,-0.0830532004228329,0.139070314375621,0.0420825028122306,-0.0647344055433719,-0.349907175472526
BASSO_CD40_SIGNALING_DN,-0.272767412288491,0.329035071540198,-0.0414005174739413,-0.408281508281542,-0.140372506925564
ZHAN_MULTIPLE_MYELOMA_MF_UP,-0.0576299117666799,0.208346188062805,0.427247563772104,-0.320446702637911,-0.375753881581365
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,-0.100356126385268,0.217352904144636,-0.146881178429945,-0.0100347169217528,-0.355980027575453
JAIN_NFKB_SIGNALING,0.0876538725347647,-0.0315386499718125,0.0901439769543246,-0.384499425504389,-0.321964026460569
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,-0.0803985883975983,-0.0888300378152713,0.197688051575815,-0.377798865207322,0.104378316899863
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,-0.0238882850681564,-0.113305021952404,0.127291199063854,-0.259828237197215,-0.0323308971598215
STAEGE_EWING_FAMILY_TUMOR,-0.109001757172576,-0.145123664743423,0.247060359059322,-0.199951576375688,0.290301467255014
GALE_APL_WITH_FLT3_MUTATED_UP,-0.060451269212455,-0.0318723367603899,0.285597491751233,-0.517651000781861,-0.288421886740553
AFFAR_YY1_TARGETS_UP,-0.128699192228535,0.0350947979051947,-0.000748121707601551,-0.210867431641896,-0.0431844082405185
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,-0.0678093555008798,0.150260727678314,0.11151313150642,-0.259805113553772,-0.286576920698875
AFFAR_YY1_TARGETS_DN,-0.181450734753196,0.114134077111857,0.1764524399549,-0.246931570882128,-0.13906818819853
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,-0.0274507191890597,-0.118560691639616,0.232103845297801,-0.451580816808188,-0.155594001649092
VERNELL_RETINOBLASTOMA_PATHWAY_UP,0.309997405015153,0.114092921807922,-0.00585829758881409,-0.203384144415106,-0.571070721320602
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,-0.247271757612145,0.22456004448271,0.173869599462203,-0.311494462515428,-0.201251021145193
KANG_IMMORTALIZED_BY_TERT_DN,-0.219079360496829,0.149672302777029,0.307488781849483,-0.386592170691868,-0.175585873356918
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,-0.168607873404384,0.312314943811876,0.167562931269239,-0.499244135728094,-0.176304822961816
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,0.124736792145867,-0.107278197036547,-0.217669341106613,0.221687225120246,-0.670030894115838
NGUYEN_NOTCH1_TARGETS_DN,-0.254596277449604,0.348406132651176,-0.334400855749625,0.104247285605,-0.349554996139887
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,-0.143480940832931,0.18714248503791,0.209126034558881,-0.349357791358801,-0.178819619549201
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,-0.0195820257438527,0.211516215083459,0.117392811921414,-0.188613735107804,-0.230501673252746
PETROVA_PROX1_TARGETS_DN,-0.127969219027528,0.0276581732855755,0.0116143223703718,0.0474663013067081,-0.410933733023821
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,-0.051829669178659,0.481202521067068,-0.330966011576526,0.0604288793486862,-0.478701999915695
XU_RESPONSE_TO_TRETINOIN_UP,-0.064746303931423,-0.0818840115416619,-0.439423550050141,0.11960175114351,0.148192287620438
MENSE_HYPOXIA_UP,-0.22890695771926,0.206422816780268,-0.410380992112452,0.209671423508083,-0.344833831757164
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,-0.0819034466392726,0.397119582328918,-0.00649550292290962,-0.21652925274117,-0.547726452154354
ZHAN_V2_LATE_DIFFERENTIATION_GENES,0.429280216728786,0.186637489644991,-0.0508322396613346,-0.489805879163751,-0.502706407384508
DORSEY_GAB2_TARGETS,-0.0403507222114711,0.399241422494511,0.0725149624204497,-0.130850719610965,-0.433281416795367
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,-0.125046092102342,0.42015227689314,0.0877112125310274,-0.251894613877988,-0.22248904517049
NAKAJIMA_MAST_CELL,0.0384928920390636,0.00618887178467481,0.225537040064845,-0.103506846757532,-0.12036820554607
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,0.356397760383318,0.148229804402351,-0.188581692349067,-0.150361366167316,-0.148430922334638
ZHAN_MULTIPLE_MYELOMA_MS_UP,-0.178116286829862,-0.183588170797753,-0.0793792864465086,-0.147464306949057,0.148151764895491
MA_MYELOID_DIFFERENTIATION_UP,0.0374032896073839,-0.440975387278271,0.126726346448808,0.152565075730379,-0.00495443119183883
RADMACHER_AML_PROGNOSIS,-0.32422413814751,0.0463443563108109,0.212043531477626,-0.149440585615354,-0.165119994946877
CROMER_METASTASIS_DN,-0.101346126367685,0.473207992177102,-0.194820036806634,-0.030862552649631,-0.469648047962122
NOUZOVA_METHYLATED_IN_APL,-0.299361269517185,-0.172172550550135,0.308263387977213,-0.309671301720413,-0.0534517561214796
ZHAN_MULTIPLE_MYELOMA_HP_UP,-0.244336615425596,0.349120145714849,-0.0439735275645318,-0.428050510879251,-0.146958124971692
TAVOR_CEBPA_TARGETS_UP,-0.295854723528306,0.0540656478614666,0.109471485872391,-0.116413197235794,-0.0786771513319055
YAGI_AML_SURVIVAL,-0.17799172379063,0.32531459167608,0.143541597100736,-0.375879459075867,-0.405241342683342
XU_CREBBP_TARGETS_UP,-0.262721786468848,0.594312074415932,0.0417017675268525,-0.286485015838366,-0.264746704738372
VERHAAK_AML_WITH_NPM1_MUTATED_DN,-0.15568929013745,0.0508965772275337,0.223780810248531,-0.234814365721921,-0.133343568960633
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.257176202265806,-0.145513781787786,0.6118572769649,-0.468163834626709,-0.356371067066645
APPEL_IMATINIB_RESPONSE,0.125447067125998,0.381435708216794,-0.196390107730998,-0.202267522264368,-0.378934836369629
YAGI_AML_FAB_MARKERS,-0.00656463126568599,-0.0327732707285635,0.129099667770497,-0.241257095366132,-0.159478609506888
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,0.246404964135184,-0.118377108596266,0.0371797493151251,-0.480852254925785,-0.177404232551436
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,-0.109030628479103,-0.0240048324018177,0.216760573984903,-0.433553915582728,0.00445160915244983
XU_CREBBP_TARGETS_DN,0.0913879959414998,0.344165923704644,-0.129669714692642,0.219608705792783,-0.154947303396786
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,-0.0539400346780106,0.308098886521906,0.292524891640589,-0.378737243788335,0.0105949971573303
IGLESIAS_E2F_TARGETS_UP,-0.217695806546055,-0.146379482387542,-0.0419779287702725,-0.0359099657942997,0.125879901875709
MUNSHI_MULTIPLE_MYELOMA_UP,0.151835311981418,0.248773239616529,-0.235307094774207,-0.128820988258508,-0.430697498563343
KAMMINGA_EZH2_TARGETS,0.21083502131328,0.202085924576831,0.128352630567505,-0.627823184561378,-0.336885922087577
ZHAN_MULTIPLE_MYELOMA_DN,0.123887756629823,0.0802091722785701,0.276430255640015,-0.158067995864416,-0.123866049892007
BASSO_CD40_SIGNALING_UP,0.0418089000762444,0.408748310129661,-0.283622205694096,-0.226413498388082,-0.129967601448127
HANSON_HRAS_SIGNALING_VIA_NFKB,0.158113114741302,0.0711316910948341,-0.168159298706316,0.246174678000505,-0.242715789459818
FAELT_B_CLL_WITH_VH3_21_DN,-0.234659121752246,0.0590937169396265,-0.00264173645223886,-0.289469632406941,-0.281038586279332
GREENBAUM_E2A_TARGETS_UP,0.00315316107326277,0.034221886088306,-0.124295084024207,-0.311628089052561,-0.0434223441223344
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,0.134086201955037,0.0700130320922135,0.277019471405734,-0.519924379319374,-0.376513441919429
BRUNO_HEMATOPOIESIS,0.0878788302192901,-0.0242645511774706,0.157460722538593,-0.496155569833542,0.0661632734621654
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,-0.0346391078062792,0.213947082950812,0.134484299169943,-0.308406996710252,-0.298245846338684
PETROVA_PROX1_TARGETS_UP,0.135459442353206,0.0165644618436586,-0.233742601938953,-0.528379950289403,0.146866195575606
HOEGERKORP_CD44_TARGETS_DIRECT_UP,-0.320621795320872,0.0477969735974311,0.3017589271471,-0.312727836438148,-0.100238871975119
KUMAR_TARGETS_OF_MLL_AF9_FUSION,-0.111323220023502,0.128114133063289,0.209609625370876,-0.282602855246835,-0.0795676081102773
FAELT_B_CLL_WITH_VH3_21_UP,-0.0222584611195481,0.270318132106431,-0.117425955270555,-0.147653051336006,-0.437111435122062
SESTO_RESPONSE_TO_UV_C8,-0.208166177351071,0.165456120520447,0.216871937093457,-0.288404025564406,-0.295398019834333
KIM_HYPOXIA,-0.195154824355589,0.024515642890287,0.120452447459473,0.466836193434135,-0.614362247357137
LIANG_SILENCED_BY_METHYLATION_2,0.0713324749128883,0.410493676449051,-0.218932256555169,-0.152842239633403,-0.359222209042903
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,-0.133046564600634,0.0261632475126359,0.175728106054487,-0.427119959952141,-0.0653881572591355
LY_AGING_PREMATURE_DN,0.262577843395047,0.197857288034776,0.228390974886611,-0.453054344877662,-0.539065067584968
MARTINEZ_RESPONSE_TO_TRABECTEDIN,-0.156875354178819,0.12292391550837,0.145589470787751,-0.240248765733485,-0.453191558497987
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,0.00398753884231809,0.277323377962912,-0.329612655550678,-0.0518494666021397,-0.534033073849212
BROWNE_HCMV_INFECTION_20HR_UP,-0.195519944350441,0.248153437509694,0.145415157299324,-0.409249473396045,-0.214210364185009
TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.0204325967108964,0.108048127219864,-0.162003563824633,0.0343820505178014,-0.266948877979082
URS_ADIPOCYTE_DIFFERENTIATION_UP,-0.223818647290724,0.244122198984048,0.0680549394757051,-0.348452706683204,-0.174600916458878
LEE_AGING_NEOCORTEX_DN,-0.231625729947193,0.130091186358794,-0.0913315522258198,-0.0979019955247853,0.00650954134984214
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,-0.3781271507624,0.16574284646251,0.259340980110579,-0.424747937146735,0.00597751831446555
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,-0.00276149716735732,-0.0346517169818869,-0.346686396732031,0.111612076900852,-0.314318294202245
TRAYNOR_RETT_SYNDROM_UP,-0.212025465192332,0.221098139196433,-0.0178397118626359,-0.0631804318838472,-0.122757860249427
MCCLUNG_DELTA_FOSB_TARGETS_8WK,-0.198425181944372,-0.0272327313731394,0.143304537039898,-0.477147216675516,0.251604982079365
BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.485261867038081,0.0913038512785602,-0.30350663368826,-0.362064873603,-0.149545723014072
BROWNE_HCMV_INFECTION_16HR_UP,-0.18093212565502,0.116673545660511,0.254133781636579,-0.408657217777951,-0.22339890396587
MODY_HIPPOCAMPUS_POSTNATAL,-0.0435910547939573,0.252359502603554,0.14180470336882,-0.262847903756779,-0.164173195570443
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,-0.348440931187674,0.245327594395036,0.423391096862812,-0.382719619046009,-0.470033086934438
BURTON_ADIPOGENESIS_10,0.0362593180400088,-0.0028187355622154,-0.271245382054974,-0.530045426884945,0.10513779286157
ABE_VEGFA_TARGETS_2HR,-0.201560858926859,0.0507062824213875,0.114451046656005,-0.141084709414627,0.04960311828387
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.0518850639893194,-0.000513127762707399,0.343730227588397,-0.218551159099753,-0.328802969396196
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,-0.111842128087978,-0.106665337944955,-0.0413129723520996,0.149448233603319,-0.12457493810678
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,-0.0355187247823009,0.160344273804323,0.0605804656355797,-0.287094385447651,-0.213758737425494
IVANOVA_HEMATOPOIESIS_MATURE_CELL,0.0328493795588353,0.0149927449240389,0.158139646376514,-0.490324459922828,-0.138975645748962
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,-0.09285493413542,0.361167595607685,0.44711744746581,-0.623713836030048,-0.256056508407662
KAAB_FAILED_HEART_ATRIUM_DN,-0.161502095757791,-0.0955738764176225,0.157176168868363,-0.257752971352856,-0.235291093502231
SU_PANCREAS,-0.179565987477969,0.139574445759833,0.16124174345261,-0.0385826689646708,-0.183973131509804
ZAMORA_NOS2_TARGETS_UP,-0.130127262892525,0.487254938963377,-0.381083703230841,-0.00240785478302052,-0.47034021546408
JIANG_AGING_CEREBRAL_CORTEX_UP,0.102365322240689,-0.0689246943397677,-0.254243029002478,-0.222292307476977,-0.181823832076441
WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.127789784028092,-0.0951931615544007,-0.451864011416795,0.2960722465941,-0.553837875844616
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,-0.0268470371576035,0.0585417548048972,-0.0643726815401567,-0.22858283961087,-0.270988761615291
BRACHAT_RESPONSE_TO_CISPLATIN,-0.0101286735075406,-0.131067276479399,0.189063476997354,-0.178312547289096,-0.296126470437992
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.0563289502302944,0.175238157672183,0.140213411996848,-0.466559243803119,-0.180035892179549
LU_AGING_BRAIN_DN,-0.059237085760283,0.151433105022797,0.243841973363186,-0.453112820068435,-0.236311432418781
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.224844268984745,0.440022730922833,-0.182411694113374,-0.289447809928181,-0.3062646926227
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,-0.0486347577267395,-0.230347842661528,-0.152209313213328,-0.122179149469575,-0.139203281382155
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,-0.236516446220146,0.0824166100275378,0.162991500970203,-0.27427894003921,0.110099596018977
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.0891775756160004,0.189098641753356,0.0329837054567561,-0.153518334297831,-0.562200949659069
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,-0.112675540455249,0.127609285547321,0.251508231304443,-0.430739258328385,-0.435944378263413
ZHOU_TNF_SIGNALING_4HR,0.230877236238357,-0.102398111009185,-0.250071628832485,0.0844474008448169,-0.315643189530024
MARCHINI_TRABECTEDIN_RESISTANCE_UP,-0.362492773787811,0.384314740153307,-0.0360619634531247,-0.0317899452842703,-0.352998097641547
GENTILE_UV_LOW_DOSE_UP,-0.0772354244504312,0.47794087491524,-0.588044463123346,0.30335101213278,-0.456545692614734
BROWNE_HCMV_INFECTION_16HR_DN,-0.141377184834649,-0.165840629088613,0.190868517061901,0.13254187594502,-0.296880185444341
WESTON_VEGFA_TARGETS_6HR,-0.216861895709773,-0.0255583841222089,-0.0818490663111413,0.0486054940410377,-0.177740928714743
RAMALHO_STEMNESS_DN,-0.106932471941787,0.0847052953916357,0.332385534161534,-0.217075394098002,-0.252142536763452
ONGUSAHA_TP53_TARGETS,0.0565005383699723,-0.387098770363497,-0.192167412643574,0.0291420979217257,0.0611611003082965
GENTILE_UV_RESPONSE_CLUSTER_D4,0.0273024087329109,0.24921645439393,0.145278193920331,-0.434621216579167,-0.445223542670802
RHODES_CANCER_META_SIGNATURE,0.187044463531773,0.14832702190559,0.281783586265837,-0.300313265921628,-0.533220419475489
LIAN_LIPA_TARGETS_6M,-0.0398859601413477,0.32057546220974,0.214454840646729,-0.252807674413586,-0.106371263504331
WU_HBX_TARGETS_1_DN,-0.238780461209881,0.556887596806551,-0.0778576469765706,-0.124949369816119,-0.509854141554797
HARRIS_HYPOXIA,-0.0379107687212114,0.133414306676764,-0.0961632130074863,0.00983428746642756,-0.411001878001678
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,0.0305339128769437,-0.195905618744411,0.090963618309049,0.100477990519757,-0.319599814414306
BROWNE_HCMV_INFECTION_10HR_DN,0.0758165343895431,0.410373019996015,-0.191933101783333,-0.547073775413483,-0.0258875411565674
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,0.0529338850170587,0.0447104803727123,0.302235586394554,-0.306416414047398,-0.491495277482066
HENDRICKS_SMARCA4_TARGETS_UP,0.0928828590395046,0.109218335622428,-0.25668997867915,0.135747811595967,-0.414411849104533
MURAKAMI_UV_RESPONSE_6HR_DN,-0.0636476209875206,0.321501717917961,-0.0110880764991994,-0.269897423637093,-0.360279305810069
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,-0.228628666040082,-0.23762613092868,0.497978638850907,-0.304979059496846,0.0849425252906129
RAMALHO_STEMNESS_UP,-0.0243057751602215,-0.0457594417296615,0.254085788800298,-0.463537495129068,-0.193175747002209
MCDOWELL_ACUTE_LUNG_INJURY_UP,-0.103190074035192,0.162449891115132,-0.168726736339093,0.208594736301024,-0.319334219958655
WANG_SMARCE1_TARGETS_DN,0.000323339449918164,0.0302998814729057,0.0732705607546363,-0.309497265267048,-0.199704930209184
SU_TESTIS,-0.359072862340359,0.208339416605151,0.486442712225154,-0.492523628643627,-0.0551031662165253
SESTO_RESPONSE_TO_UV_C6,0.321431859916427,0.288693643137874,-0.287621833318036,-0.0978797799754123,-0.400297684469168
MCCLUNG_CREB1_TARGETS_DN,0.162289120044454,0.153936519312605,0.15542584727745,-0.493723775002755,-0.362997768612836
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,0.0821273882228041,-0.0302583481176873,0.3271628884546,-0.577853796345389,-0.144765826231396
SESTO_RESPONSE_TO_UV_C2,-0.0147085288197143,0.466171246520851,-0.379764447630832,-0.296614251720201,-0.468274925552601
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,-0.217753403089161,0.100897941075035,-0.0169966562066291,-0.0272891978294304,-0.141673333092454
HU_GENOTOXIC_DAMAGE_24HR,-0.310691238841505,0.248653057145742,-0.0091054149393705,-0.206131435056683,-0.317251891945696
CUI_TCF21_TARGETS_UP,-0.541547488014665,-0.25831424265227,-0.148536913053236,0.395282357332061,0.120644469227534
CUI_TCF21_TARGETS_2_DN,-0.137160010937119,-0.0114254128124686,0.156775672339104,-0.361629982399729,-0.0733163665659057
VIETOR_IFRD1_TARGETS,0.281434429394131,0.382047858948104,-0.0575677209968556,-0.343022587009461,-0.341635594138398
PAL_PRMT5_TARGETS_UP,0.0371253974000846,-0.0682576614853377,-0.0197425327542605,-0.182593579018112,-0.313291839605519
VARELA_ZMPSTE24_TARGETS_DN,0.152037010896602,-0.0206101468029511,0.183587484733352,-0.184806701447817,-0.235025447197589
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,-0.112826328652801,0.13352940272238,-0.158752504973309,-0.121154929341298,0.026714989199917
JIANG_AGING_HYPOTHALAMUS_DN,0.485319373873769,-0.371115256042329,0.0295169960146805,0.338519524691933,-0.514804905108249
CHANG_IMMORTALIZED_BY_HPV31_DN,0.113750284606432,0.0964530884334311,0.140462557617145,-0.230029533052171,-0.318700644707884
BROWNE_HCMV_INFECTION_24HR_DN,-0.236302391118193,-0.0350124685943709,0.106839544483951,0.0274617655582272,-0.228841650331992
CHIBA_RESPONSE_TO_TSA_UP,-0.174235702055678,-0.104897962771182,-0.120034866904235,0.380931073154952,-0.485189606569379
RAMASWAMY_METASTASIS_DN,-0.359622868506115,0.0708571399804637,0.325245486622537,-0.197728794237375,-0.204784581563986
MODY_HIPPOCAMPUS_NEONATAL,-0.268271801422062,-0.407615450047225,-0.250020554756842,0.161302454713422,0.096128777043601
MCCLUNG_COCAINE_REWARD_5D,-0.339372108804383,-0.0455906037349341,0.394798723754469,-0.259721550070285,-0.0220492090060629
KAYO_AGING_MUSCLE_UP,-0.214167320037924,-0.0225640917281724,0.28628096392608,-0.315615704790795,-0.154400648691652
BROWNE_HCMV_INFECTION_14HR_DN,-0.122013734385252,0.0386497975293126,-0.00254900933936013,-0.186454726430191,-0.14574116792316
DELASERNA_MYOD_TARGETS_DN,-0.210047685258032,0.118517118253682,0.0443402261199916,-0.0703928876864467,-0.195674991477636
YAMAZAKI_TCEB3_TARGETS_UP,-0.366698970453697,0.0426723426945238,-0.0154549360824047,0.0770565630809424,-0.103537165914059
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,-0.163596201016175,0.251681385892851,0.214803825547555,-0.354270866792552,-0.194144660063266
JIANG_VHL_TARGETS,0.178295134072285,-0.0310708577714999,0.0278993673365869,-0.405836208801748,-0.308369194450743
MACLACHLAN_BRCA1_TARGETS_DN,-0.493808237666872,0.0109912766374995,0.0265225411440252,-0.0158408569211099,0.0484857473199569
LEE_AGING_CEREBELLUM_DN,-0.293977292428239,0.170465254878876,0.203310910101958,-0.108710215796793,-0.226286573453352
BROWNE_INTERFERON_RESPONSIVE_GENES,-0.159677790139212,0.407848265654039,-0.356036327176969,0.00967330406905098,-0.285061766599318
MCCLUNG_DELTA_FOSB_TARGETS_2WK,-0.398998530482449,0.103335026175016,0.325730527525197,-0.382820561759889,0.166306055781157
CUI_TCF21_TARGETS_DN,-0.0513554332541531,-0.107701425697234,0.34014430397267,-0.420827176279489,-0.254723314147893
SU_THYMUS,-0.199642324983515,-0.176924089861818,0.522054519111861,-0.392871412408548,-0.00139028888307199
KANG_FLUOROURACIL_RESISTANCE_DN,-0.204926603572856,0.383071993780342,0.0898238300157522,-0.238595586287687,-0.161646369013137
BROWNE_HCMV_INFECTION_8HR_UP,-0.0872552350358391,-0.0550608347233377,0.175076836063953,-0.220367057416584,-0.187674647601832
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,0.000145999253263307,-0.0661802233844693,-0.183189656679488,0.255077602035599,-0.309714531725309
JI_RESPONSE_TO_FSH_DN,0.225127728753116,-0.103801756480914,0.423007530137608,-0.451121736115448,-0.53703933976556
WESTON_VEGFA_TARGETS_12HR,-0.244140648660182,-0.0115933080530622,-0.12100706123959,0.318541337156286,-0.245016296397896
KRASNOSELSKAYA_ILF3_TARGETS_UP,0.0527689119356927,0.185371588834837,-0.361870643780041,0.176086130771281,-0.37014207256119
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0630911213960159,0.15519133589994,0.0722736935116396,-0.190544322498247,0.0295445551652596
BAELDE_DIABETIC_NEPHROPATHY_UP,0.108845550236758,0.183157776381458,0.257055540285117,-0.289250981255636,-0.3749629630661
LINDVALL_IMMORTALIZED_BY_TERT_UP,-0.061822877413548,-0.22425437797089,-0.248255162650085,0.263791885262,-0.359768958376491
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,-0.036487430979908,0.208013800836583,-0.0478464418413757,-0.128552232420864,-0.383273395173797
MURAKAMI_UV_RESPONSE_6HR_UP,-0.118308371436396,0.0176162562703353,-0.131204391381987,0.124825332017957,-0.323814989416912
BROWNE_HCMV_INFECTION_20HR_DN,-0.0842178623358334,0.086292808203425,-0.0563018226403436,-0.136728555860891,-0.234502349565716
SIMBULAN_PARP1_TARGETS_UP,-0.00985790990193697,-0.442263420383554,-0.287571436613649,0.473320297257086,-0.080839051903508
ULE_SPLICING_VIA_NOVA2,-0.362492125938256,-0.212149419753985,0.380141724957479,-0.26740799935756,-0.0512059632949498
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,-0.274000597351552,0.194504182829071,0.326523101729794,-0.410631415501528,-0.145245546295348
IVANOVA_HEMATOPOIESIS_STEM_CELL,-0.233858156738583,0.123798506079671,0.20643253993792,-0.399739610249567,0.112922885504281
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,-0.353518597772989,0.0621427610039115,0.15519096192201,0.185132187502455,-0.325866547307105
MEDINA_SMARCA4_TARGETS,-0.276673351227462,0.402324890341347,-0.164292398582231,-0.166737476421835,-0.313360029592349
MAHAJAN_RESPONSE_TO_IL1A_DN,-0.0955292833435258,-0.316918149708962,0.225809323425589,-0.31442736760422,0.0153869231119332
RUAN_RESPONSE_TO_TNF_DN,0.0220630547275424,-0.161276872970885,0.165849404008782,-0.150594341944567,-0.170805729018577
DELASERNA_MYOD_TARGETS_UP,-0.177478062867453,0.0404774969184549,-0.097421780336948,-0.0291221893726017,-0.226527946217253
BURTON_ADIPOGENESIS_12,-0.225329077228339,0.00713111931257498,0.338162852203544,-0.366036531749488,0.00872590171801513
LEONARD_HYPOXIA,-0.307443565219845,0.208863473772342,-0.311181664715301,0.141520230616977,-0.241430188338569
KAYO_AGING_MUSCLE_DN,0.128148960259987,0.215312494976312,0.0678340807713916,-0.305441912361401,-0.413244567323678
KAAB_FAILED_HEART_ATRIUM_UP,-0.214589106737413,-0.172028419003923,0.271718179848443,0.276639541791751,-0.236503938338984
INGA_TP53_TARGETS,-0.158676665677172,-0.207463018764674,-0.560465101537419,0.58160183164752,0.195548517635658
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.154231844740322,0.278458573745528,0.450267023185263,-0.584673566921788,-0.494614561972567
DASU_IL6_SIGNALING_SCAR_UP,0.032652526802061,0.143023604851417,-0.0929651614731506,0.0211852313262383,-0.465846294552712
LINDVALL_IMMORTALIZED_BY_TERT_DN,-0.218289427554656,0.278483481049311,-0.17392733973128,0.138259592217257,-0.26415022732299
DAZARD_RESPONSE_TO_UV_SCC_DN,-0.201681389628159,0.395362128890723,-0.111975059775538,-0.208320671753671,-0.452639616624911
CHIBA_RESPONSE_TO_TSA,0.261849786141728,-0.34484996803136,-0.216458257375749,0.152688245541009,-0.281880059730162
RODWELL_AGING_KIDNEY_DN,0.054904056116093,-0.16965565277174,0.387962136902781,-0.58411014337779,-0.0388022982043125
KANG_DOXORUBICIN_RESISTANCE_UP,0.251063901706759,0.409061259920481,0.180313695173026,-0.591731760393974,-0.493360766622988
BROWNE_HCMV_INFECTION_48HR_DN,-0.243916703365261,0.0745790449332982,0.0380949992539399,-0.152997043706774,-0.165576006661677
BROWNE_HCMV_INFECTION_48HR_UP,0.185694177394242,0.091392766598028,0.0731554206554837,-0.361034931245333,-0.215736352489219
BURTON_ADIPOGENESIS_5,0.258337132155906,0.047663979443661,-0.0682946944179879,-0.354165749169253,-0.335337039407295
WESTON_VEGFA_TARGETS,-0.128911295661988,0.190990264898628,-0.00860203276913307,-0.179371317202648,-0.269739978831691
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,-0.120474412667528,-0.0547795161520088,-0.0965590893750068,0.134268251513579,-0.294934237876959
BROWNE_HCMV_INFECTION_8HR_DN,-0.187433432233231,-0.133342386923547,-0.133639072579336,0.138079643204645,-0.330852512973093
APRELIKOVA_BRCA1_TARGETS,-0.304534576932992,0.11938916604379,0.287839337549537,0.0102196071312602,-0.261487142314838
VERRECCHIA_RESPONSE_TO_TGFB1_C2,-0.246130082139135,-0.331708604902234,-0.508805627862757,0.569981730549357,-0.563842024483249
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,0.000801305790129853,0.205557804633869,0.362776295915601,-0.461944146912216,-0.446580390669932
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,-0.208404362178951,0.156014204285496,-0.141955242838633,0.162151128685616,-0.357594866105119
BRACHAT_RESPONSE_TO_METHOTREXATE_UP,0.0542124088254769,0.23604313791405,0.119127051882363,-0.311864303029365,-0.36299861502009
RHODES_UNDIFFERENTIATED_CANCER,0.0371675485642783,0.32735299006043,0.0961740449606364,-0.52668968172861,-0.424392448000302
BROWNE_HCMV_INFECTION_14HR_UP,0.0484473238780264,0.130930190785346,0.285275359568581,-0.463335474756027,-0.350281855301042
YAMAZAKI_TCEB3_TARGETS_DN,0.198531735633828,0.235321525343074,-0.0150383260587574,-0.492577637208191,-0.327347393080924
LEE_CALORIE_RESTRICTION_MUSCLE_UP,-0.16334217857829,0.239877472765119,0.196907092819872,-0.10801204563447,-0.303344487583979
LEE_AGING_MUSCLE_DN,-0.412932688566622,-0.197314645243473,0.169857837343145,0.090475202861124,-0.237316922368474
ZHANG_PROLIFERATING_VS_QUIESCENT,0.0438696723287093,-0.00435382369530696,-0.237128796203591,0.0972380310699859,-0.271033023874305
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.207547849710462,0.122879035240994,-0.327391275566629,0.0670994669488671,-0.467977956400084
GERHOLD_ADIPOGENESIS_DN,-0.304788299587172,0.24910775439893,-0.316446529586299,0.156099936658627,-0.39715275666565
LU_AGING_BRAIN_UP,-0.0971693140844589,0.0332632550543435,0.0893073510101302,-0.252800029027299,-0.0790823096859001
BURTON_ADIPOGENESIS_3,0.168286495918616,0.310824450686446,0.124794304814343,-0.506002741510531,-0.420778261778419
DAZARD_RESPONSE_TO_UV_NHEK_UP,-0.0208758889161602,0.300412167344219,-0.0575978472621421,-0.0494481737185759,-0.389796513393716
LIAN_LIPA_TARGETS_3M,-0.0149941718290437,0.369378905786306,0.23840831985181,-0.181099810660179,-0.224882948320729
ZHU_CMV_ALL_UP,-0.0255307951426821,0.293918322561623,-0.189416409048483,-0.226696696889973,-0.311335688639002
BURTON_ADIPOGENESIS_8,0.0843941507497014,-0.183032066606855,-0.159475127623345,-0.0548015994962304,-0.152468520041733
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,-0.253489280937504,-0.0603022199367095,-0.195515388677421,0.174626919565919,-0.181082616917344
BURTON_ADIPOGENESIS_2,-0.498222386745122,0.0411845851360405,-0.0622009409984395,0.179080578042213,-0.173237239021276
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,-0.355223002291757,-0.421156836881088,-0.324451026469605,0.468097301819515,-0.385967882386558
XU_GH1_EXOGENOUS_TARGETS_UP,-0.229344154496245,0.450631386841589,-0.0510832322259888,-0.126646672481427,-0.165386457790686
ZHU_CMV_8_HR_DN,0.0314101658680326,0.108899220966869,-0.381945221805008,-0.0106281169068105,-0.13488351326524
ZHU_CMV_24_HR_DN,-0.373411644195507,0.0394812220167219,-0.276215628941546,0.368570466653362,-0.272690589086983
SU_KIDNEY,-0.598473882800219,0.476782577382694,0.34919191023224,-0.433193543765337,-0.0454368883476269
GENTILE_UV_RESPONSE_CLUSTER_D2,-0.589031931355367,0.159545008813537,0.192906621638717,-0.137169634704804,0.136562504012969
PAL_PRMT5_TARGETS_DN,0.0263201618436238,0.279577973459708,0.169837959985088,0.030801213111689,-0.593010547342969
VISALA_AGING_LYMPHOCYTE_DN,0.307014647716771,0.12821714662624,0.145001855630844,-0.620644642924784,-0.347837509049868
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,-0.0362136521193578,0.326715727704809,0.151477390368386,-0.337114081641608,-0.480740535507142
CHEN_ETV5_TARGETS_SERTOLI,-0.0261105916345624,0.34618108219182,0.175897471302838,-0.353302636027062,0.165328803797882
BROWNE_HCMV_INFECTION_18HR_DN,-0.177173703119845,0.259158614142873,-0.0373964346565356,-0.103857915668424,-0.229228578730433
MOREIRA_RESPONSE_TO_TSA_UP,-0.0231638787213982,0.44796811989108,-0.317366096890996,0.248415987923756,-0.629061757253383
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,0.00310487010120408,0.152817568773143,0.074750986497745,-0.0800464729737971,-0.525561482739283
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,-0.191146123609129,0.0290015887283234,-0.371787804966781,0.567177323944133,-0.522929806855876
DAZARD_UV_RESPONSE_CLUSTER_G4,0.319838243133418,0.365580748094037,-0.0823692479639386,0.249299913239137,-0.726353790532178
GENTILE_UV_RESPONSE_CLUSTER_D7,0.10131518404564,0.461362437377918,-0.276044281906111,0.165019942352807,-0.650088856230248
EHRLICH_ICF_SYNDROM_DN,-0.187770720807534,0.353012444532432,0.0860595569620002,-0.455413612909153,-0.289091987244101
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,-0.12888309444094,0.0389382956602147,0.286536495823871,-0.374264306100638,-0.179389585868553
GENTILE_UV_RESPONSE_CLUSTER_D6,-0.476988508979065,0.124922489069004,-0.467085491121272,0.19124686465061,-0.167022972020112
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,-0.172064657269522,-0.0296046996725691,-0.241914853874192,-0.0558393759933248,-0.161613703341787
BROWNE_HCMV_INFECTION_18HR_UP,-0.221304173567689,0.136544551989022,0.181945340432544,-0.378887389554915,-0.0986450967314152
LEE_AGING_NEOCORTEX_UP,0.161505446694186,-0.185340129399134,-0.0995354336593927,-0.0545960006632454,-0.347521968375176
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,0.278472406256626,0.34048193530612,0.204424612443862,-0.629289346714999,-0.491315907528013
BURTON_ADIPOGENESIS_PEAK_AT_24HR,-0.0642255171082445,0.662695656315914,-0.0851719002033427,-0.474202370011177,-0.476078415173801
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,-0.295688683303132,0.182647369606152,-0.189125270311879,0.182239416544014,-0.211917228644408
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,-0.0720206570645143,0.294428110359571,-0.276392423679466,-0.153278413515817,-0.179387061210416
GENTILE_UV_HIGH_DOSE_DN,-0.210758720813212,0.305208861903628,-0.164789462883607,-0.128484942602309,-0.352908540070726
HENDRICKS_SMARCA4_TARGETS_DN,-0.378117139876461,0.217226369445424,0.155122213094207,-0.100833053917066,0.0623045137875808
HAN_JNK_SINGALING_UP,-0.384291602148473,0.196725126891781,-0.28415425154561,0.174355052729663,0.0156949178378824
SESTO_RESPONSE_TO_UV_C0,0.318814678605866,0.106218366158225,-0.0992854094363258,-0.169910447437943,-0.444869835917237
MCLACHLAN_DENTAL_CARIES_DN,-0.387023023102768,0.0784111316603606,0.294622428415802,-0.322463877438472,0.00701706091681917
BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.0925493559441906,0.260631051692474,-0.498451223422848,0.440628243905535,-0.386635564848846
MCCLUNG_CREB1_TARGETS_UP,-0.276809732987135,-0.055535789825344,0.187348533068555,-0.175275937303474,0.115118648664679
LEE_AGING_CEREBELLUM_UP,-0.0843520733167391,0.108944029585234,-0.0812994205464133,-0.190489750824419,-0.0415848057647026
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,-0.282536660319558,0.118248717606514,-0.125428299064524,0.0558354626421322,0.0984468183557776
TSENG_IRS1_TARGETS_DN,-0.278447811306857,0.0428149506677286,-0.10971062141065,0.0400962032574934,-0.277305969470523
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,-0.265913977351208,0.0715443824729283,0.212147836618795,-0.00347747212546659,-0.414511503471476
RODWELL_AGING_KIDNEY_UP,-0.195252398582708,0.11760468983907,0.0675890960010657,-0.0168734868902045,-0.330493949914398
MCCLUNG_COCAIN_REWARD_4WK,0.0413619805993942,0.177289880138066,-0.0273638862572987,-0.142578998792578,-0.158957925517809
ZHOU_TNF_SIGNALING_30MIN,-0.196026336165633,0.25313393865876,-0.48975906775525,0.366547876264484,-0.317628592308729
WELCSH_BRCA1_TARGETS_UP,0.0553374920902972,-0.197839458952119,-0.00778848229376033,-0.201794344993323,-0.181130259439231
JACKSON_DNMT1_TARGETS_UP,-0.0137646319600039,0.0450413687483419,-0.122985990351325,0.207297894465963,-0.343980648807717
CHANG_IMMORTALIZED_BY_HPV31_UP,-0.0543058560696744,0.151006135686479,0.251320323719189,-0.270841523729644,-0.229434660995604
MODY_HIPPOCAMPUS_PRENATAL,0.216028935270794,-0.49582993691253,0.0651535856225628,-0.459596723591915,0.443195928634551
BURTON_ADIPOGENESIS_4,-0.0822142469651694,-0.134788543364165,-0.285933546719157,0.0499909895251915,-0.0538791103649419
ZHU_CMV_ALL_DN,-0.302405256696463,0.0553386353748375,-0.274894339337314,0.319192182560215,-0.239393020841864
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,-0.114626053693533,0.0565228796787312,-0.0507197036261659,-0.247130661766466,-0.148709245756381
SU_LIVER,0.0887463688950594,0.226393085473945,0.336670479999817,-0.43813305853299,-0.111863224815935
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,-0.201965475703039,0.0331834135048011,0.0678601460569369,-0.105096004520368,0.103082395487952
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,-0.0679195666623087,-0.153562406767903,0.255472764353976,-0.380039273803199,-0.107943533362516
LIANG_SILENCED_BY_METHYLATION_UP,-0.0438599433318571,0.363032355567782,-0.393081113006012,0.300635921172204,-0.538779191068744
SONG_TARGETS_OF_IE86_CMV_PROTEIN,0.278073146399826,-0.0643981617353707,-0.0443122074297879,-0.580235831487019,-0.186409217308572
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,-0.253644766451965,0.345250717878647,0.267662844155804,-0.122715506601092,-0.473980990505631
CUI_TCF21_TARGETS_2_UP,-0.221155073036761,0.193358669723104,0.0325790868273731,-0.245346835774553,-0.195095001440975
SESTO_RESPONSE_TO_UV_C1,0.0256861364775101,0.278942611239141,0.0521988465117371,-0.0184609835527862,-0.496191993394124
LY_AGING_MIDDLE_UP,0.290170214653163,0.0869427676928826,-0.303822053098687,0.276553296279335,-0.372657088316989
WENG_POR_TARGETS_GLOBAL_UP,0.411360398743737,0.0271543144065539,0.0966749657267255,-0.400281172271615,-0.200930561735864
GEISS_RESPONSE_TO_DSRNA_UP,0.466609483407597,0.149764416788715,-0.570132129431732,-0.193536413951506,-0.2369119223268
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,0.0147754819588417,0.0800748989033616,0.222156705947856,-0.319807655930139,-0.444394174883736
BURTON_ADIPOGENESIS_1,-0.324119712316472,0.546413348024886,-0.502331870691773,0.125033706310965,-0.383188290604271
WENG_POR_TARGETS_GLOBAL_DN,0.00877533542340486,-0.0939646570369831,-0.122452701553158,0.0553042582494786,-0.0606623326963403
BURTON_ADIPOGENESIS_7,0.153349841756823,-0.000259124935162225,-0.466465341680026,-0.0195950581225681,-0.121893074808419
BROWNE_HCMV_INFECTION_10HR_UP,-0.0873728947561187,0.159299243808521,-0.170086066482442,-0.310235533182366,0.0691344613958382
LIU_SMARCA4_TARGETS,-0.201332933807109,-0.0836099873785233,0.0597527770903848,-0.0487059218196695,-0.149719362843008
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,-0.137970303614689,0.124608380130038,0.141254084510281,-0.285864297147693,-0.390491622535186
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,-0.347183480136212,0.442515192926855,0.241741299577506,-0.0082157266270082,-0.401356104952788
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,-0.413628728434239,-0.318923961802935,-0.411110890321298,0.685355908591597,-0.182849983618479
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.170974369495311,0.0302619668456777,-0.323937369690268,-0.0631835964278091,-0.336256075449986
BURTON_ADIPOGENESIS_PEAK_AT_0HR,-0.146502621584897,0.0609715521454013,-0.149892580124548,0.00684091443118895,-0.142074564275169
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,-0.0847185894951788,0.14325590695509,-0.0144417175147416,-0.0211374718627446,-0.307553621156765
JACKSON_DNMT1_TARGETS_DN,-0.0298449878497314,0.267613121719155,-0.0539247009636984,-0.0104916641590085,-0.173587727053353
DAZARD_RESPONSE_TO_UV_NHEK_DN,-0.255223489593513,0.105930319081198,0.0920853587137724,-0.448065454701546,-0.089879748073248
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,-0.305003960623424,0.144602444671091,0.122889111981285,-0.303852135117018,0.0490015563146532
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,0.373216266150739,0.300536166174555,-0.202587634170857,0.0043283176204372,-0.640626665057733
ZHU_CMV_24_HR_UP,-0.0904474542745754,0.122092527818028,-0.163297305285399,-0.133350951657463,-0.309141487633118
BURTON_ADIPOGENESIS_11,-0.405846636718117,-0.0710320039074504,0.215810486706252,-0.208684912826396,-0.0757586978440857
BROWNE_HCMV_INFECTION_12HR_UP,-0.307779399116607,0.215715572942378,0.117797872173742,-0.353881198372339,-0.0426847487968987
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,-0.17045258058301,0.147936338058147,0.0392281453916238,-0.385707340022499,-0.0297833354273278
RAMASWAMY_METASTASIS_UP,-0.12386685825495,0.0313489609209211,-0.00582928131120233,-0.169366428038129,-0.319490519012772
DAZARD_RESPONSE_TO_UV_SCC_UP,0.0586430297561253,0.0250449037326755,0.0119769979974628,-0.327204205154118,-0.118405834673784
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,-0.335457094123507,0.140805769551651,0.122629839782475,0.0689307087207977,-0.276248006435153
JIANG_HYPOXIA_NORMAL,0.0656141796463407,-0.0359466256228745,-0.148992019337443,0.0766538915637675,-0.374886851244945
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,-0.185966101288361,0.433577708619224,-0.340028029616722,0.426398698561431,-0.533627211780627
ABE_INNER_EAR,-0.242071346549683,0.358447335750145,-0.087691246607971,-0.568520538208141,0.115009014019234
TSENG_IRS1_TARGETS_UP,-0.201595640567578,-0.062546594163028,0.0639106616060808,0.0413038642053616,-0.0437953090387351
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,0.153879274049276,0.399340801324697,0.183528780061558,-0.130859090880253,-0.729839808499228
XU_GH1_AUTOCRINE_TARGETS_UP,0.00353443772980003,0.0797937273314552,0.0679898642728799,-0.316226385570376,-0.0466512248239276
XU_GH1_EXOGENOUS_TARGETS_DN,-0.260178396293518,0.194088638767326,0.275165927685687,-0.389354787615688,-0.0939776588125071
BAELDE_DIABETIC_NEPHROPATHY_DN,-0.189046987646451,-0.0691290544157641,-0.109392760374157,-0.173696932784752,-0.0979943097063959
BROWNE_HCMV_INFECTION_6HR_UP,-0.22562515343608,0.210981208456763,0.0247702402736496,0.00740660929745532,-0.180345748863437
DAZARD_UV_RESPONSE_CLUSTER_G1,0.0668490906995919,0.394957934554302,0.0670749354111866,-0.23823105806415,-0.36078637830671
LY_AGING_OLD_DN,0.113441736390835,0.032301043366628,0.142722609005383,-0.259584394384107,-0.542081367377546
WENG_POR_DOSAGE,-0.100044522110858,0.323898323935228,-0.251196591102618,0.302510775360613,-0.498276455751503
SEMENZA_HIF1_TARGETS,0.0214599026480068,0.200829546901923,-0.347968617358087,0.202551576684132,-0.582207645261189
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,-0.288429249039174,-0.198858862271971,0.414628055471832,-0.246686016173355,0.151963255308915
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,-0.0040358493916724,0.224439036911477,0.0658488468612309,-0.352058806393715,-0.180446357449366
VARELA_ZMPSTE24_TARGETS_UP,0.127091189858308,-0.0124962355906678,-0.141936660790141,-0.0233571848024003,-0.0848292377978333
YIH_RESPONSE_TO_ARSENITE_C3,0.361643259647429,0.00445282260154387,0.581651662429729,-0.504941764706407,-0.499132363665077
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,-0.00691319725159875,0.196518401436859,-0.0368610308608272,-0.262941020767071,-0.179257790712894
CHENG_RESPONSE_TO_NICKEL_ACETATE,0.0418190716395623,0.226094450690997,-0.418847981669361,-0.0832552278995238,-0.43563600376326
TSENG_ADIPOGENIC_POTENTIAL_DN,-0.422832852591943,-0.03996272276413,0.093426020019437,-0.0142737995075546,-0.223364613679126
DAZARD_UV_RESPONSE_CLUSTER_G6,-0.265708607556773,0.027174117003634,0.276030207997157,-0.481723386376742,-0.0444147159080771
XU_GH1_AUTOCRINE_TARGETS_DN,-0.0259444243767959,-0.225164348581069,0.131083869538903,-0.36005664741655,-0.0445468846429646
SESTO_RESPONSE_TO_UV_C7,0.288097687221992,0.164538386187045,-0.238642096348462,-0.248154017941709,-0.325431660715141
KAAB_FAILED_HEART_VENTRICLE_DN,0.0711364960616294,0.253640583510248,0.117319259598105,-0.343576188508702,-0.509143383312715
JIANG_HYPOXIA_CANCER,0.0891247810338784,0.340977856860146,0.167338911150838,-0.301207266231862,-0.698187831405262
ZAMORA_NOS2_TARGETS_DN,-0.155614182579248,0.0947936842726544,0.14775338708599,-0.000332403466334147,-0.500321327609224
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,0.0852842764090611,0.118722375534677,-0.0625163691190649,-0.0736762569550182,-0.353755861568138
BURTON_ADIPOGENESIS_PEAK_AT_8HR,-0.355683089263139,0.170839711202444,-0.0885714834150033,0.404744070225779,-0.394006909135
SAFFORD_T_LYMPHOCYTE_ANERGY,-0.157094449183511,0.265700959800712,0.0233359683564114,-0.360890015644803,-0.024935220941157
WU_HBX_TARGETS_2_UP,0.212586489297766,0.549703149034591,-0.413468705182305,-0.0456146616187993,-0.596370334211165
SESTO_RESPONSE_TO_UV_C5,0.152952878653547,0.38837267871579,-0.0602391682019572,-0.427917910752697,-0.613972872725014
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,-0.329626256768068,-0.0844711523639835,-0.0593329389312967,0.559124910838798,-0.356657675312217
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,-0.102255987139456,0.244114818441852,0.0178492409549866,-0.163195043215078,-0.282348132727162
WENG_POR_TARGETS_LIVER_UP,0.196328404081933,-0.0682987542988217,-0.0841157995659439,-0.241260699337089,-0.0424580995181904
HU_GENOTOXIC_DAMAGE_4HR,-0.0453914593530407,0.0867098922578968,0.24099238504861,-0.0700241803474121,-0.563752451786563
MCDOWELL_ACUTE_LUNG_INJURY_DN,-0.142349844179582,-0.0225602749526804,0.460120106283499,-0.422446854877342,0.00542549840130296
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,0.326538548930101,0.0187777247624436,0.0309317827570448,-0.509406897116008,-0.223309600629747
GENTILE_UV_LOW_DOSE_DN,-0.0553396409822068,0.0651071706630237,0.00553866002726158,-0.247395087723838,-0.415831566719486
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,-0.185599938829034,-0.0319114969187502,-0.287675610280709,-0.115040668911596,0.0593852839373907
GENTILE_UV_RESPONSE_CLUSTER_D8,-0.00742396799276571,-0.428400518596554,0.170018050493177,-0.50544553532378,0.173765689904711
BROWNE_HCMV_INFECTION_24HR_UP,-0.167308929578917,0.18350803744352,0.00623881378902147,-0.278830251639188,-0.173217157767397
WANG_SMARCE1_TARGETS_UP,-0.173006955802373,-0.113664731727745,0.037749386297794,-0.0962024471967592,-0.126936354015981
SESTO_RESPONSE_TO_UV_C3,0.273637357840826,0.571630541748732,-0.384730309602391,-0.147949033236902,-0.524350463277013
HAN_JNK_SINGALING_DN,-0.0619979702334779,0.0295477396969654,-0.259275019424964,0.061287262807961,-0.000266949911421288
KRASNOSELSKAYA_ILF3_TARGETS_DN,-0.31079986151492,-0.147386257212165,0.167499748159621,-0.239575552927,0.0239366679465792
GENTILE_RESPONSE_CLUSTER_D3,0.3695064172231,0.239576641299084,-0.298293868250554,-0.410682257175763,-0.545193512315814
JI_RESPONSE_TO_FSH_UP,0.0171505685369008,-0.216420946887729,-0.0247116898681029,-0.394698928656272,0.135470014960552
LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.0360808187526069,0.0571435179542142,-0.0481364713917168,0.139911772679645,-0.477487657058425
ABE_VEGFA_TARGETS_30MIN,-0.0959640125509259,0.0947531876129119,-0.0229468144712217,-0.40225255865517,0.118751324442148
BROWNE_HCMV_INFECTION_6HR_DN,-0.236251047087214,-0.048290799895781,0.0180895365184851,-0.383209421262237,0.0161634432778277
LEE_AGING_MUSCLE_UP,-0.295056125850666,-0.39026876853568,-0.0993512100730662,0.101463978521191,0.0743449360575927
CHEN_ETV5_TARGETS_TESTIS,0.112394218076858,0.433875936669457,0.337775906825648,-0.587765976823667,-0.497866418597358
ZHU_CMV_8_HR_UP,-0.173791903546423,0.432208250150119,-0.21593510193773,-0.176667380447854,-0.352053562329269
WELCSH_BRCA1_TARGETS_DN,-0.017978284470247,0.340427795415717,-0.325420669518394,-0.058275196911726,-0.427985947371857
JIANG_AGING_CEREBRAL_CORTEX_DN,0.262081412574331,-0.0188400434924319,0.391856408631928,-0.511906509170911,-0.205476656798091
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,-0.151093920691465,0.110582427577024,0.207458420255379,-0.378916554233058,-0.238620813602077
BURTON_ADIPOGENESIS_9,-0.173395535749501,-0.31180798041519,-0.268398246742137,0.134380666848704,-0.0732261723163491
URS_ADIPOCYTE_DIFFERENTIATION_DN,-0.161492645304877,0.0591683535016107,0.0199531907496694,0.232587296184078,-0.473331033565145
BROWNE_HCMV_INFECTION_12HR_DN,-0.457358242351263,-0.0155016253361804,0.321489265490818,-0.223422105473531,-0.0791233210205777
MAHAJAN_RESPONSE_TO_IL1A_UP,0.00945877341432511,0.182235861558525,0.208901866832427,-0.291637652106653,-0.256407791769011
JIANG_AGING_HYPOTHALAMUS_UP,0.519836478507991,0.10114068602456,-0.204083908647063,-0.571700057818784,-0.190487937389518
KYNG_RESPONSE_TO_H2O2,0.0555591189179972,0.298896357823074,-0.387418091985735,0.153086933279942,-0.437913760488236
DAZARD_UV_RESPONSE_CLUSTER_G2,0.10426315390116,0.401258685947514,-0.461035402375925,0.0473243005364185,-0.253754109341201
WESTON_VEGFA_TARGETS_3HR,0.041241261298538,0.267791536761374,0.120580555833733,-0.434989592304183,-0.321443199219686
TSENG_ADIPOGENIC_POTENTIAL_UP,-0.290277987735277,-0.147329628118229,0.417964992064408,0.22951440649135,-0.192093950274405
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.344952961603182,-0.011901572321863,-0.517544670091359,0.219580494514222,-0.366611322593067
MCLACHLAN_DENTAL_CARIES_UP,-0.062092747149449,0.237503308988369,0.132189232131668,-0.239811831001163,-0.153176627686851
GERHOLD_ADIPOGENESIS_UP,0.0181204674420118,0.0617043495701558,-0.0629760922167413,0.0383244682250699,-0.374224248831949
WENG_POR_TARGETS_LIVER_DN,-0.406734977150531,0.175292393978486,-0.0913270571932153,-0.235345584341444,0.217318852585355
SU_PLACENTA,-0.294382797146092,0.0128963189469122,0.0643543657188531,0.127842447473962,-0.0688799714284459
BURTON_ADIPOGENESIS_6,0.0488324075026097,-0.110706103623189,0.13926514175168,-0.250420068100848,-0.263094160127533
BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.197294800561971,0.499664049905339,0.0123834426240779,-0.436534819675438,-0.563865098231558
MARCHINI_TRABECTEDIN_RESISTANCE_DN,0.0179169859515639,-0.0203684210018842,-0.45421938686387,0.159610879709208,-0.314056711151849
BILD_MYC_ONCOGENIC_SIGNATURE,-0.139819178285154,0.272389540578082,0.034015306233397,-0.226507977319658,-0.429730850810391
BILD_E2F3_ONCOGENIC_SIGNATURE,-0.00325946286589873,0.0145559440490014,0.0537708917755887,-0.286017355143302,-0.197011346953501
BILD_HRAS_ONCOGENIC_SIGNATURE,-0.255543344776327,0.195417454869347,-0.0790685112269324,-0.0718684414170156,-0.164583490868306
BILD_SRC_ONCOGENIC_SIGNATURE,-0.117840553846306,0.0418405625089811,0.319367010496982,-0.395665360371299,-0.241437074496612
BILD_CTNNB1_ONCOGENIC_SIGNATURE,-0.0226019805552489,0.0902679684868894,0.25932622997293,-0.383081988505256,-0.434012157547518
DOUGLAS_BMI1_TARGETS_UP,-0.0955439570196479,0.0446831341442509,0.00828163257054851,-0.148395328181267,-0.2242008852098
DOUGLAS_BMI1_TARGETS_DN,-0.00726360874568813,-0.147519626062868,-0.00789350835764879,-0.288857819980624,0.0331657842409378
KRIGE_AMINO_ACID_DEPRIVATION,0.117695219613734,0.295314154801027,-0.339119541227841,-0.181463167456766,-0.296488828312187
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,-0.039228256164173,0.125905892856468,0.0747368183432819,-0.343848154941197,-0.210009109197052
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,-0.0120127891153869,0.107311356424891,0.0698683421575511,-0.321731493472156,-0.277260194813277
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,-0.00827540502620777,0.146117181307562,-0.0179453691844835,-0.321008949429688,-0.224500236271044
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,-0.0256064688763598,0.10638335409245,0.10215091178769,-0.335869630415175,-0.248939118879337
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,-0.162253654941125,0.0449588781037464,0.212444199810008,-0.177969395361955,-0.26639383174597
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,-0.133737559936873,0.10046250129001,0.140117469043636,-0.253041670182933,-0.156517795466602
KIM_LRRC3B_TARGETS,-0.272980585947268,0.413729430691005,-0.176936562272645,0.0977144335626287,-0.0618043755743188
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,0.119441672983762,0.28695042710269,-0.399113098219997,-0.0793982873925856,-0.505355206682173
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,0.289708296201488,0.210537049033364,-0.41236217842683,-0.031996560923402,-0.540281370860751
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,0.326551494920982,0.139198977469868,-0.104101303122977,-0.288489981852945,-0.481477695881257
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,-0.392182380094607,0.599644343059961,-0.189171439240871,0.235236260168868,-0.434931702539078
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,-0.29391698609517,-0.336034820253092,-0.466442344361449,0.485103957097657,-0.198548769888879
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,-0.128869728414343,0.195929166157489,-0.0225081092619918,-0.250762431115343,-0.278887760864515
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,-0.147038919511078,0.0079386350366647,0.0169819609840701,-0.222371978984013,-0.139144827716323
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,-0.0724034096497509,0.0965532808132503,0.113016076483118,-0.350953030020516,-0.212379371279612
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,-0.14481806925494,0.21414773981632,0.259150141805295,-0.418461119366464,-0.263314662427792
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,-0.148588323099354,0.0100634915040178,0.0841203526585347,-0.350390026543101,-0.0105576238797847
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.0582908291722442,0.0818545995493933,0.0870037228456393,-0.326465407380684,-0.177117210804881
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,-0.23109368654363,0.029419617438478,-0.00502629933698295,-0.225434210295788,-0.030835892670638
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,0.156083528066184,-0.000941511051700761,-0.22343861616525,-0.22280499444769,-0.201611384643437
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,0.451550875905113,0.455354561301626,0.073061900486125,-0.573928851069716,-0.590665372913662
LOPES_METHYLATED_IN_COLON_CANCER_UP,-0.132950838528839,-0.152428938326646,0.167176807966831,-0.0919751956044343,0.00949218095709203
LOPES_METHYLATED_IN_COLON_CANCER_DN,0.00738639892579579,0.196025160653324,0.212193300388347,-0.512585614442361,-0.0349086788356812
HARRIS_BRAIN_CANCER_PROGENITORS,0.0372068338976861,-0.0483835640032123,-0.32525375499583,0.226706436528283,-0.18134542417127
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,-0.303989255264857,0.573466326479457,0.196912870795663,-0.559275235988898,-0.0930132806643921
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,-0.325154644963139,0.216514617029895,0.632134761095828,-0.263702783281896,-0.27646112309799
HOWLIN_CITED1_TARGETS_1_UP,-0.0672427964798788,-0.0636088785158168,0.187129967737395,-0.423978559939248,0.342629462992615
HOWLIN_CITED1_TARGETS_1_DN,-0.148864790364384,0.0401026664458967,0.317574562507616,-0.200106579557477,-0.436375622802314
HOWLIN_CITED1_TARGETS_2_DN,-0.35151610192396,-0.266072648116181,0.403632359665728,0.277059020599659,-0.468875461070544
HILLION_HMGA1_TARGETS,0.0128660422828048,-0.0683164878038512,0.0109306277523456,-0.12195606574187,-0.32470167775214
HILLION_HMGA1B_TARGETS,0.0277389635797647,-0.0938068202204008,-0.0479537778410561,-0.115179047404912,-0.129565776539682
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,-0.220793342688452,0.303143203600102,-0.136821066058998,0.00578268822532574,-0.364332799332797
LEIN_NEURON_MARKERS,-0.373639313495062,0.203966237189195,0.396330999164727,-0.487417608296222,-0.126513995109486
LEIN_ASTROCYTE_MARKERS,0.127314449731126,-0.106258122922625,-0.218395267437074,-0.4701230649493,0.152643234513694
LEIN_OLIGODENDROCYTE_MARKERS,-0.161023825256915,-0.059233703624241,0.000859554059831347,-0.14853061132472,-0.00772822109017063
LEIN_CHOROID_PLEXUS_MARKERS,0.0386599819493482,0.0585485549894954,0.13396890163234,-0.296270167561414,-0.136145118929438
LEIN_MIDBRAIN_MARKERS,-0.0947988951238462,-0.108706708023436,-0.0569550929972202,-0.0592584390510241,-0.0503860251063596
LEIN_PONS_MARKERS,-0.249574576396509,0.0814594921952034,0.167502048772449,-0.17714360459335,-0.144310260704527
LEIN_MEDULLA_MARKERS,-0.05261423407973,0.0480269455003355,0.254955481239848,-0.226070838828975,-0.364340236643147
LEIN_CEREBELLUM_MARKERS,-0.156139548536058,0.193592144376475,0.111671355626506,-0.298199848820073,-0.219095274755344
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.247702175956302,-0.234223192276082,-0.434541532261943,-0.334320940632736,0.194442483679013
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,-0.0378169164681713,-0.0343765924400616,0.303294155828228,-0.399786107588986,-0.0916812091686615
GAVIN_FOXP3_TARGETS_CLUSTER_T4,-0.145360837380615,0.194721861293269,0.068592440849478,-0.385529833862819,0.0439701087248428
GAVIN_FOXP3_TARGETS_CLUSTER_T7,0.00140469773709367,0.113734565464491,0.0731488531038125,-0.136860377578746,-0.34471875059334
GAVIN_FOXP3_TARGETS_CLUSTER_P2,-0.135743652139132,-0.00437994991811341,0.258646101258748,-0.296410120671768,-0.0565288229253651
GAVIN_FOXP3_TARGETS_CLUSTER_P3,-0.0684409937674292,0.143103103411472,0.143221405073979,-0.38279491734977,-0.24637635662775
GAVIN_FOXP3_TARGETS_CLUSTER_P4,0.202787196089913,0.0763291742574246,0.165322792411619,-0.328316636919493,-0.204583959492476
GAVIN_FOXP3_TARGETS_CLUSTER_P6,-0.137398784592318,0.221106014878525,0.377251923784202,-0.478308672644943,-0.146178336524255
GAVIN_FOXP3_TARGETS_CLUSTER_P7,-0.173697174911596,0.120583489362316,0.0301217721062212,-0.259870947381971,-0.0464884875040791
GAVIN_PDE3B_TARGETS,-0.0215870402382901,0.0480339319387032,0.0181568732885867,-0.168578022715569,-0.117321612652089
ZHENG_BOUND_BY_FOXP3,-0.30323324942081,0.17561174235504,0.29942418143765,-0.413161388364752,-0.0809975370782863
MARSON_BOUND_BY_FOXP3_STIMULATED,-0.0821846956835598,0.064523118024467,0.0127582749029278,-0.327952187263396,-0.0655706737624674
MARSON_BOUND_BY_FOXP3_UNSTIMULATED,-0.0670804088539229,0.140249125604222,0.070242390696056,-0.310314966933641,-0.196500313956549
MARSON_BOUND_BY_E2F4_UNSTIMULATED,-0.0945084231541446,0.325524975063704,0.0301584521480369,-0.43709728696132,-0.344946816145556
MARSON_FOXP3_TARGETS_STIMULATED_UP,-0.215975089646757,0.426731798582551,0.234757453800768,-0.210205434082177,-0.274842321574131
MARSON_FOXP3_CORE_DIRECT_TARGETS,0.0659563958341406,0.293036746338073,0.0472217417303694,-0.139714505036003,-0.320078245872346
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,-0.237580330712736,0.303010552560454,0.339118916048217,-0.475392106847513,-0.240242097192708
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,-0.252887671905977,0.103546407317077,0.386423737842612,-0.222036904084408,-0.0396973890207954
ZHENG_FOXP3_TARGETS_UP,-0.15151583132406,0.121899162940105,0.326350988957297,-0.468923374753334,0.0386888434495112
SANSOM_APC_TARGETS,-0.195528990295603,0.124350552461459,0.242770889965934,-0.374706844902352,-0.144587081601403
SANSOM_APC_MYC_TARGETS,-0.160008945607078,0.339259963675406,0.0872910453292899,-0.374062455781524,-0.41856179503055
SANSOM_APC_TARGETS_REQUIRE_MYC,-0.187161500720423,0.192750389335934,0.0439655090990663,-0.324361441006227,-0.226721160443806
SANSOM_WNT_PATHWAY_REQUIRE_MYC,-0.219454784523616,0.203073859677259,-0.134037225861192,-0.0514811759617527,-0.0871497131054054
YEGNASUBRAMANIAN_PROSTATE_CANCER,-0.173842557641172,0.217832855222116,0.278996378263379,-0.389360995370156,-0.147984348528517
RIGGINS_TAMOXIFEN_RESISTANCE_UP,-0.190045044530603,0.00731699639461392,0.0699455857757505,-0.1381538087723,0.00249038863772133
RIGGINS_TAMOXIFEN_RESISTANCE_DN,-0.017377813371516,-0.00126217458546607,-0.0163041705083423,-0.220995911286631,-0.115314289517537
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,-0.0975868290592754,-0.30118878601031,0.241949616018048,-0.264728804764434,0.0422362748267003
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,-0.265826720726773,0.235769605845561,0.137463780500361,-0.167804270266375,-0.422624004457146
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,0.238053436195056,0.16550523759813,0.120139044117555,-0.633023769450852,-0.258413904962421
STEIN_ESRRA_TARGETS_UP,-0.03091753176906,0.0734097286899537,0.0520149302400424,-0.360831293799427,-0.253449516710441
STEIN_ESRRA_TARGETS_DN,0.0774107943544533,0.24571577545523,-0.098850479979612,-0.231380415213654,-0.378638368400237
WANG_LSD1_TARGETS_UP,-0.441896505923622,-0.377822343501029,-0.244918203131336,0.349382601111967,-0.261701947990627
WANG_LSD1_TARGETS_DN,0.229294462649899,0.0278567023774833,0.266299463313692,-0.447954573092872,0.0817288568089141
FOSTER_TOLERANT_MACROPHAGE_UP,0.0879367779770302,0.0238089020613521,0.219198001747551,-0.291256833738789,-0.179491063092943
FOSTER_TOLERANT_MACROPHAGE_DN,-0.198207400638596,0.209531259698013,0.212854963780616,-0.274994940060262,-0.228333179291766
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,-0.210854956586826,-0.273449357657285,0.0241568695417869,0.448018874755888,-0.477777397397421
JEPSEN_SMRT_TARGETS,0.153619369566789,0.0182868909497395,-0.388416225424731,-0.105019289574038,0.0195769291690886
KYNG_DNA_DAMAGE_BY_4NQO,-0.116985370763445,0.0886060550773501,-0.184540452009602,-0.241038795462287,-0.127680267975732
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,-0.0311949048655321,0.0145888274285201,0.286074097079626,-0.487339763975373,-0.0973332436725658
KYNG_DNA_DAMAGE_BY_UV,-0.0202418680035026,0.374853923128666,-0.0409591577375791,-0.40961414469162,-0.504964292722229
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,0.0521077065448679,0.201680898333233,0.115077423773188,-0.440087583886833,-0.308595170525674
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,-0.227500944435952,0.0788654950363896,0.0124677333479553,-0.201821738080086,-0.0109269773410944
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,-0.595836994428771,0.176937839737203,0.374353327628682,0.103962269809375,0.0582361991155053
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,-0.312770624926288,0.0869727080948306,0.441665913278488,-0.433260833886211,-0.00444799544896818
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,0.115229886567282,0.0825573600179682,0.0795747294367249,-0.104041185329289,-0.247385100905086
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,-0.174037201501793,-0.0896237098370869,0.429058982355928,-0.287470855402469,-0.257417428386941
KYNG_DNA_DAMAGE_DN,-0.103617238320913,0.184239032117571,0.065719551147035,-0.250880811330461,-0.240823772183388
KYNG_DNA_DAMAGE_UP,-0.166743345845663,0.146124492776874,0.1447056018718,-0.347067746233496,-0.11213675067059
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,-0.0220350325399845,0.0299407186745831,-0.042230596736416,0.0456006239551112,-0.333728463372388
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,-0.131781124138349,0.114507693345545,-0.0138970250801296,-0.270661326009195,-0.109655433596759
KONDO_PROSTATE_CANCER_WITH_H3K27ME3,-0.216506803814882,0.230644900182948,0.422013671073927,-0.377475379868532,-0.123162174657187
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,-0.222787797596044,-0.0188839657236264,0.515929592903823,-0.462834092353886,-0.0555008820531142
KONDO_EZH2_TARGETS,-0.183467449334146,-0.0707086482521563,0.0868970100407738,-0.236548232793066,0.020615115274799
ZHANG_GATA6_TARGETS_UP,-0.159132602662408,0.57672171280204,0.403223578026566,-0.658330596501892,-0.0279546267351593
ZHANG_GATA6_TARGETS_DN,0.010616525789046,0.192537074654829,-0.0795566743734475,-0.15221012548464,-0.252920157746685
MCGOWAN_RSP6_TARGETS_UP,0.334009581455219,-0.100856900006812,-0.108175055749664,-0.335328736484627,0.064933796802585
STEARMAN_TUMOR_FIELD_EFFECT_UP,0.340965075665419,-0.0646339999832266,0.257497324419968,-0.416101624032613,-0.0845153495395208
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,-0.0641012760320543,-0.0796393030242654,0.30600960065324,-0.391871026727512,-0.0543166536619879
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.0970746840268035,-0.213007469535189,0.0164267172483319,-0.154213292694203,-0.0812743509936801
HELLER_SILENCED_BY_METHYLATION_UP,-0.22298488113662,0.299168882889306,0.0758569655426927,-0.236234400220346,-0.167012787963385
HELLER_SILENCED_BY_METHYLATION_DN,-0.149793290145337,0.0838847927187365,0.183892271045684,-0.465941910686778,-0.0464713724599487
HELLER_HDAC_TARGETS_UP,-0.135390335831195,0.0934711063886248,-0.0297305047140014,-0.019141343161635,-0.266608998354151
HELLER_HDAC_TARGETS_DN,-0.25015458721837,0.130700744228951,0.176320501445782,-0.334167986780065,0.0149973635225623
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,-0.116555607434512,0.109181167080692,0.0430731582673193,-0.183207046312759,-0.214550587534555
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,-0.182908600697489,0.135047296839725,0.0676458338866859,-0.298543181179994,-0.150781054972831
WONG_MITOCHONDRIA_GENE_MODULE,-0.0339744793603612,0.0768059306077957,-0.0800356036970191,-0.166005285289594,-0.175480246198661
WONG_PROTEASOME_GENE_MODULE,0.329304390194689,0.197081287910238,0.267592771633138,-0.518705890110012,-0.528224849644843
COATES_MACROPHAGE_M1_VS_M2_UP,0.0259413625667892,-0.212917786064061,0.248745203396301,-0.435680468928147,0.151265419708724
COATES_MACROPHAGE_M1_VS_M2_DN,0.0643475494037228,0.0501335498050543,0.00286925361820115,-0.360398526394455,-0.275557402529723
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,-0.200472404421872,0.315417644784819,0.00215922378709268,-0.267147411824817,-0.236275665292256
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,-0.0406022736672444,0.20675133673339,0.294638042017338,-0.468633034359362,-0.338988622564557
LIN_MELANOMA_COPY_NUMBER_UP,-0.271940457304547,-0.0323641414574662,0.0729378411593941,-0.260090070933764,-0.184514293733458
LIN_MELANOMA_COPY_NUMBER_DN,0.235674904487887,0.053329783886865,-0.367970617978924,-0.291845413393459,-0.0206809323156787
MARTINEZ_RB1_TARGETS_UP,-0.0670705483694359,-0.0188504219007482,0.0998527365611683,-0.227197549593493,-0.0883435031506365
MARTINEZ_RB1_TARGETS_DN,-0.214248693421057,0.0618009516883898,0.0632497175657972,-0.205893097755597,-0.0930209895371898
MARTINEZ_TP53_TARGETS_UP,-0.0631197281539541,-0.0613865997153595,0.0500945933798687,-0.211975501236813,-0.0258007199959548
MARTINEZ_TP53_TARGETS_DN,-0.168403868091971,0.101790739735327,0.124846053000644,-0.225032660330616,-0.179755704346306
MARTINEZ_RB1_AND_TP53_TARGETS_UP,-0.0716689617977785,-0.0793500736509546,0.0771421018045332,-0.225557759037351,-0.00363288307527021
MARTINEZ_RB1_AND_TP53_TARGETS_DN,-0.191180506685307,0.124095015761236,0.101198182475755,-0.220324460901101,-0.197241720485421
MASSARWEH_TAMOXIFEN_RESISTANCE_UP,-0.159703749888679,0.017856884089352,0.0937532929772224,-0.279418391083536,-0.0728423592153948
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,0.017353431279037,-0.0423000762023978,0.108792004460059,-0.335724680934084,-0.0726052003712338
MASSARWEH_RESPONSE_TO_ESTRADIOL,0.038897278138621,0.0419008426086008,0.118701936249052,-0.423429294113968,-0.0832045116667938
WALLACE_PROSTATE_CANCER_UP,0.246109471918496,0.246702261427477,-0.0793618285526561,-0.222869310697045,-0.418338671930676
WALLACE_PROSTATE_CANCER_RACE_UP,-0.149918309776514,0.256112297440092,0.0241830422237114,-0.177314978275868,-0.110898180724471
WALLACE_PROSTATE_CANCER_RACE_DN,-0.0106151902249054,-0.07725862212407,0.422589490722483,-0.346327154107091,-0.353790734770567
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,-0.0097429816838441,0.20045146005046,-0.0532760209484508,-0.224755482532754,-0.41686348241398
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,0.120447696609365,-0.0262215793764519,-0.0073367418502136,-0.129063230569496,-0.191845728786177
OUILLETTE_CLL_13Q14_DELETION_UP,0.0216016647949499,0.158985777587292,0.152684219254471,-0.544676771400322,-0.16952705183621
OUILLETTE_CLL_13Q14_DELETION_DN,-0.142766853780713,-0.0406271376052382,0.0143172788527928,-0.288751819672883,6.3562939943751e-05
YOKOE_CANCER_TESTIS_ANTIGENS,-0.0199768388382944,0.514083299836279,0.213309981972823,-0.455082003431654,-0.505772126373084
MARZEC_IL2_SIGNALING_UP,0.0286525587836047,0.389702243804209,-0.254734256815659,-0.208646024195297,-0.212910141034135
MARZEC_IL2_SIGNALING_DN,-0.079195211970223,-0.306856845754886,0.263731455178733,-0.425690477683837,0.14016069368578
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,0.103445420480625,0.114263609344449,0.110334461078281,-0.437531655210253,-0.0595142909167856
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,-0.259381950742451,0.213286697374942,0.11295983376135,-0.265499262882352,-0.209567453642932
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,-0.0396596265058672,-0.0585828998167346,0.140371212586984,-0.267819667297745,-0.13862516728764
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,-0.350688608683502,0.317369153223036,0.0332248889519741,-0.429338519204064,0.0286239487543012
CAMPS_COLON_CANCER_COPY_NUMBER_UP,-0.119767583571415,0.381634693703205,0.0806644457708911,-0.221857953779856,-0.342656100465012
CAMPS_COLON_CANCER_COPY_NUMBER_DN,-0.0119638817705763,0.126396499710042,0.197549023761527,-0.299386665152497,0.1911175424829
RIZKI_TUMOR_INVASIVENESS_3D_UP,-0.195932309045854,0.0611205764947219,0.296419714260096,-0.423028056254069,-0.042398696129476
RIZKI_TUMOR_INVASIVENESS_3D_DN,-0.0209523104341081,0.219648556124418,0.103497513085925,-0.319137660748353,-0.282450085223687
RIZKI_TUMOR_INVASIVENESS_2D_UP,0.224323510550744,0.315788879290821,0.217951609695654,-0.478774999001276,-0.441552766349408
RIZKI_TUMOR_INVASIVENESS_2D_DN,-0.0725803144943835,0.0414216091472809,0.00470486115716218,-0.0972372814973652,-0.396555763439629
FUJII_YBX1_TARGETS_UP,-0.273022453641291,0.166973162081134,-0.286769971374192,0.0084673142595254,0.036742412612054
FUJII_YBX1_TARGETS_DN,0.134924735393057,0.0568708973053293,0.16140857661597,-0.517561709006454,-0.319750959718473
OSADA_ASCL1_TARGETS_UP,-0.0156013212518456,-0.0580294973183684,0.254202222804797,-0.373227419698827,-0.169535563961034
OSADA_ASCL1_TARGETS_DN,0.314322525573386,0.131198306149499,-0.106530491150487,-0.375188057624888,-0.563549913580469
CHENG_IMPRINTED_BY_ESTRADIOL,-0.235142374391101,0.17743612286568,-0.236625384269221,-0.235509198606275,0.123375838978874
DE_YY1_TARGETS_UP,-0.118886716609074,0.0726516908750131,-0.156725104394571,-0.278793206092729,-0.104717694953477
DE_YY1_TARGETS_DN,-0.243351820050765,-0.181129177225271,0.162164140767481,0.0902269810044953,-0.0108461948292936
MCCABE_BOUND_BY_HOXC6,-0.0534556144552985,0.131976521656677,0.215568188832223,-0.310845816908368,-0.215080922664216
POS_HISTAMINE_RESPONSE_NETWORK,0.247817058122402,0.41047331446788,0.0316424805451322,-0.439712613518051,-0.486502095778356
DAIRKEE_CANCER_PRONE_RESPONSE_E2,-0.389111575384166,0.187905132060071,0.139285391702804,-0.39694283992893,0.0582965205568242
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,-0.0910386917599469,-0.265878678597585,0.326431823166999,-0.265194029251478,-0.0411442883604086
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,0.0791918189128032,0.195038958687422,-0.0185734854572049,-0.25355854827992,-0.401928855373154
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.122266219162782,0.0426358198674836,0.0561599218290381,0.00217654244245905,-0.265096258379277
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,-0.331583799330762,0.519678484747753,0.177079576877703,-0.131762958015795,-0.472618938723068
OUYANG_PROSTATE_CANCER_MARKERS,0.422995781987316,-0.351920274368373,-0.13272435307366,0.0140251082332101,-0.267563653942259
RIGGI_EWING_SARCOMA_PROGENITOR_UP,-0.258415393398338,0.0390320951889414,0.241345686114751,-0.278163936762951,-0.0685689356609924
RIGGI_EWING_SARCOMA_PROGENITOR_DN,-0.347072170855,0.185149698970435,0.0181449920900016,-0.109452298667656,-0.146370542525656
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.1550962128319,0.102406756196102,0.0538818892765793,-0.463752967180683,-0.333176817348758
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.21054003445756,-0.500076513148946,0.202844222069703,0.0332384544007459,-0.256803842942568
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.16692595778853,0.255765368889901,-0.0239346128222948,-0.000767247481006428,-0.343507231964586
ENGELMANN_CANCER_PROGENITORS_UP,-0.390565986386845,-0.0356958934630513,-0.0367770183117449,-0.0718930703365968,0.0282391040408826
ENGELMANN_CANCER_PROGENITORS_DN,-0.118104587000742,0.226012330415309,0.0048123940146485,-0.0815691584029818,-0.229773272128576
WORSCHECH_TUMOR_REJECTION_UP,0.150317171665298,0.114687109781325,0.101925965753323,-0.0575133200769104,-0.023058974999568
HUANG_FOXA2_TARGETS_UP,-0.155281932403535,-0.0777269451866897,0.0557317946348686,-0.257356899415087,-0.168661577893256
HUANG_FOXA2_TARGETS_DN,-0.388461694541545,0.277774894083716,-0.279600768568515,0.0332336216380288,-0.0968409658894355
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,0.0624495053837667,-0.114968550817236,0.108745908851653,-0.550555865810139,0.261052561522738
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,-0.345850312475503,-0.395434043998259,-0.382089455616103,0.486326326009785,-0.0338929250560132
TING_SILENCED_BY_DICER,-0.531978483958012,0.306147523192466,-0.0334812667761718,-0.06543748223828,-0.289672903301615
MCCABE_HOXC6_TARGETS_CANCER_UP,-0.246214064125256,0.366297993735579,0.253604941817592,-0.090436078306771,-0.354944254826229
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,-0.340436373791022,-0.0217012108479022,0.367396423262486,-0.448076301959572,0.0628809280256729
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,-0.0136851930179072,0.0441495651006335,0.276689186982809,-0.486004974196103,-0.0844874801783291
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,0.0534220795146853,0.0235754591579655,0.172499642775525,-0.327672600648374,-0.211462440771407
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,0.0143074902012266,0.168580830404365,-0.0231153003557572,-0.244722048757093,-0.344628146982253
ACEVEDO_LIVER_CANCER_UP,0.0161608778031727,-0.00580207167308455,0.0656799634276873,-0.338831268301723,-0.145602173990506
ACEVEDO_LIVER_CANCER_DN,0.0172335312237693,0.160567238985422,0.0811988880724023,-0.243714111133528,-0.286447774345159
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,-0.0364788217099092,0.0228873026560748,-0.00923914321839152,-0.330400949160436,-0.145678214411062
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,-0.112794826894835,0.17209725467694,0.158228362644392,-0.312362974146645,-0.311766946576397
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,-0.255381550514662,0.144187201811941,0.321644885120563,-0.393061969376701,0.0785847375571395
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.135315905323775,0.178690336873311,0.370440481283253,-0.396145820672185,-0.401890664981492
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,-0.299609026594289,0.212435537967739,0.39704213550346,-0.335184073503148,0.00265478104146888
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,-0.177963772928329,0.222591989235528,0.340664902670381,-0.369792911676264,-0.335282886756732
MITSIADES_RESPONSE_TO_APLIDIN_UP,-0.145524421386319,0.147162294904039,-0.0408769319135706,-0.256080029820973,-0.140398475628679
MITSIADES_RESPONSE_TO_APLIDIN_DN,0.0200635449430933,-0.142561199344159,0.0736846088511292,-0.379806370468271,-0.0913128869092271
HOQUE_METHYLATED_IN_CANCER,0.0654831556418451,-0.171788255396705,0.175945624341182,-0.117806083332166,-0.0120204470148755
SAGIV_CD24_TARGETS_DN,-0.344811423944541,0.386425011776561,-0.382882258159885,0.302712794607373,-0.438666879836706
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,0.0144609322732979,-0.192576364749999,0.281250738406326,-0.356882012184793,-0.100986338600744
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,-0.262246228700102,0.0931303603157726,0.336222653799358,-0.272908781931121,-0.247283281164945
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,-0.204532854280401,0.217290323133105,0.24534824679975,-0.324836312555343,-0.0477433962837014
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,-0.163727944874692,0.224916572405558,0.237702726721028,-0.344040709692907,-0.094799882702288
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,-0.241401097210913,0.253307839401073,-0.0705564442070008,-0.309688438620373,-0.0902382457198556
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,-0.434563100155269,-0.0027344506541597,0.314059963645588,-0.0436755869498826,0.0278805715472006
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,0.0540828551230118,0.316738385603329,-0.0326410000064279,-0.364449488742574,-0.140185780966239
SMID_BREAST_CANCER_LUMINAL_B_UP,-0.194198265365915,0.301518726405416,0.134721492093228,-0.35584646433563,-0.190769451951828
SMID_BREAST_CANCER_LUMINAL_B_DN,-0.125371113028272,0.160649789158192,0.17443624263679,-0.240122827878315,-0.142039233116195
SMID_BREAST_CANCER_LUMINAL_A_UP,-0.291394294838711,0.0696219709238839,0.349574768994227,-0.122092519786692,-0.306423072147094
SMID_BREAST_CANCER_ERBB2_UP,-0.0265761621151714,0.0928064475535711,0.188689896616117,-0.366342665917283,-0.16985842027314
SMID_BREAST_CANCER_NORMAL_LIKE_UP,-0.211552720660873,0.191158708328598,0.29851761697256,-0.308378967113216,-0.0947991840910146
SMID_BREAST_CANCER_BASAL_UP,-0.175484457790509,0.202674765513835,0.0920717099385037,-0.258900944213726,-0.113340151394538
SMID_BREAST_CANCER_BASAL_DN,-0.144000076108979,0.147063605943376,0.182837010609268,-0.343008997478248,-0.180858211876635
LE_SKI_TARGETS_UP,-0.540863436139351,0.230227516703619,0.274969397817675,0.0791469456495443,-0.306265388710691
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,-0.36055575724528,-0.376758392916986,0.162888217453215,-0.0931680732046907,0.313025981144902
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,-0.245552560526468,0.177684666912498,0.0582255306076589,-0.335794984363007,0.0137453934408377
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,-0.142651013367973,0.0696647098678106,0.158944188416479,-0.235243356708634,-0.209326799253376
MOSERLE_IFNA_RESPONSE,-0.206428494250298,0.493784181943032,-0.246097789725738,-0.121183725143301,-0.375379886005364
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,-0.328472953052573,0.326071975545397,0.0172023731434215,-0.211024975551018,-0.14004603841185
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,-0.363466359265317,-0.273247215926245,0.418517799431504,-0.146397710499861,-0.170596809432666
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,-0.298041685778026,0.33583281949909,0.363583107368615,-0.508041396648908,-0.0645368501329228
WEBER_METHYLATED_HCP_IN_SPERM_DN,-0.105887372350166,0.313195258338074,0.40274210067256,-0.496074432237569,-0.0730695757478478
WEBER_METHYLATED_HCP_IN_SPERM_UP,-0.460629655505447,0.292324790721846,0.326851448789418,-0.505240043445084,0.131343445442989
BASSO_HAIRY_CELL_LEUKEMIA_UP,-0.0952666308368028,-0.0168445061713266,-0.0598980749716963,-0.365898246314195,0.116215745937368
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,0.0650966817744278,0.160340115352811,0.177993338096466,-0.524227253830847,-0.261645887844971
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,-0.206213811021096,-0.0529972487440076,0.137675340774684,-0.214792438278197,-0.0518499760480223
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,-0.378337391137541,0.149945388457813,0.0247258672059209,0.00200418349260698,-0.133817338473563
ZHANG_BREAST_CANCER_PROGENITORS_UP,-7.96220760908017e-05,-0.0190497249674697,0.181048457661121,-0.515462792445204,-0.0360393027507896
ZHANG_BREAST_CANCER_PROGENITORS_DN,-0.109991826788547,0.181765238802151,-0.0149783081774339,-0.259560123146105,-0.369825183179648
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,0.140535464921296,-0.160563855288993,0.0511845306826335,0.231605944995532,-0.431582484826589
BERNARD_PPAPDC1B_TARGETS_UP,-0.262314055348915,-0.460823158511827,0.378716479929073,-0.208452576180008,-0.0186166864429555
BERNARD_PPAPDC1B_TARGETS_DN,-0.0617879932879546,-0.0146455644526827,0.191580022325244,-0.233222854014463,-0.239614048680169
GAURNIER_PSMD4_TARGETS,-0.118295427482759,0.397973252094743,-0.0554857823022151,-0.105685452490765,0.0508432678385795
EHLERS_ANEUPLOIDY_UP,-0.128028397693517,-0.00344314857706507,0.0872331039284623,-0.52625802390812,0.16207173429105
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,-0.169212014906431,0.331787019920087,0.0424600879378914,-0.351072000794343,-0.25789809544748
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,-0.317494262895335,-0.120538557750575,0.13896208104065,0.143949861101942,-0.293555935905024
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,0.0936406470147115,0.00358866878637004,-0.0751778256582256,-0.323049084857006,0.0526619744620436
ZHENG_IL22_SIGNALING_UP,0.0254790298302738,0.167559595717174,0.0595459316498213,-0.0760595468571912,-0.221585252605213
ZHENG_IL22_SIGNALING_DN,-0.318558105614739,0.251906184380013,0.333798533771603,-0.639670545979299,0.040257221883944
BOCHKIS_FOXA2_TARGETS,0.0799256532920879,0.147164793469528,0.0716259178007413,-0.37557195396307,-0.252109550496471
HONMA_DOCETAXEL_RESISTANCE,-0.153122003661795,0.163229585992104,-0.493561717580084,0.25562649823483,-0.431032294339805
WILENSKY_RESPONSE_TO_DARAPLADIB,-0.157870308916637,0.534162814947966,0.0811248513751457,-0.113409195160062,-0.51089602470657
MATZUK_OVULATION,-0.230759794207262,0.574759589618807,-0.0599405376315071,-0.282604699448566,-0.564619459781944
MATZUK_MEIOTIC_AND_DNA_REPAIR,-0.15363899458307,0.127863470555723,0.0615014053538412,-0.277980779513462,-0.00953248806910623
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,0.109478580569375,-0.121172357271156,0.163151599672361,-0.380017653227981,0.34058039264697
MATZUK_EMBRYONIC_GERM_CELL,0.193507928584084,-0.451365222020944,0.152710802199796,-0.309982811537585,-0.260627423602089
MATZUK_MALE_REPRODUCTION_SERTOLI,0.00272843741400633,-0.322008280878951,-0.0788074389015119,-0.202045695212855,0.208405460814629
MATZUK_SPERMATOGONIA,-0.345740808531647,-0.128223787364955,0.445409680555968,-0.152948208228468,-0.170556891702888
MATZUK_SPERMATOCYTE,-0.328070019448565,0.0869784756670137,0.420767185825454,-0.399760053844981,-0.0364661784864078
MATZUK_SPERMATID_DIFFERENTIATION,-0.116463760976862,-0.316457789131568,0.34189605913981,-0.374494411448368,-0.112893160136814
MATZUK_SPERMATOZOA,-0.116092646585346,0.00908860958398641,0.307030452998402,-0.50120511408722,-0.0659529063768211
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,-0.154939011892157,0.0856362332140538,0.15852288375174,-0.341501798733238,-0.220405093074163
CHUNG_BLISTER_CYTOTOXICITY_UP,-0.364402300006673,0.193439628099396,0.117574378659944,-0.355558929898712,-0.0846869664515566
CHUNG_BLISTER_CYTOTOXICITY_DN,0.176199159495298,-0.16152715190608,0.21750925636211,-0.477899290137902,0.142293040273287
WHITEFORD_PEDIATRIC_CANCER_MARKERS,0.011923847911841,0.194671823779034,0.209042361388401,-0.46103296643784,-0.407849351738807
GRADE_COLON_AND_RECTAL_CANCER_UP,0.164138716104944,0.0439945653654398,0.145173469789965,-0.421963904018895,-0.322829408284217
GRADE_COLON_AND_RECTAL_CANCER_DN,-0.0962033200555033,0.168447892435625,0.292489682260688,-0.516524752455022,-0.0476015707704071
GRADE_COLON_VS_RECTAL_CANCER_UP,0.0523088954264271,-0.00793071159677297,0.00136432773255915,-0.220808208076732,-0.154632822526704
GRADE_COLON_VS_RECTAL_CANCER_DN,0.0765933215206252,0.173931331367229,-0.0393196355063132,-0.123390335881318,-0.41545416575686
BOQUEST_STEM_CELL_UP,-0.363726837389885,-0.0591651806830002,0.0402830879223262,0.0608671747498787,-0.135366541813318
BOQUEST_STEM_CELL_DN,-0.165772407880597,0.339427123471267,0.102746339888004,-0.365502976877289,-0.0859850793768015
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,-0.149612473233975,0.0250036210384366,0.0268607603547857,-0.120718236127393,-0.0866603709774282
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,-0.189017742884139,0.0623049956350233,0.306047542317561,-0.465653688576707,0.047723441818075
NAKAMURA_METASTASIS,-0.0676876148952706,0.0432183008508876,-0.0695349333771948,-0.120609136069821,0.109473505629835
NAKAMURA_METASTASIS_MODEL_UP,-0.0394832582093928,0.172726653761357,-0.149536246786237,-0.156267084430854,-0.111157246836267
NAKAMURA_METASTASIS_MODEL_DN,0.0416731798251121,0.0873077930012687,0.17709995216265,-0.343023739216215,-0.0428241831322325
WEST_ADRENOCORTICAL_TUMOR_UP,0.116899008333378,0.0480661092034521,0.0695311745595427,-0.496798484699384,-0.263733106316326
WEST_ADRENOCORTICAL_TUMOR_DN,-0.297149059187995,0.212806088820254,0.125646426031429,-0.195083922534809,-0.172544028849046
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,-0.421532638746107,0.216876773819603,0.243238850298557,-0.0420442333262808,-0.320691613217428
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,0.0046806628664168,0.539933277300582,0.214101096351,-0.433531792028885,-0.145685428014682
CHO_NR4A1_TARGETS,-0.392853439700001,0.0490481911749197,0.0904910174097452,-0.354582529747959,0.251542193185806
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,-0.175176639042037,0.0453608544214626,0.0826466864081256,-0.382600716235422,-0.184940513931264
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,-0.0231265791273719,0.13956974479329,0.065657779925447,-0.326251598534625,-0.079483198314397
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,-0.132931129198217,-0.200428379830052,0.35633424244559,-0.203543392300872,-0.103453882996388
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,-0.05759951768393,0.238133502464942,0.111004512979451,-0.340752064102474,-0.13158725043374
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,0.168527457285806,0.0547123078344259,-0.00746781872970526,-0.340060868458179,-0.29891462732871
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.241531492719621,-0.250429683477944,-0.141224422754725,-0.341152621834499,-0.128971846113075
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,0.0452399813216661,-0.00392295318801755,-0.0519559435264255,0.0467104459824395,-0.430685230409299
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.0209226698312957,0.200005173733836,-0.109253023971376,-0.202018527902896,-0.386911839735428
LU_TUMOR_ENDOTHELIAL_MARKERS_UP,-0.073038335262254,-0.0348810496920034,0.386951101837724,-0.162709003053467,-0.401204855310694
LU_TUMOR_ANGIOGENESIS_UP,-0.206348822369386,0.176348411378585,0.23150386882496,-0.445196072286094,-0.279207093222873
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,-0.311141176495764,-0.171450235962353,0.291987454080674,0.042539531579474,0.0487557152142133
CHEN_HOXA5_TARGETS_9HR_UP,-0.183627589169701,0.193943101256215,0.126437575564106,-0.288056899577243,-0.331039781240145
CHEN_HOXA5_TARGETS_9HR_DN,0.0140917604029508,0.322773571948838,-0.505366425997335,0.234192780767437,-0.275298189998971
LIN_NPAS4_TARGETS_UP,-0.281096465383497,0.100542701250385,0.196761235778968,-0.496618215321666,0.00444090513266979
LIN_NPAS4_TARGETS_DN,-0.367161077427142,0.214443858815017,0.115664052638599,-0.260676449565082,-0.0951146410517666
CADWELL_ATG16L1_TARGETS_UP,0.0531222674376707,0.222750627597815,0.0875024348871353,-0.261318559951856,-0.114332152002126
CADWELL_ATG16L1_TARGETS_DN,-0.458092654699104,-0.060559846302794,0.491549404720572,-0.319637281804717,-0.0550194535704728
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,-0.194355536370459,0.127114440583703,0.252826722897967,-0.442623493024934,-0.115636419540423
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,-0.31795352689833,-0.252605455824165,0.405610836011907,-0.0728829073193586,0.00617375457958663
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,-0.236071225322798,0.499723068323597,-0.118442853202644,-0.27136703450839,-0.24680083604124
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,-0.200294236862582,-0.135877294383672,-0.110839632405085,-0.122157382420046,-0.150140225202852
CONRAD_STEM_CELL,-0.377869978991495,0.306258260628108,0.376691158112919,-0.408607009655348,-0.287858131681397
THUM_MIR21_TARGETS_HEART_DISEASE_UP,-0.405584930002503,-0.511574380697959,-0.073862127641059,0.496509734320559,-0.00140639926189756
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,0.0529983083459337,0.253306081867799,-0.0334679138307656,0.16463177375223,-0.393243568370266
HUANG_DASATINIB_RESISTANCE_UP,-0.267509268440656,-0.0293302579625925,0.0607038740737296,0.185416350863188,-0.45535529834191
HUANG_DASATINIB_RESISTANCE_DN,-0.0745883043680806,-0.24794951386341,0.0473760097888415,-0.360793939556907,0.359434108246316
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,-0.0299400835615185,0.486498981803858,0.263872801615529,-0.254831209914898,-0.655170690324247
QI_PLASMACYTOMA_UP,-0.0598675735056789,0.345329921451478,-0.0174243355048394,-0.276591668547945,-0.200588963146766
QI_PLASMACYTOMA_DN,-0.417368392525142,-0.0533212725950976,0.0224906718138369,0.142470172878096,-0.287439346188436
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,-0.2457213938193,-0.0498063900894735,0.121797448078931,-0.457440485704367,0.23299951578053
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,0.434141800516247,0.291609662820879,-0.101397059668526,-0.529429242882812,-0.573453833168099
HUPER_BREAST_BASAL_VS_LUMINAL_UP,-0.378453135933234,0.0873706646206779,0.287319794903825,-0.0653044228274014,0.148967220803318
HUPER_BREAST_BASAL_VS_LUMINAL_DN,-0.0999995733498476,0.225217874035197,-0.305080373021439,0.0262342955230471,-0.229586391852255
MALONEY_RESPONSE_TO_17AAG_UP,-0.0191435718924039,-0.0609049643820965,-0.223208574361077,0.320223621961924,-0.434856302253268
MALONEY_RESPONSE_TO_17AAG_DN,0.023430275212608,0.224978145542225,0.0586815676499624,-0.453152038780852,-0.310095210674229
CUI_GLUCOSE_DEPRIVATION,0.144184922798793,0.215637562968868,-0.0201974234945509,-0.431407966155106,-0.17838008060706
BLUM_RESPONSE_TO_SALIRASIB_UP,-0.0281830433758465,0.0733657927273546,-0.179631479158998,-0.0682648578427282,-0.285110218272475
BLUM_RESPONSE_TO_SALIRASIB_DN,0.0508702256560362,0.118045354623263,0.00143187316437685,-0.22381542744463,-0.343871551837627
WINTER_HYPOXIA_METAGENE,0.118590105067663,0.0831124279514472,-0.0707625639134311,-0.131405050280714,-0.388109337160834
ALONSO_METASTASIS_EMT_UP,0.312107328867275,-0.193077634175318,0.216305562401799,0.447957182787255,-0.570495863128918
ALONSO_METASTASIS_UP,0.282281363573109,-0.216151360590648,0.140107850977968,-0.341312798640213,-0.270986456993689
ALONSO_METASTASIS_DN,-0.484623830875903,0.199111292819999,0.366991473399517,-0.143099014042371,-0.0672712671565113
CROMER_TUMORIGENESIS_UP,-0.0438182466176975,0.166784275236028,0.136630701729336,-0.0339574092383072,-0.473020536869711
CROMER_TUMORIGENESIS_DN,-0.186331873906521,0.119920524818269,0.461426421890152,-0.359599761178957,0.00791577329785198
MUELLER_PLURINET,-0.0246026199576171,0.397086311111037,0.0593452930478256,-0.408500772874006,-0.374506152012636
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,-0.112383853966318,0.129986051593993,0.223382559391178,-0.243969334227975,-0.187578028345784
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,-0.212674829957064,0.100768724727646,0.312513314147933,-0.339414188926041,-0.0984469392109953
FIRESTEIN_CTNNB1_PATHWAY,0.117309842866106,0.319006452654909,0.0807674169574797,-0.600958703700587,-0.096310929262108
FIRESTEIN_PROLIFERATION,-0.315980235807998,0.122875911613437,0.175105659959149,-0.392658332396586,-0.0786878794957633
WANG_TUMOR_INVASIVENESS_UP,0.0846793431993564,0.140025628125951,-0.0131385017203016,-0.247274571745917,-0.377593065164215
WANG_TUMOR_INVASIVENESS_DN,0.151580751704441,-0.133667733133492,0.00680850118882731,-0.276137829587828,-0.318966944548905
JIANG_TIP30_TARGETS_UP,0.151889832451251,0.21282679650358,0.171375596023639,-0.380874363362891,-0.44694901660803
GRESHOCK_CANCER_COPY_NUMBER_UP,-0.156635821756144,0.0964185087482871,0.272530875438958,-0.276001615148974,-0.319672740758531
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,-0.478366672469603,-0.253757059376337,0.148122796101557,0.252136741518109,-0.0375458737178814
TSAI_RESPONSE_TO_RADIATION_THERAPY,-0.363453298655213,0.434746110552869,-0.232556036328747,0.241303974678385,-0.410467895531239
BEIER_GLIOMA_STEM_CELL_UP,-0.290070496814361,0.18362786699872,0.0952029770639037,-0.320124694175896,0.186014811066341
BEIER_GLIOMA_STEM_CELL_DN,-0.278748733725748,0.0316035583513833,-0.263061946181157,-0.129196681240733,0.0112624620988238
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,-0.297750998668477,0.232584490131885,0.0970789167410611,-0.0444777095817095,-0.258997108306856
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,-0.193133729137456,0.170246461472202,0.16353851742136,-0.052463638603845,-0.291804367950399
MOOTHA_HUMAN_MITODB_6_2002,-0.0321600813577619,0.0347783673702392,0.0727442306806475,-0.359743139600164,-0.171206490783586
MOOTHA_PGC,0.020158531786615,-0.104560035436969,0.0505145134252854,-0.214518022958859,-0.32952673362412
LEE_LIVER_CANCER_SURVIVAL_DN,0.158041864689791,0.0819127977381406,-0.0913158541524952,-0.302906980282086,-0.191877068571944
LEE_LIVER_CANCER_SURVIVAL_UP,0.00904022590856068,0.168921334699283,0.236440001944397,-0.359878468759799,-0.201748529805631
MOOTHA_MITOCHONDRIA,-0.0488854336901449,0.0215144039764809,0.128862482082826,-0.388049150269947,-0.192528008249959
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,0.0866391995950407,0.206103290943422,-0.0514136305448152,0.338897644257902,-0.574246362703643
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,-0.501177698675117,0.260059449108175,0.333482876057249,-0.384967650917306,0.102383872207875
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.0741655188372217,-0.178664379215144,-0.00316242048683982,-0.162561258003391,0.249670406371494
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,-0.0385353481996327,0.0988002822865108,0.132685953384259,-0.0386107287221009,-0.485432448195934
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,-0.395729077647173,0.346413538221659,0.451324773102383,-0.309895754720062,-0.429081070259067
BOYLAN_MULTIPLE_MYELOMA_D_UP,0.0191002353362589,0.274637135524159,-0.12207232812585,-0.099570798370711,-0.415295761969884
BOYLAN_MULTIPLE_MYELOMA_D_DN,-0.328510349006266,0.243469593920292,0.204902837569466,-0.243290881782069,-0.230505693807773
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,0.0606775112734478,0.0576161139567217,0.0583757570020464,-0.407244660514938,-0.0873687167843596
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,-0.11245072042896,0.0994503368477442,0.215035056512733,-0.25232222200626,-0.0982923837003366
BOYLAN_MULTIPLE_MYELOMA_C_UP,-0.452584148550617,0.243883601412036,-0.139830017516473,-0.327878034936766,0.38276095848585
BOYLAN_MULTIPLE_MYELOMA_C_DN,-0.257723333987358,-0.279846483110257,0.314871761767576,-0.0366932725285364,-0.0482490870454493
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,-0.0715393204650518,-0.0158095753712674,-0.0638930364365005,0.0207688582974217,-0.0426713171433891
FERRARI_RESPONSE_TO_FENRETINIDE_UP,-0.0464392918705646,-0.300794447966951,0.0581008988679487,0.286185547720157,-0.187883331867607
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,-0.0259761284705682,-0.0703673984843381,-0.276834717881815,0.0433770463815764,-0.268830974554731
GU_PDEF_TARGETS_UP,-0.511426459075022,0.0774488491873759,-0.161360211002138,0.267147316856568,-0.347516355185901
GU_PDEF_TARGETS_DN,-0.138293010568863,0.275851078851055,0.222538136852837,-0.237164492895665,-0.33813673895927
TOOKER_GEMCITABINE_RESISTANCE_UP,0.0576380113054518,-0.0503552577398113,-0.130874519226469,-0.148715860542457,-0.327081823619772
TOOKER_GEMCITABINE_RESISTANCE_DN,0.307243223110511,0.0753920374359666,-0.200495649394462,-0.257104045225088,-0.411449629757902
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,-0.242487827064854,-0.027726752462653,0.386195959765392,-0.334314892677692,-0.0786453349883512
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,0.159886895333413,0.147830493619259,-0.0674768786833582,-0.402322348405758,-0.244459600065748
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,0.0575638441473857,-0.20742910758057,0.405047745884438,-0.560382976561515,0.00167022378111031
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,-0.212258293287909,0.357778459083747,0.13741635931055,-0.619698706076004,-0.275618526612419
VILIMAS_NOTCH1_TARGETS_UP,0.189753798766981,0.115552496280923,0.258154578684296,-0.349811542090687,-0.0519555584645861
VILIMAS_NOTCH1_TARGETS_DN,-0.122270987075208,0.606585822837766,-0.0451535848127212,-0.194975281389268,0.0237889348561864
SPIRA_SMOKERS_LUNG_CANCER_UP,0.0869978961452118,-0.0588823448151821,0.22488502496764,-0.512173923184565,-0.0335288529225763
JU_AGING_TERC_TARGETS_UP,0.108798888308547,0.00839025904099261,0.54752246593319,0.255374194458826,-0.331397933510531
WAGNER_APO2_SENSITIVITY,-0.522760106996952,0.280146438507722,0.284114436288299,-0.229163501809645,-0.133422866509823
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,-0.292604999585809,0.175626451903017,0.123972211572994,-0.022922264265026,-0.203069658833376
SEKI_INFLAMMATORY_RESPONSE_LPS_DN,-0.137333617378003,0.409079342591062,0.0798314115826574,-0.112790082164342,-0.120016364398774
RAY_ALZHEIMERS_DISEASE,-0.0141782963505312,0.55428139926662,0.0224766944626102,-0.0013641281339421,-0.433616417580473
HUNSBERGER_EXERCISE_REGULATED_GENES,-0.298968555504987,0.00301684756156201,0.435719300201042,-0.487229722114096,-0.161896781468062
PIONTEK_PKD1_TARGETS_UP,0.306667736893625,-0.046697618298574,0.328169230376565,-0.59769661925514,-0.289138162309113
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,-0.259323865384853,0.157724888370654,0.24204631024105,-0.402664258073483,-0.163497701563704
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.197556451341659,-0.050340810869366,0.0404141193437994,-0.27087384975516,-0.15343874001844
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,-0.197309976714507,-0.216214078217971,0.073047556966049,-0.675853054215067,0.312829445457527
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,-0.315588764642074,0.282018506909001,0.265065124467311,-0.451957834725737,-0.327801327741279
GOLDRATH_ANTIGEN_RESPONSE,0.098795450031301,0.0374193791681793,0.0146708012335916,-0.28027573184978,-0.219042233777037
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,0.0231329995679726,0.158273619274691,0.0190286275956259,-0.108983594967726,-0.122387611373469
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,-0.123799094839233,0.356682704377599,-0.0336885681813582,-0.443903583945469,-0.123551971451275
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,0.267171162446849,0.207318562516853,0.0183350838218931,-0.249599396403552,-0.25041998011062
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,0.0547268675298636,-0.117739522385242,0.244624162495429,-0.382016113727819,0.04782865685171
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.00653560018759225,0.226851063515778,0.227020111943031,-0.408236711635608,-0.0369003362922555
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,-0.117252605895372,0.271505309924672,-0.353059667485139,-0.000145651517373807,-0.078914141660481
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,-0.226347166913493,0.217672552239327,-0.0220068152617051,-0.22310837938893,-0.127480273595724
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,-0.0122476500012546,-0.149766880889065,0.109792335568198,-0.139955588239338,-0.0671226869558186
MARSHALL_VIRAL_INFECTION_RESPONSE_DN,0.379317234125803,0.166042574978685,-0.288791110816928,-0.101182326997402,-0.153805622647645
NICK_RESPONSE_TO_PROC_TREATMENT_DN,-0.0585477633953498,0.251531622500477,0.281165614670147,-0.460406901644594,-0.423336139559532
NUTT_GBM_VS_AO_GLIOMA_UP,-0.269713811572732,-0.269285358251422,-0.145942345964127,0.111928802366015,-0.0970490469480949
NUTT_GBM_VS_AO_GLIOMA_DN,-0.280380912990354,-0.164482738274834,-0.347911427210414,-0.00813643923369622,0.100822314114777
PARK_APL_PATHOGENESIS_DN,0.383554878059094,0.173636633881823,-0.225108262922136,-0.0615915513477505,-0.363759367387576
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,-0.155799809250861,0.657943123979177,-0.467787205862331,-0.00493452087371352,-0.465829380574608
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,-0.27411696685585,0.600801222465159,0.15374551315091,-0.09011204162844,-0.595287626134692
ZHANG_INTERFERON_RESPONSE,-0.0619315491886175,0.35459611787973,-0.440662221869531,0.185889852292092,-0.116733638498177
WU_ALZHEIMER_DISEASE_DN,-0.379033383880406,0.166179404824624,0.115444047176443,0.0932905187075511,0.0190971705465661
YOSHIMURA_MAPK8_TARGETS_DN,-0.154393717479737,0.0209797640664665,0.0666428327491896,-0.233294037970947,-0.117631210993968
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,-0.0189852841268984,0.232443781697558,0.185859240171763,-0.284694284632213,-0.270840786532781
RUIZ_TNC_TARGETS_UP,-0.0124325862164859,-0.153527521859005,-0.0589663918854725,-0.133828014965356,-0.245668041356293
RUIZ_TNC_TARGETS_DN,0.133504397411276,0.313343449147822,-0.211843332721589,-0.22833412044847,-0.536544361421129
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,0.0155570067528631,0.0609048657793461,0.0999227353355126,-0.1768694600145,-0.279604850559916
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,-0.0783775191915653,0.100483287065374,0.121236979569303,-0.185604344243139,-0.227563569139593
RUTELLA_RESPONSE_TO_HGF_UP,-0.0350952029772844,0.0399324682679414,0.12228040494115,-0.238339398756149,-0.200818017245225
RUTELLA_RESPONSE_TO_HGF_DN,-0.0345750241268908,0.144151327232203,0.0849954012605768,-0.0732627535805194,-0.331671641971177
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.0155405404095455,0.0964229417050614,0.0486615373527767,-0.249041671822796,-0.18671668942726
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,-0.143548659973949,0.0519227363551332,0.229145793791846,-0.016237681794086,-0.359017295976211
SCHRAETS_MLL_TARGETS_UP,0.0833137273415938,-0.219368469530634,-0.135638087874063,-0.0502417841128761,0.1415992006411
SCHRAETS_MLL_TARGETS_DN,-0.545811781949833,0.337052536070356,-0.0402756459851521,0.159912171683454,-0.165530230672962
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,0.0736984639967417,0.239735801457058,-0.175951038942781,-0.186973661227269,-0.255173319269908
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,-0.00828895065872362,0.0855522003851533,0.134572759945805,-0.235813016737569,-0.150033514997393
VANASSE_BCL2_TARGETS_UP,-0.386541956121469,0.164373583600028,0.452166932294163,-0.464841762608717,-0.13025895827176
VANASSE_BCL2_TARGETS_DN,-0.414926246288069,0.259043914511041,0.11276853107872,-0.160152704548579,-0.0671359294409148
VANTVEER_BREAST_CANCER_ESR1_UP,-0.13178523588755,0.301462561807336,0.144755343362772,-0.447021727706086,-0.143865440899709
VANTVEER_BREAST_CANCER_ESR1_DN,-0.17076111225411,0.282532547917015,0.0843815178722568,-0.273701242696942,-0.23084132762641
VANTVEER_BREAST_CANCER_BRCA1_UP,-0.410036481958109,0.336153077540923,0.249435347261443,-0.337493845504985,-0.156726542217141
VANTVEER_BREAST_CANCER_BRCA1_DN,-0.211670600784046,-0.0472515580536242,0.171406738311163,-0.385047126720852,0.230567073101898
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,-0.0771193530072825,0.229346504445907,0.0999024312121872,-0.284070990864611,-0.435038959641507
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,-0.16111046937283,0.17138200288362,0.0301147366408342,-0.235931519730451,-0.314115808719171
SWEET_LUNG_CANCER_KRAS_UP,0.00828821331364402,0.0728987737324472,-0.0589220084584028,-0.23217657269593,-0.137718925513722
SWEET_LUNG_CANCER_KRAS_DN,-0.272731719480679,0.048283289005459,0.151190900880609,-0.125473579335929,0.0117566250020381
SWEET_KRAS_ONCOGENIC_SIGNATURE,-0.195950385996912,0.268307945372118,-0.332999588808479,-0.0702457781168884,-0.0809320668482398
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,-0.00426958973321628,0.327871525496852,-0.197420159227236,0.0771623027828884,-0.360644230573138
HINATA_NFKB_TARGETS_KERATINOCYTE_DN,0.017731123909069,0.195476408078824,-0.0493250316911536,-0.181609826520931,-0.150969581547168
HINATA_NFKB_TARGETS_FIBROBLAST_UP,-0.0899852491198368,0.518220440331365,0.00451742013785214,-0.175024362106841,-0.514136584978004
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,-0.14337322690881,0.174135292879713,-0.154186962339183,-0.379040781723635,-0.00905331748206961
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.0533853379874088,0.0009907354947645,0.04133700003629,-0.309650294809776,-0.1705204432705
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.00778449610379331,0.310959418903883,-0.0559625206087046,-0.32549179244844,-0.394926107276459
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,-0.0853018103749892,0.210682724047263,0.119067133243634,-0.324295502761305,-0.210617156975596
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,0.118097517147292,0.269271053443621,0.104743298992682,-0.456355009086013,-0.157405952400963
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.031857509564179,0.272637768385889,-0.115518934574198,-0.484701752084355,0.0312036501418897
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,-0.002352942369762,0.488555136379781,0.142997519475835,-0.360698817530681,-0.429604371794371
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,-0.00166282654677759,0.377563304152672,-0.0301146947952435,-0.288261220509499,-0.241257393027697
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,-0.354211299106101,0.56947673975729,0.00209448778956672,-0.124899631869333,-0.205013204237762
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,-0.136048290607571,-0.293744593517065,0.264159406205685,-0.219700030426532,0.190898674644418
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,-0.0947959288137171,-0.340197130422191,0.333664968473999,-0.186499695191742,0.241227593323463
LEE_EARLY_T_LYMPHOCYTE_UP,-0.176249974507834,0.14083947433546,0.226732472131875,-0.499734111689258,-0.0237580047386055
LEE_EARLY_T_LYMPHOCYTE_DN,-0.18684720034738,-0.118887742591707,0.137434493498425,-0.137381018337308,0.125097136487939
LEE_DOUBLE_POLAR_THYMOCYTE,-0.103077807233831,0.0173962797150067,0.333892397589061,0.108063605570215,-0.132075413202878
LEE_SP4_THYMOCYTE,-0.507450789904184,0.302451616543276,-0.524390337022518,-0.409463393293916,0.361458319461353
LEE_RECENT_THYMIC_EMIGRANT,-0.144311738508892,-0.0532420324282236,0.25480588541577,-0.317266353263695,-0.140257966047951
LEE_NAIVE_T_LYMPHOCYTE,-0.306998713622368,0.245868110295977,0.0216381748198753,-0.280626268685848,0.222092252702666
LEE_DIFFERENTIATING_T_LYMPHOCYTE,-0.135817742690057,0.116547165917148,0.214538041784171,-0.377115287134801,-0.0338428959728317
LI_WILMS_TUMOR,-0.583302132921983,0.282830887398282,0.187696356584744,-0.0581031596405001,-0.0820632228553398
FINAK_BREAST_CANCER_SDPP_SIGNATURE,-0.118796606011211,0.352836741698829,0.290135536321192,-0.322000481739806,-0.325476396570983
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.0706638304676791,0.223605504269379,0.0827522558729877,-0.453298753321746,-0.346302668806608
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,-0.00268550493813752,0.106473561590692,0.0905911253315589,-0.331080035484647,-0.197102615827823
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,0.00845889724890853,0.137069088701754,-0.0474032972618347,-0.263472792705283,-0.411608063367843
MELLMAN_TUT1_TARGETS_DN,-0.0146590055818909,-0.0505861378158385,0.270521178340583,-0.578446309259873,-0.077860273329785
HAN_SATB1_TARGETS_UP,0.0101436544924455,0.0299811417823915,-0.0642508533588318,-0.19761531460008,-0.100566603130751
HAN_SATB1_TARGETS_DN,-0.237735542100246,0.0804617993997086,0.112384222333721,-0.184962928888779,-0.16347494016251
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,-0.108890631786348,0.255129918919071,0.148313079332653,-0.250787163133391,-0.287396450644683
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,-0.0867770909564443,0.00244131421166424,-0.0729927419199925,-0.0918189412196343,-0.218855580511494
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,-0.290994299807823,0.115765900396679,0.14091832008804,0.050662565191716,-0.0469863492214581
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,0.0475837663348973,-0.0846852828626353,0.12868499724809,-0.305143578285526,-0.115122952728263
ELLWOOD_MYC_TARGETS_DN,-0.0159336683990681,-0.0530654915960001,-0.220591746970258,-0.348183460729753,0.114334482274891
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,0.0612370178987327,0.138924958251709,0.169078679148805,-0.289882050194295,-0.360802582178888
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.225457112974493,-0.0377214427799859,0.114504194413321,-0.302559506378084,-0.402233587352492
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.0784444146048726,-0.0377781221939577,-0.0455075153968983,-0.0138536341558839,-0.408334273645137
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,0.146887154387182,0.0245502368649608,-0.0562131783298077,-0.233403607622294,-0.182619556521343
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,-0.0752075337183581,-0.0265875654686707,0.281393686474433,-0.439265194244304,-0.201801877803853
HSIAO_HOUSEKEEPING_GENES,0.19421910834453,0.00175804971433208,-0.0672023151033991,-0.0871318366065209,-0.431763007821928
MEISSNER_ES_ICP_WITH_H3K4ME3,-0.201307447252804,0.408155467724636,0.00655172387072453,-0.223025889606874,-0.105444112398755
MEISSNER_NPC_HCP_WITH_H3K27ME3,-0.150979035399844,0.089816804119108,0.376779217821318,-0.179064545736548,-0.226612496892406
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,-0.259135071395293,0.125900697470179,0.306468614246517,-0.287622087390878,-0.117765782598066
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,-0.171841690452902,0.246580712536782,0.0517577516758282,-0.199190031465917,-0.222480284677204
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,-0.372559253109462,0.426052509615632,0.331109323688905,-0.363751702818361,-0.205020542378221
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.0225919163791718,0.164124017865351,0.16539711008863,-0.279196419651058,-0.161500399690182
MEISSNER_BRAIN_ICP_WITH_H3K4ME3,-0.316725785334332,0.406343756413942,0.181797635612413,-0.191761716242645,-0.249339126746306
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,-0.366551036601856,0.514037391009389,0.213514779266055,-0.460101338365974,-0.170806525222689
TAVAZOIE_METASTASIS,-0.292501509826532,0.184628662733462,0.217475422847152,-0.255527926663113,0.0121243217234679
FERRANDO_HOX11_NEIGHBORS,0.413933582779123,0.451561217834931,0.0394185991815459,-0.441134232248222,-0.505350543946074
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,-0.139515300759907,-0.317070849916363,0.529101370101557,0.00309205834415183,-0.410473011225758
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,-0.0813807768068629,0.35715767181338,-0.0579171259681031,-0.159263457751961,-0.30329037713759
MILI_PSEUDOPODIA,-0.292045522618039,0.33817726997451,0.133471211886712,-0.292219859599017,-0.460106986547143
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,-0.150233278505924,0.254882137167829,0.146906890933471,-0.282134395616627,-0.225294408915905
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.04758591274834,0.040238396091943,-0.0625091418407642,-0.246773082954251,-0.247666603615742
MILI_PSEUDOPODIA_HAPTOTAXIS_UP,-0.0503649551942478,0.0310875228883388,0.174351422860734,-0.365913077327283,-0.240739925987074
MILI_PSEUDOPODIA_HAPTOTAXIS_DN,0.036091203944769,-0.00877431072067791,-0.0154920393347371,-0.206309041526058,-0.319415306067379
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,-0.043810336205713,0.00486486941087796,0.0216962531817571,-0.201793744354471,-0.0208873503013011
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,-0.220230208571976,0.30705301797364,0.0333323480240741,-0.253567669787982,-0.451422716209659
CROONQUIST_IL6_DEPRIVATION_UP,0.172129471219045,0.168828132013047,0.00718280672282426,0.0256782079133596,-0.475653697111802
CROONQUIST_IL6_DEPRIVATION_DN,0.223688136592564,0.31634383818907,0.0130972407853752,-0.53018713197267,-0.379361588595132
CROONQUIST_STROMAL_STIMULATION_UP,-0.11233017944781,0.246401070795458,-0.323614163613488,0.294938495572245,-0.433583790678989
CROONQUIST_NRAS_SIGNALING_UP,-0.293630744422242,0.328529877578216,0.341008117420673,-0.353354876570722,-0.141439653206433
CROONQUIST_NRAS_SIGNALING_DN,0.286263724512159,0.239261771183784,0.0292762219238213,-0.52931357167938,-0.39819189749833
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,-0.278444307384807,0.370453644847748,0.212169331225778,-0.373433888089731,-0.0324344611021297
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,-0.213155557235426,0.320477150502604,-0.132977885560647,0.0636477761249071,-0.430309368917138
IRITANI_MAD1_TARGETS_DN,-0.0542264242314314,0.273248358075353,0.313573299701295,-0.548174584011488,-0.521125784193706
ZHAN_LATE_DIFFERENTIATION_GENES_UP,-0.215512983440839,-0.376404390637272,0.0164651644163585,-0.0451266213735833,-0.106400917424636
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,0.245901712738339,-0.266440710194763,-0.0559746181447673,-0.0659788761673012,-0.52145441206592
ISHIDA_E2F_TARGETS,0.17983891957762,0.251431745379829,-0.23923589142479,-0.537569496658528,-0.130649068392313
VALK_AML_CLUSTER_1,-0.234065917646666,0.454406430875592,0.155464752131456,-0.222289249900623,-0.10060409781984
VALK_AML_CLUSTER_2,0.267862271514693,-0.126519458695894,0.220980622615995,-0.469358966963223,-0.147693714102356
VALK_AML_CLUSTER_3,0.504099201608177,-0.34894522692364,-0.015046759118094,-0.192206167500773,-0.41557843879198
VALK_AML_CLUSTER_4,-0.242628426522883,0.0890648716445203,0.00114563448211974,-0.195640273973513,-0.0799043967382792
VALK_AML_CLUSTER_5,-0.447967051533467,0.390605535478968,-0.0460652243509178,-0.0236016896522636,-0.0907558261076547
VALK_AML_CLUSTER_6,-0.34152997004578,0.291823724304789,0.140803488141796,-0.328712000288933,-0.138167394831209
VALK_AML_CLUSTER_7,-0.375732812335941,-0.106413761921318,0.445123613465599,-0.147502572786316,-0.406505059281983
VALK_AML_CLUSTER_8,0.179985797929624,0.258037207646821,0.229648327571514,-0.273528164816199,-0.293851992675246
VALK_AML_CLUSTER_9,-0.254109379760025,0.0095539174434951,0.175885181847693,-0.0671467557784196,-0.123413668023325
VALK_AML_CLUSTER_10,-0.241380178123975,-0.0748701362481101,0.318739850227459,0.335984727667323,-0.384267123845958
VALK_AML_CLUSTER_11,0.10639013180666,0.0234910847728841,0.117719717492624,-0.412641441448092,-0.160265289665494
VALK_AML_CLUSTER_12,0.0383992303284946,0.375006038438033,0.458883780739076,-0.618222642661687,-0.351297478852337
VALK_AML_CLUSTER_13,-0.506673759727778,-0.0697453305971159,-0.250450241743271,0.184948850014825,0.00852762856510553
VALK_AML_CLUSTER_15,-0.121237923663519,0.312500813719351,-0.0554828149720053,-0.0986796954747718,-0.508751566481199
VALK_AML_CLUSTER_16,-0.242212586509919,0.208565012461643,0.0705164005822391,-0.190711559787911,-0.303394410789363
VALK_AML_WITH_11Q23_REARRANGED,-0.198336220575961,0.372324451777804,0.204047050552785,-0.244980405541887,-0.367803997715309
VALK_AML_WITH_EVI1,0.353898725757571,-0.480295602517317,0.473696325666163,-0.0827015557123817,-0.556684164360158
VALK_AML_WITH_CEBPA,-0.0904747900300744,0.356979689220589,-0.280372861939897,-0.155073674288475,-0.430577799983505
VALK_AML_WITH_FLT3_ITD,0.0811824376873198,0.125423367531804,0.20315892262874,-0.579253039856876,-0.10543313043359
JISON_SICKLE_CELL_DISEASE_UP,-0.00376546160471602,0.18510788513389,-0.169364670439013,-0.0833454587562198,-0.353479344812669
JISON_SICKLE_CELL_DISEASE_DN,-0.0639799691588716,0.0588944715450408,0.23230864230079,-0.401955243094977,-0.167431235101108
POOLA_INVASIVE_BREAST_CANCER_UP,-0.14360150751157,0.175634110850426,0.254460402874808,-0.268928975518416,-0.186291495767428
POOLA_INVASIVE_BREAST_CANCER_DN,-0.232999521619005,0.129677120864684,0.157171970817673,-0.0553358744272224,-0.341223245684616
DING_LUNG_CANCER_BY_MUTATION_RATE,-0.470231116438672,0.531565230724857,0.552491220102657,-0.463572812749235,-0.532883866268999
CHEN_LIVER_METABOLISM_QTL_CIS,-0.206592696841571,-0.0978307409046652,0.0635521611673879,-0.13660650653082,0.230812793698154
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,0.044081406027751,0.0988314722150054,0.0321320694740587,-0.4244084518629,-0.135484614349361
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,-0.09287867285112,0.250487445549701,-0.187274065127023,-0.299040564618945,-0.167655155124561
BOYAULT_LIVER_CANCER_SUBCLASS_G2,-0.148243116952978,-0.17511837797252,0.0582697230139493,0.0909347470132521,-0.430509615133231
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,-0.121488226071666,0.322536763866721,0.0714035158443782,-0.471068104170858,-0.451300007494978
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,-0.331099472945049,0.0380749258943507,0.426806891322116,-0.263100123831534,-0.21429748405916
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,-0.384971376819343,0.329760891800514,-0.0169222264873601,0.130466081443636,-0.279484426727938
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,0.0401236361990568,-0.0927890812173688,0.110239039255107,-0.548916359780965,0.159309726520465
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,-0.27513198711887,-0.00975757610505018,0.180335970842178,-0.359596514385737,0.0956169340998535
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,-0.0784522444344032,0.227019518779781,0.456813704006682,-0.640109198824939,-0.0677579731974781
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.125999486897097,0.255712752549179,0.120349052873227,-0.554662289967876,-0.41733832071077
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,-0.00979665125352833,-0.371922142740603,0.197974073977687,-0.489079177149554,-0.0103029282496576
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,-0.126143255807591,0.347381611725556,0.202273960605811,-0.480927941715988,-0.0445156558237219
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,-0.117737970315026,0.11152817798144,0.194158049759351,-0.435338270126391,-0.0034722610070092
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,-0.125801779051506,0.0563673602548788,0.105699917580161,-0.150523716088335,-0.170907597515214
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,0.0616817109238547,0.30481993019409,-0.154550379237642,-0.381241349370153,-0.244426925556003
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,-0.00425229633481097,0.146136857985996,0.18408766062516,-0.40673452371566,-0.0435043898019448
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,-0.409292146637618,0.0752953775198338,-0.0732487717892007,0.0214860711594153,0.103259381162316
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,-0.268551151125782,0.0945999473592483,0.207858709087542,-0.247383847063069,-0.0893653999254627
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,-0.14979051266231,0.0685122142945868,-0.0232068388026403,-0.340122205049666,0.0420953776596516
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,0.224444356799278,-0.144795986448984,0.159210158230817,-0.581126604075701,-0.103751345967888
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,-0.160386137425299,-0.020597164038217,0.168331730619206,-0.437766697702155,0.0147487547598356
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,0.257061125467912,-0.31949171304604,0.16750408825043,-0.428276616192756,-0.234127215477692
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,-0.00109964530511233,0.211404550621268,-0.0887451093265934,-0.229553138534561,-0.345130688085928
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,0.0901685907156124,0.135961991100857,0.0947585632524773,-0.258760751683401,-0.356982239423451
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,-0.312483231776046,0.0211906732901709,-0.226589182406325,-0.0230371507586429,0.0241869568786014
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,-0.132868190394948,-0.0970867244250576,0.334097963785812,-0.449093774464118,-0.0607499015829398
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,-0.20084610777078,0.133667518538047,0.210742707502338,-0.0973527327156566,-0.258446489295706
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,-0.0503770599712837,0.177085540806067,0.469813496643229,-0.521991260664595,-0.222463461479323
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.368315323070795,-0.424746943215049,0.215416538488639,-0.271276202386758,-0.161860939147086
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,-0.234945823558658,0.588756357957876,0.34436939134073,-0.45835094954988,-0.335215255801865
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,0.0506584702241425,0.360099453844919,-0.19590485289923,-0.376069571298808,-0.394344617272646
YAMASHITA_LIVER_CANCER_STEM_CELL_DN,0.0295115179430757,0.324446337742911,0.209967199160153,-0.335787237057974,-0.447034955258541
WANG_RECURRENT_LIVER_CANCER_DN,0.26095748794017,-0.23377349958609,0.0170840797218961,-0.235481227043604,0.0559531122825715
WOO_LIVER_CANCER_RECURRENCE_UP,-0.328980516836706,0.0246462567208954,0.133098062733899,0.0543505844287302,-0.149539142809396
WOO_LIVER_CANCER_RECURRENCE_DN,0.132574416266782,0.0468104236958858,0.190019407189369,-0.395251270985801,-0.348165187369153
YAGI_AML_WITH_T_8_21_TRANSLOCATION,-0.0996106796845422,0.0821036208969939,0.0647188071472757,-0.198049625384789,-0.256182589479726
YAGI_AML_WITH_INV_16_TRANSLOCATION,0.0342285463012993,0.0648191038022083,0.135120158685628,-0.323657193728522,-0.22968732157607
YAGI_AML_WITH_T_9_11_TRANSLOCATION,-0.290564133058869,0.0135932454477822,-0.175297593308236,-0.075203596944826,-0.00951285894877496
YAGI_AML_WITH_11Q23_REARRANGED,-0.133523886773409,0.0260392000552123,0.0694839664321647,-0.204495945771849,-0.137872326025628
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,-0.130849295112443,0.201990453847571,0.175349471000159,-0.330354892233941,-0.0404508947919945
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,-0.299854820045776,0.419650860555984,0.248184113770976,-0.261552440351275,-0.176849841331082
MEISSNER_NPC_HCP_WITH_H3K4ME2,-0.139280003264947,0.176717626596596,0.224954726950081,-0.286295985441055,-0.25271680267268
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,-0.110850697461629,0.268373473195518,0.31337605978137,-0.376577735772831,-0.275809333535728
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,-0.399478575305715,0.014347153951924,0.263534229729251,-0.327499675618607,0.166615489930602
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,-0.239827170193988,0.408770437262549,0.107594225862707,-0.331734001735702,-0.0909989952170285
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,-0.0754065799750939,0.393754136439894,0.366698827375961,-0.390917559441435,-0.372275084282715
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,-0.0762597182203411,0.245906924490358,0.153505839266244,-0.362429149269272,-0.308509346562257
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,-0.391341752085855,0.373888476941217,0.204553298013362,-0.276233847415595,0.0280767069201989
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,-0.0377891820763458,0.254081416805121,0.311940511090335,-0.440439180824878,-0.19251612836781
MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.0881042873399813,0.31911134663561,0.291703797642949,-0.493141273062817,-0.23814690831039
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,-0.243906964815063,0.155335589131424,0.234304772783299,-0.259046432250106,-0.142468748653764
MIKKELSEN_IPS_WITH_HCP_H3K27ME3,-0.120141803929909,0.054522517476138,0.312902301133286,-0.368866320499812,0.0420525903187853
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,-0.162420093094148,0.22232048255193,0.17631314263068,-0.256682534593395,-0.0631002812689103
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,-0.19335329056847,0.250955569169834,0.136161130381275,-0.327408523511741,-0.0543494265884026
MIKKELSEN_IPS_ICP_WITH_H3K27ME3,-0.0905388716589653,0.17571213211617,0.255774691913021,-0.353294551650513,-0.126942331974704
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,0.169191435183694,0.183999076304074,0.241566935318503,-0.368748628896969,-0.375451965572367
MARSON_FOXP3_TARGETS_UP,0.00749438093583407,0.175169718490062,0.0171743261081296,0.218984635582038,-0.444339986255211
MARSON_FOXP3_TARGETS_DN,-0.0876660939284796,0.328044032387066,-0.03572986827171,-0.203337425238302,-0.41666193523493
ONO_AML1_TARGETS_UP,0.11802043095127,-0.0479206339790662,0.143868924917118,0.127983806124364,-0.345822380183268
ONO_AML1_TARGETS_DN,0.015151389321869,0.166080762610252,0.328499940809445,-0.0424147473219125,-0.314852995548316
ONO_FOXP3_TARGETS_UP,-0.145567405947204,0.183444008825972,-0.238527980619047,0.309796138415863,-0.334636348735511
ONO_FOXP3_TARGETS_DN,0.0634028036058835,-0.0537931722275658,0.250813690643595,-0.232145519392326,-0.0583614536802224
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,-0.245406856235863,-0.0403958864650416,0.238067209875352,-0.360972505374775,-0.0309318225207477
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,0.0334126831045455,0.0340545140949002,0.121632361799825,-0.429169842080425,-0.24349528529059
SCHOEN_NFKB_SIGNALING,-0.247939168002397,0.161335042407056,-0.204133501858885,0.21566629012835,-0.0528441750951
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,-0.043635637756572,0.0833631229125586,-0.209498989238863,0.249836849395087,-0.475685470844449
WINNEPENNINCKX_MELANOMA_METASTASIS_DN,-0.176323081751758,-0.26747997925161,0.227947406694834,-0.0746866068065117,0.138704946928558
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.0998771002008306,-0.29804987290626,0.0614990417003069,-0.395474020737075,-0.0496368165038315
LI_PROSTATE_CANCER_EPIGENETIC,0.423895179397485,-0.0998811739689328,0.435379450848838,-0.596061679480722,-0.109974512407813
UROSEVIC_RESPONSE_TO_IMIQUIMOD,-0.299045142247907,0.247893636480202,-0.521102650519807,0.267400332528443,0.13755491510628
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,0.0791863363114852,0.361880624736578,0.016248876509829,-0.0800646919321937,-0.216214098687977
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,-0.0500802048459679,0.525126748958785,0.283292867606889,-0.0662251590439417,-0.341801940068869
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,0.0482027517608475,0.438267219165677,-0.208971067568114,-0.396776840660113,-0.374167053113902
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,0.0413656805805797,0.0969815932600473,0.0797783787248429,-0.249589916906309,-0.10537903550805
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,-0.291118653069609,0.0118176912811942,0.0807824600851896,-0.187808602787741,0.173978977450676
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,-0.250750934817248,-0.113949850790968,-0.0161062278373204,-0.0563210860241524,-0.0509244155171357
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,-0.0169830896655097,0.0393374415075321,0.0387065339721749,-0.305672593263039,-0.228208539166811
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,0.137481742874924,0.0551465388983044,0.172541153604029,-0.34957043568903,-0.342723643269858
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.0592879558947174,0.4690571403015,0.605643535102368,-0.426276512119492,-0.562345934884051
WEBER_METHYLATED_ICP_IN_FIBROBLAST,-0.553813065351421,0.550812875788705,0.389046811738847,-0.478759937902953,0.0813849555439919
WEBER_METHYLATED_LCP_IN_SPERM_UP,-0.0666427395644995,0.272508589020219,0.644639831548141,-0.0294004152353736,-0.344255049706479
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,-0.265185186384472,0.394471613941177,0.350692968287639,-0.2689487189014,-0.539125407597573
GYORFFY_DOXORUBICIN_RESISTANCE,-0.0487072712284603,-0.301672301425214,0.276097733050275,-0.0682874851132685,-0.185746000862556
GYORFFY_MITOXANTRONE_RESISTANCE,-0.0176134417872456,-0.209275686096914,0.287697498795994,-0.432353669703255,-0.155450145672236
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.0457485678418842,0.218374702150007,0.339197222274222,-0.226095154287314,-0.24138928483285
STEIN_ESR1_TARGETS,0.0570590841793397,0.19379298612414,0.118038373187455,-0.548159549847019,-0.337142735816419
STEIN_ESRRA_TARGETS,-0.0124555980768014,0.132933837013454,0.0367839413883975,-0.343637034389008,-0.313733466384184
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,-0.00382163590445081,0.345017665408671,0.0950951980250601,-0.503050013529497,-0.323723986918626
LOPEZ_EPITHELIOID_MESOTHELIOMA,0.0511978135677428,-0.00378955750213608,-0.289202503280528,-0.441999271292121,0.437369985937447
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,-0.0275299034041776,0.325381914142125,0.0503821994949947,0.346054615252404,-0.674167017710544
KORKOLA_CORRELATED_WITH_POU5F1,0.0794212240050587,0.367377321451462,0.143051323114256,-0.272700230973195,-0.448615161868861
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,-0.131995361825135,-0.0163875154057048,-0.0478923598042747,-0.0209678828806378,-0.004041450890584
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,-0.0551028062475359,0.228673660052278,0.372282183548347,-0.510291108349134,-0.203106766003388
KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.258723895169667,-0.349543797807675,0.0613368451752135,-0.197550902948419,-0.199619733194777
KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.0698724747654367,0.373036093276055,-0.0240728669229678,-0.45628647805775,-0.477609466014566
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,-0.0424308740947942,0.271166935712837,-0.011204906993939,-0.415797176691755,-0.32585100494724
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,0.0190220636853014,0.226760184025781,0.231797004301255,-0.207649827928986,-0.238660477983496
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,0.0229460181686244,-0.130096373566767,0.205541534271574,-0.174055759348435,-0.361571101037609
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,-0.26579225664463,0.172786678997921,0.274214019547551,-0.424831545874887,0.0558561871656677
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,-0.172302031511584,0.139136006744315,-0.123130838124868,0.046930757904219,-0.299431604646258
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.00611774153202263,-0.02842164608862,0.0710564654180944,-0.429134089086656,-0.127506844831077
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,-0.0201360035199773,0.145145729160095,0.164715169069456,-0.374189399632603,-0.273474683599523
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,-0.0512915474144207,0.255833276271983,0.000688726417042387,-0.5147036732517,-0.120260123966111
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,0.255381478944148,-0.0440436945402707,0.258897700809063,-0.111721523451595,-0.108916570672103
CAIRO_HEPATOBLASTOMA_UP,-0.186609727324492,-0.0420219270443722,-0.0279843138081714,-0.350286934602272,0.095622902362263
CAIRO_HEPATOBLASTOMA_DN,0.0570851801232114,0.21112426338271,0.10408999987065,-0.372989368828396,-0.298937633327957
CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.0495556032271815,0.240469599067925,0.0224103882612134,-0.437977385648887,-0.369643570421757
CAIRO_HEPATOBLASTOMA_CLASSES_DN,-0.25985154086332,0.151774481178058,0.12997644809916,-0.135749409129489,-0.0972525902706347
CAIRO_LIVER_DEVELOPMENT_UP,-0.415164577927825,-0.0721152613973342,0.133638562626441,0.0938736391957974,-0.0545634507716838
CAIRO_LIVER_DEVELOPMENT_DN,-0.0894883746328419,0.290413176439583,0.296964840875916,-0.441746145197431,-0.228012235168042
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,-0.263656932393712,0.524307616833734,0.29307279249582,-0.314822846465747,-0.455889402959912
GUTIERREZ_MULTIPLE_MYELOMA_UP,-0.0202615490316846,-0.0741921641778141,-0.168753200248726,-0.460797207244589,0.0676176250214355
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,0.0554739887342915,0.138181117247723,0.22576222466979,-0.579140381050581,-0.183676985270142
HAHTOLA_CTCL_CUTANEOUS,-0.160262497408033,-0.0620499045078821,0.351067592569559,-0.20616369634041,-0.142372483065677
HAHTOLA_CTCL_PATHOGENESIS,-0.242061615257963,0.373180340621556,0.243542345724149,-0.0183554555562266,-0.294040088214009
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,-0.405765679446272,0.145046429826931,-0.0778419876556607,0.245523238715689,-0.350337280639282
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,-0.190179203431348,0.142830155313875,0.233178694667348,-0.335876696977132,-0.178230648711432
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,-0.0471197729026528,0.344311854937054,-0.173090535098653,-0.366721125825636,-0.122064735026669
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,0.0225300419598818,0.277440373802292,0.15302382118561,-0.380197135389613,-0.346251543064794
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,0.0784620839618619,0.347602394783431,0.287028764596953,-0.331224527981972,-0.356707173481557
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,-0.476346195404832,0.383573436657572,0.635105141230362,-0.481694039424828,-0.231127779245814
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,-0.475401604995712,-0.0235321587720023,0.0344265353065207,-0.072875844988282,0.152663786879883
ZHAN_MULTIPLE_MYELOMA_CD1_DN,-0.192361357366195,0.211947679148198,-0.0571205559989085,-0.108118605731883,-0.166177257861458
ZHAN_MULTIPLE_MYELOMA_CD2_DN,-0.138619110731143,0.126266895133266,0.0455846419531687,-0.357626337568502,-0.0978100315462416
ZHAN_MULTIPLE_MYELOMA_LB_DN,-0.507001520576776,0.218143640188696,-0.17452047476967,0.290720963272566,-0.409320934198452
ZHAN_MULTIPLE_MYELOMA_HP_DN,-0.503232410774062,-0.242499596586814,-0.261881794202546,0.140988998531219,0.373985584384016
ZHAN_MULTIPLE_MYELOMA_MF_DN,0.172030140248277,0.0513360466447483,0.00847236022432407,-0.375817039259964,-0.29290436937217
ZHAN_MULTIPLE_MYELOMA_MS_DN,0.330688726984096,0.163744275391113,0.0911395463138926,-0.300902374369832,-0.515178920892687
ZHAN_MULTIPLE_MYELOMA_PR_DN,-0.258201354067261,-0.254999012122004,0.309424315420342,-0.195140855040585,0.0729634728267912
DANG_REGULATED_BY_MYC_UP,0.309006414816586,0.274522268317253,-0.116012384463427,-0.510295311564273,-0.471378543956386
DANG_REGULATED_BY_MYC_DN,-0.223219976425249,0.0492610451626774,-0.087555574128412,0.0743350086222561,-0.303789583341364
DANG_MYC_TARGETS_UP,-0.0381053052654279,0.0483146627766955,0.193579316765316,-0.436132489954281,-0.202527877393396
DANG_BOUND_BY_MYC,0.00577907362642888,0.11492536909061,0.0265497894167334,-0.337937243699542,-0.25344116294961
DORN_ADENOVIRUS_INFECTION_12HR_UP,-0.287466779162189,0.165220569218496,0.0190857451166256,-0.132295828748627,-0.00800482139946185
DORN_ADENOVIRUS_INFECTION_12HR_DN,0.10411423773699,0.512889311030395,-0.466044062597945,0.113392658069309,-0.53241281052866
DORN_ADENOVIRUS_INFECTION_24HR_DN,-0.0400763172112301,0.510655479172011,-0.488394140860992,0.0402455360476796,-0.304321369157214
DORN_ADENOVIRUS_INFECTION_32HR_DN,0.0406066232801272,0.435955634553548,-0.42711768535704,0.139025854519928,-0.334259526501265
DORN_ADENOVIRUS_INFECTION_48HR_DN,0.00046320540885475,0.447035326407823,-0.455785375391623,0.129499547084345,-0.397888182639921
TIAN_TNF_SIGNALING_VIA_NFKB,0.141247913494291,0.314372925107292,-0.390823251755696,-0.0565959447796809,-0.0622834815292574
WONG_EMBRYONIC_STEM_CELL_CORE,0.0769709180467759,0.253008376605443,0.127195693831125,-0.502537908921595,-0.368556575174369
WONG_ADULT_TISSUE_STEM_MODULE,-0.293913885564898,0.0303590166950531,0.0351538377518033,-0.0795395507813433,-0.110152964484445
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,-0.0217852334251661,0.174008740711627,0.00682152900686592,-0.223512570858572,-0.0271673504874291
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,-0.280556640264662,-0.0842065121456096,0.294666756503587,-0.370189598428523,0.0344338567293483
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,-0.407228397233819,0.238394842740443,-0.00625048556151227,-0.0221995446606377,-0.186524690215651
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,-0.0925632085816707,0.200964442942389,0.179998862460535,-0.219130001413356,-0.138880854943495
CHANDRAN_METASTASIS_UP,-0.0263090885032924,0.185739602852521,0.00272424294302176,-0.315030817651862,-0.292879250912276
CHANDRAN_METASTASIS_DN,-0.202118895098147,0.0457602440142858,-0.0304374196610288,-0.125681651537703,-0.157517916158799
MIKKELSEN_ES_HCP_WITH_H3K27ME3,-0.0723784371445716,-0.0910548162260997,0.0534843792171364,-0.179044537375718,0.0739424004914789
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,-0.215864943465022,0.259475266143648,0.407436449166207,-0.513104553002081,0.0770758920499334
MIKKELSEN_ES_ICP_WITH_H3K27ME3,-0.219767344194114,0.357636901265213,-0.101456312080991,-0.0907050435761529,-0.0542469084869326
MIKKELSEN_ES_ICP_WITH_H3K4ME3,-0.0763130179322875,0.0799389101000306,0.178272964791773,-0.311571567068599,-0.175665438444038
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,-0.244882142360689,0.194275533970416,0.267316909911434,-0.274449833614211,-0.101227832829035
MIKKELSEN_ES_LCP_WITH_H3K27ME3,-0.170569391318611,0.496623848409428,0.176823033246288,-0.2442171510039,-0.116282816142204
MIKKELSEN_ES_LCP_WITH_H3K4ME3,0.273926559421368,0.192872595471885,0.329333712912672,-0.354123609352693,-0.443804877238992
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,-0.00955924681099962,0.0856915282925862,0.278186326085864,-0.342916994302245,-0.178886530053118
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,-0.235461259780435,0.26076011862064,0.122665038564004,-0.293454707470831,-0.0672267177107172
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,-0.143350311231836,-0.0427579420570754,0.0924826030284322,-0.321343094748364,-0.00969731640671748
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,-0.148089706018645,0.193238353835088,0.326229554042632,-0.33130630143594,-0.27486530110214
MIKKELSEN_MEF_HCP_WITH_H3K27ME3,-0.0128488538984554,0.18543758764222,0.326186683837228,-0.407994047140409,-0.201797441872683
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,-0.129767755179788,0.29602199191067,0.196516959340834,-0.387827618048079,-0.138992330918705
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,-0.273633840514464,-0.254517037024918,-0.0711924135723642,-0.0243951514969988,-0.0920500988518507
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,-0.290854812617948,-0.108609137213886,-0.000742528139287324,-0.0641976952978435,0.0755262902638477
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,-0.0608432444770978,0.173049612476469,0.304046817000637,-0.257702202051508,-0.264210057366307
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,0.250821778328542,-0.0171719853054409,-0.208847862177805,-0.0803957322914043,-0.264161828577625
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,-0.257442627550656,0.0346276257441422,-0.10431945487344,-0.0850801459246687,-0.181226882087095
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.235164890237092,0.159457127080894,-0.181209246332846,-0.273752518760113,-0.120394833845187
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,0.235867403114739,0.166879787137557,-0.258528962475831,-0.272990510257605,-0.382065142254688
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.194736995989024,0.00855112024153745,0.252937279482376,-0.282477803077843,-0.441805855909929
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,0.0982228273855911,-0.130032845546684,0.106720600507135,-0.267564779305628,-0.0841721814951763
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.010990738028008,-0.201217325220927,-0.138057417418338,-0.161925308526231,-0.199654246579659
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,-0.279690886978781,0.282668962738879,0.28831654115932,-0.494665969035416,-0.306391882284684
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,-0.212934716827485,-0.213537227349583,0.00660567989491515,-0.0345933936927676,-0.284601188303414
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,-0.102192318192139,0.067475905655924,-0.037211838749159,-0.124986863244196,-0.220630661373994
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,0.0649013760373761,-0.007924123513567,-0.0559381172579828,-0.193166228480859,-0.123541696771336
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,-0.208818470277342,-0.325642832686681,0.353941183812455,-0.12993590439045,0.113734449863512
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,-0.401443964130205,-0.114584502746358,-0.0951614542740534,0.178576297212837,-0.0925207305183193
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.134918655581644,0.122675654219184,-0.0842077682393108,-0.186808087499988,-0.470355823106189
SENGUPTA_EBNA1_ANTICORRELATED,-0.192849059545149,0.209528293319737,0.210099315886743,-0.242773534941458,-0.368762895984594
MOOTHA_FFA_OXYDATION,0.174545736586874,-0.159759031057256,-0.151627098301721,-0.242451739639457,-0.0540609148849961
MOOTHA_GLUCONEOGENESIS,0.129716230368213,0.185656109569462,-0.0622323922891764,-0.00449717306487174,-0.612828552084636
MOOTHA_GLYCOGEN_METABOLISM,-0.438476321180385,0.36576463055884,0.417364018086226,-0.386926320338095,-0.148990774991647
NAKAMURA_ADIPOGENESIS_EARLY_UP,-0.216403457004055,0.188866670756668,-0.353180411014082,0.285488232918397,-0.273910611829179
NAKAMURA_ADIPOGENESIS_EARLY_DN,-0.324788043167392,-0.124470317642549,-0.287925941762241,0.313168442588676,-0.0954662993584597
NAKAMURA_ADIPOGENESIS_LATE_UP,-0.239803736412516,0.13052500280218,-0.0294158495618249,-0.198366992977606,-0.268233198425983
NAKAMURA_ADIPOGENESIS_LATE_DN,-0.385687650670874,-0.125903853796971,-0.366762348224911,0.330181875098981,-0.0536891502241018
BAUS_TFF2_TARGETS_UP,0.274967566590134,0.20422927271802,0.0457266398928927,-0.214088719906239,-0.133392043037974
KAMMINGA_SENESCENCE,0.137125207431234,0.201092041334656,0.419277269417931,-0.235721046289564,-0.451267880959583
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,-0.224492195233732,0.198114218046524,0.232730303461632,-0.376383772229166,-0.0408983825717382
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,0.138749071886885,0.342519101129995,-0.304052212103239,0.0121094664017906,-0.43531359699111
DAZARD_UV_RESPONSE_CLUSTER_G24,-0.260820086059462,0.261622846888257,0.0667442034741633,0.144981409023583,-0.23167574562742
DAZARD_UV_RESPONSE_CLUSTER_G28,-0.128520783494262,0.493386482718749,-0.511926165791634,0.363121665764749,-0.531342652562012
DASU_IL6_SIGNALING_UP,0.158703546206787,0.0697296653384892,-0.330944878881803,0.0486631752380264,-0.219618861044147
WHITFIELD_CELL_CYCLE_LITERATURE,-0.0744280841080002,0.115832334482186,-0.0408147741963474,-0.177498270552563,-0.263528981629008
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,-0.244887760501475,0.404808976715536,-0.075268103442746,-0.2063249391068,-0.585851074468691
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,-0.244374811721096,-0.0476827106344153,-0.0320760798982404,-0.326492760437061,0.055477974908634
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,-0.0869326038462374,0.0368084763604389,-0.103292527502988,0.00628455490483229,-0.23057689009223
SASSON_RESPONSE_TO_FORSKOLIN_UP,-0.229824743282696,-0.0510362182244002,-0.0214784526512616,-0.349484611737612,0.0560264719432817
SASSON_RESPONSE_TO_FORSKOLIN_DN,-0.083185894866213,0.0399667881660312,-0.100474431452393,0.0500287827706735,-0.231300107908339
BAE_BRCA1_TARGETS_UP,0.0480606297284542,-0.146830481580339,-0.0325854067633085,-0.064856912491548,-0.306431228098034
BAE_BRCA1_TARGETS_DN,0.0484857490573815,-0.0465171166999577,0.343674903085819,-0.472640569765344,-0.0622277434335745
BROWNE_HCMV_INFECTION_30MIN_UP,-0.430824238069805,0.365525468030846,-0.0710870346532667,-0.161569526507591,-0.137829976287549
BROWNE_HCMV_INFECTION_30MIN_DN,-0.134809186259538,0.00556675594822623,0.192324692870272,-0.383363605353288,-0.0727030645190973
BROWNE_HCMV_INFECTION_1HR_UP,-0.0742771319852925,-0.0572384344010649,0.100623926327879,-0.174379270118843,-0.091036332634643
BROWNE_HCMV_INFECTION_1HR_DN,-0.0474958850745971,0.137491613528827,0.310048357508789,-0.292197399516911,-0.326580652849607
BROWNE_HCMV_INFECTION_2HR_UP,-0.139158402898293,0.21654285067165,-0.0672040848240696,0.0195538350959196,-0.175963603806495
BROWNE_HCMV_INFECTION_2HR_DN,-0.041179114055857,0.301882829559461,-0.317366862492825,0.00990551085480354,-0.221525194193255
BROWNE_HCMV_INFECTION_4HR_UP,-0.235038216145012,0.371629239445733,-0.159378238960335,-0.342325825153183,-0.0374639974815097
BROWNE_HCMV_INFECTION_4HR_DN,-0.158646444028604,0.176029393828101,0.051303083477278,-0.1131614172067,-0.345116607731423
WHITFIELD_CELL_CYCLE_G1_S,-0.00507238885232561,-0.0279020758923775,-0.117655948349309,-0.239837625498114,-0.120214972831604
WHITFIELD_CELL_CYCLE_S,0.224308380512624,0.207896936986451,0.161795899052882,-0.548698763390438,-0.361088805007217
WHITFIELD_CELL_CYCLE_G2,0.1624724207088,0.125491492563448,-0.150526949574935,-0.30403143166687,-0.40195101794603
WHITFIELD_CELL_CYCLE_G2_M,-0.14302351440336,0.315110317773199,0.0984364070661598,-0.329013715701366,-0.421916420389285
WHITFIELD_CELL_CYCLE_M_G1,-0.133121392493923,-0.125413412417387,0.152483469785676,-0.423274723874075,-0.0207140665334062
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,-0.0151478660978395,0.146770671814938,0.112721542436675,-0.278260860738119,-0.233524013808543
KARLSSON_TGFB1_TARGETS_UP,-0.304755593863683,0.281162755987546,-0.108524486868231,-0.287499302158134,-0.247718648270159
KARLSSON_TGFB1_TARGETS_DN,-0.0474202225265657,-0.228309861100868,-0.129426883679863,0.0803170939945473,-0.296799490550154
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,0.153085244644232,0.0457281574523808,0.294889472065652,-0.356366902471869,-0.642274674820582
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,0.0490282330855208,0.402370101603438,-0.00784099516968365,-0.435273279428009,-0.24926731877403
LI_INDUCED_T_TO_NATURAL_KILLER_UP,-0.0283880865823912,0.151473675718377,0.00803365735145981,-0.252960447394359,-0.093141380438502
LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.0755629734810982,-0.0163676553423529,-0.0335467885813474,-0.239617980542421,-0.206797260450654
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,-0.138138962627184,0.0960411092510341,0.462779149053565,-0.202504144789226,-0.392541688234133
KAMIKUBO_MYELOID_CEBPA_NETWORK,0.374676487339401,0.317348234223652,0.213826843630223,-0.654441933482412,-0.27264993708081
MARTENS_BOUND_BY_PML_RARA_FUSION,-0.139937393212034,0.24961096507077,-0.048860223740501,-0.181222617037315,-0.339325801027681
MARTENS_TRETINOIN_RESPONSE_DN,0.00966964288233788,0.191625901593152,-0.0589926880273573,-0.203338134655641,-0.32561552454389
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,-0.110002305664945,-0.0570628141681113,0.143613484346811,-0.243580979457924,-0.0584492287129372
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,-0.312477425112605,0.362397427332887,-0.0332397313213026,0.084613038476616,-0.535598178921657
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,-0.28062712678312,0.0530196634886342,0.291600598640131,-0.306893424092786,-0.0637654766762714
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,0.0526087693168144,-0.043638978438606,0.387737969914727,-0.530568401734955,-0.248516576599542
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,-0.101941883470626,0.0759754892307423,0.0623804961777978,-0.205388495593747,-0.338920987712908
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,-0.208057789478598,0.0387606756836362,0.103636273946046,-0.198765665483197,0.101233603053985
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,-0.0443062841569143,-0.0400648675139034,0.0892049807264107,-0.265132798603999,-0.262333709184
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,0.352224261326423,0.0173160132068829,0.00696413009150246,-0.210827225551523,-0.140582408935071
KIM_ALL_DISORDERS_CALB1_CORR_UP,-0.115237720898389,-0.0438062802662158,0.18909406700901,-0.341710325506688,-0.147283126372278
KIM_ALL_DISORDERS_CALB1_CORR_DN,-0.128510608579539,0.1974156266071,0.220954311739446,-0.261560288882121,-0.141620280547054
KIM_ALL_DISORDERS_DURATION_CORR_DN,-0.24117063474039,0.333398845743756,-0.0721504806134228,-0.0307091656506193,-0.380408724504062
VERHAAK_GLIOBLASTOMA_PRONEURAL,-0.150564325617665,0.0523582439442261,0.351053825024918,-0.412648191026234,-0.185815712659116
VERHAAK_GLIOBLASTOMA_NEURAL,0.0371330591282706,0.0998132051654571,0.302465301410841,-0.512007846966679,-0.133704610214186
VERHAAK_GLIOBLASTOMA_CLASSICAL,-0.326212116516884,-0.0285304483331912,0.142795385307837,-0.200998632657851,0.0180432643426361
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,-0.120987457314476,0.245547893489376,-0.0100426434200362,-0.0634157409550432,-0.3584942793259
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,-0.00914414179245596,0.266579116537869,-0.14832190746073,-0.258768420584675,-0.343772381862476
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,-0.183379006746532,-0.12830237717386,-0.1817356130337,0.144729912862746,-0.277753211413698
CHICAS_RB1_TARGETS_SENESCENT,-0.0321788639670274,0.12743439061598,0.136822864736715,-0.273896271159753,-0.226416311169636
CHICAS_RB1_TARGETS_LOW_SERUM,0.140581547094181,0.01451949340767,0.135536125101339,-0.347433606545011,-0.308083057535247
CHICAS_RB1_TARGETS_GROWING,-0.0991967059369283,0.0897329354239943,0.0762621233682519,-0.202326018405915,-0.215473100218286
CHICAS_RB1_TARGETS_CONFLUENT,-0.204596719354269,-0.0153556008194021,-0.0578143388581393,0.0404579452879628,-0.212294158024289
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,-0.122443230775586,0.145024679573678,0.232708700957317,-0.386971951580684,-0.183791903840705
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,-0.035514235486639,0.301543872109847,-0.0600476085191419,-0.41224696846873,-0.371752598767978
QI_HYPOXIA,-0.107028612120583,0.152715729653496,-0.0864828189771304,-0.0889308207861564,-0.330402382207314
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,-0.23232441333694,-0.16219009105917,-0.171096509443418,0.503763743687032,-0.412293119253768
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,-0.197497059883048,0.149164103934781,0.187954706336432,-0.429338152659791,-0.0242633792672288
LU_EZH2_TARGETS_UP,-0.04411973573426,0.24766319368799,-0.119444848450917,0.0215951394501179,-0.381700347003331
LU_EZH2_TARGETS_DN,-0.130010130254733,0.0452078213621489,0.151651294472258,-0.401591047679279,-0.0699408966416261
HOELZEL_NF1_TARGETS_UP,-0.190343901479911,-0.0818790902326747,0.230877004052699,-0.26240535500956,-0.0231594743054909
HOELZEL_NF1_TARGETS_DN,-0.2089544079544,-0.0320537668340028,-0.0992127744291974,-0.0877191802365966,-0.0268594014323341
DEMAGALHAES_AGING_UP,0.208771187677446,-0.00619516598719053,0.117416069335328,-0.368567474648133,-0.0107103560456725
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,-0.0319824646719291,0.247542322610524,0.0175135370967405,-0.333838083933794,-0.342229599506252
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,-0.38749152262147,0.324875074250931,0.289265347824966,-0.362799475097849,-0.339862688695967
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.132878875819789,0.28030191969492,0.0423326611597235,-0.496952041018106,-0.384700815406913
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,-0.277736524582169,0.120452961848519,0.174266974307542,-0.220148115952085,-0.218314888873067
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,-0.374062262110729,0.254576758945357,0.152236011773971,-0.363928363713541,-0.0999816958182965
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,-0.284195268294208,0.167620254052787,0.2753641238077,-0.428419898220315,0.211014965908489
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,-0.224831975257946,0.163044990377396,0.312865435495304,-0.439428857706635,-0.240138838117071
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,-0.253740843121756,0.175916540012181,0.329600512268618,-0.419780903764578,-0.290118141356382
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,-0.180552293127146,0.259250335703019,-0.410025909257136,-0.120584686578804,-0.0626664845397508
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,-0.329059857296395,0.226774704980868,0.203366495608425,-0.33882739970339,-0.131988620607111
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,0.0508348933287177,0.333817860203206,-0.10674672617429,-0.0810821362204379,-0.196659280883623
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,-0.0668029591283446,0.0397389303652639,0.229672127571012,-0.273150832137832,-0.0174517019473266
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,-0.384682046604297,0.294679688485384,0.134714463849106,-0.330792781364011,-0.182376953006272
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,-0.159191362359018,0.268828621571097,-0.0372329232815125,-0.11801642538756,-0.119166429396647
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,-0.283397323632035,0.325174894997284,0.221789593054498,-0.303051169567739,-0.269707143269188
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.250465830830947,-0.342426788560316,0.176431061945969,-0.297521401660368,0.200377216492125
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,0.162903962548282,0.380857865965495,-0.0263177364339133,-0.342323992683865,-0.347419601860226
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,-0.0932785521083429,0.00894119739018395,0.118350578955245,-0.0977134127040378,-0.201885052464958
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,-0.0977320065695907,0.0126503803934601,-0.0148114566678104,-0.271152990320535,-0.115394944541117
LI_DCP2_BOUND_MRNA,-0.159620413939371,0.438234689472404,-0.0452794122978711,-0.279667776053331,-0.563325900428702
WAGSCHAL_EHMT2_TARGETS_UP,-0.225549386299885,0.133121290350653,0.413721499470638,-0.0290444066663025,-0.49464583294427
SUBTIL_PROGESTIN_TARGETS,-0.195566821476475,0.403605460590506,-0.297992247613789,-0.207633773271472,-0.264052570409766
OHGUCHI_LIVER_HNF4A_TARGETS_UP,-0.109492814482954,0.300245084481985,0.250260498146986,-0.336859906707374,-0.329147925351069
OHGUCHI_LIVER_HNF4A_TARGETS_DN,-0.0862089875071481,0.0939763832869703,0.288571098725457,-0.387345595073679,-0.0554154713502134
GABRIELY_MIR21_TARGETS,-0.237711374117091,-0.170441439222096,0.178411301467309,-0.37652561070975,0.0615005980010364
THILLAINADESAN_ZNF217_TARGETS_UP,-0.122462238457495,-0.193825909909544,0.384228167466116,-0.486022634288162,0.0040851621579476
CHYLA_CBFA2T3_TARGETS_UP,-0.0127993985285395,0.141059114894162,0.109939836661104,-0.377528067910232,-0.0391328118650483
CHYLA_CBFA2T3_TARGETS_DN,-0.154475481632365,0.175803471576032,0.0153195985328572,-0.257403070351142,-0.148154566567579
CARD_MIR302A_TARGETS,-0.130755476153034,-0.00370026390964479,0.136544777220198,-0.352292957627714,-0.0676818682302396
WIERENGA_STAT5A_TARGETS_UP,-0.0971469499474813,0.282639773462756,-0.0646235174092629,0.00272071808811924,-0.326835974008425
WIERENGA_STAT5A_TARGETS_DN,-0.158856651115436,0.193264290873609,0.0909795345854484,-0.207828222041231,-0.225611542467808
WIERENGA_STAT5A_TARGETS_GROUP1,-0.0622178093688721,0.331441951102855,-0.127106888302146,0.0692046299454788,-0.471702850392657
WIERENGA_STAT5A_TARGETS_GROUP2,-0.133636549983318,0.273204214693787,-0.0701168321821403,-0.113677490483168,-0.198599807017642
WIERENGA_PML_INTERACTOME,-0.0130620475284578,0.214063177257514,0.26559706408199,-0.402864036241536,-0.386371484980991
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.0941941931854762,0.122077152855228,0.0719666667294438,-0.537482622375866,-0.347997319557967
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.0501956173634811,0.181970103763316,0.0281303012475458,-0.156572890275725,-0.425706065328391
KANG_AR_TARGETS_UP,-0.679178297049814,-0.595076508056722,-0.154209099866468,0.57050385637196,-0.364100264339734
KANG_AR_TARGETS_DN,-0.460967986849929,0.330379977519967,-0.273558495732982,0.100464226185175,-0.111766391113036
PILON_KLF1_TARGETS_UP,-0.170392585715463,0.0659611777847126,0.177768943982155,-0.25663130700711,-0.156408725617304
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,-0.0617653183301536,0.170144225868471,0.0104850037761517,-0.157123503679471,-0.271348175961943
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,-0.302478449786034,-0.185869779513268,0.418345322298179,-0.262612118643652,-0.123536242441047
BHAT_ESR1_TARGETS_VIA_AKT1_UP,-0.130211463954574,0.264697150403695,-0.0873339812573408,-0.0923779863350792,-0.312208429531491
BHAT_ESR1_TARGETS_VIA_AKT1_DN,-0.371268801104689,0.295433662304827,0.326333601620755,-0.326941038956,-0.295757760934229
JOHNSTONE_PARVB_TARGETS_1_DN,-0.169160942328676,-0.449892944055521,0.354460729403339,-0.375900663123143,0.112427747907067
JOHNSTONE_PARVB_TARGETS_2_UP,0.0994083861412716,0.0659527585205751,-0.314118687220365,0.0473914385701272,-0.446433191635806
JOHNSTONE_PARVB_TARGETS_2_DN,-0.0750994723325258,-0.100057622137482,0.266431098834416,-0.431439613956437,-0.189860315400698
JOHNSTONE_PARVB_TARGETS_3_UP,0.0344878419004429,0.119953416322372,-0.185937715322557,-0.107844204729129,-0.390902265152125
JOHNSTONE_PARVB_TARGETS_3_DN,0.0954030701223256,-0.0873613388546633,0.108731805932576,-0.463085843104014,-0.0763136186142125
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,-0.112437228170048,0.112137649480246,0.23684308882285,-0.342862717330771,-0.128468026472525
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,-0.0832870556288839,0.0921410529351794,0.08863819337941,-0.203711720232176,-0.215379049508915
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,-0.099973725816634,0.0958801652404335,0.316973106254567,-0.389739952075622,-0.160174218380381
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,-0.00679441524812338,0.205618036048637,0.193729813305107,-0.330463254214096,-0.248000387048222
BRUINS_UVC_RESPONSE_EARLY_LATE,-0.0641252539155469,0.114917297808335,0.109540119454151,-0.204322590693683,-0.217285741060093
BRUINS_UVC_RESPONSE_MIDDLE,-0.147703318708632,0.0784207404367458,0.0190356529416311,-0.215145301033913,-0.0845556644405215
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,0.190563613702093,0.253925057586504,0.351370704889816,-0.320509976239853,-0.289919509397038
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,-0.156459879187734,0.314742244266739,-0.104663769548884,-0.410317429440702,0.0116777845787843
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,-0.220379492348785,0.0707266049373659,0.0826707642242534,-0.179566869684975,-0.13939616909667
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,-0.225466389763014,0.00325783941023716,-0.0619483240929941,0.0544237402273717,-0.157489182326759
IVANOVSKA_MIR106B_TARGETS,-0.0724182418911744,0.422136542726547,-0.131498860103213,-0.403246829914504,-0.326799354293148
KIM_GLIS2_TARGETS_UP,-0.384244779670224,-0.18257093559083,-0.322128988150372,0.246871312854822,0.0754872029500445
STEGER_ADIPOGENESIS_UP,-0.0284597814589715,-0.0917207086321995,0.319761854562972,-0.554068468277063,0.415598501663995
STEGER_ADIPOGENESIS_DN,-0.222141512653331,-0.551359117594432,-0.255938851271547,0.424545528480829,0.114525965775921
MAEKAWA_ATF2_TARGETS,0.328718613218439,-0.129385191769552,0.463912223838718,-0.347820406094919,-0.15902777259051
ISSAEVA_MLL2_TARGETS,0.06708084027525,-0.288615562928453,-0.0516785298243383,0.0434050869258948,0.0293330823085435
LINSLEY_MIR16_TARGETS,0.114707032984527,0.138321741980232,-0.210314781206087,-0.317441411156478,-0.323317909028022
CHANGOLKAR_H2AFY_TARGETS_UP,-0.278700051270235,-0.0329946988472695,0.288195947982548,-0.409279056922181,0.101885488381932
CHANGOLKAR_H2AFY_TARGETS_DN,-0.322621959644788,0.0433875585548872,0.316115761852491,-0.387136049644081,-0.0341889375980368
PASINI_SUZ12_TARGETS_UP,-0.0476617668552768,0.173710290328137,0.0854455577814426,-0.344842710432485,-0.218269572897646
PASINI_SUZ12_TARGETS_DN,-0.163006424567731,-0.118308970817576,-0.0878983778484833,0.0598840039787022,-0.148295410438435
BAKKER_FOXO3_TARGETS_UP,-0.082697736829274,-0.071324406919218,0.107048433315241,-0.255648809826573,-0.0737089271172073
BAKKER_FOXO3_TARGETS_DN,-0.145669687024979,0.231061073017995,0.0350349336115711,-0.25921032865102,-0.311999920589358
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.121009037255014,0.195137461756237,0.0679203515964255,-0.168348827360376,-0.387661903983233
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,-0.0954706572495156,0.34294363724584,0.117967059326725,0.0165736899372065,-0.434648567502848
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,-0.15146853717879,-0.0156441293061457,0.504386320002601,-0.412241978295726,0.0971150100017604
VANDESLUIS_NORMAL_EMBRYOS_DN,0.280041310161324,-0.114465414817634,-0.575907987892455,0.103783120709836,0.0447519954241721
SUMI_HNF4A_TARGETS,0.00716123378428346,-0.283640753468435,0.189932840217439,-0.524079389293122,0.348578925345708
WANG_NFKB_TARGETS,-0.18487573871071,0.368796464412479,0.0843117224698084,-0.220034419992665,0.0406926570554925
WANG_TNF_TARGETS,0.369126768548752,0.358675433092278,0.171583238525808,-0.384715507567762,-0.361674978408422
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,-0.266843374566741,0.100573322493673,0.0005923532835308,0.113447158829843,-0.193894932674408
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,0.114040040441828,0.1608427181041,0.38983179786687,-0.264720677097294,-0.452961206211268
DELPUECH_FOXO3_TARGETS_UP,0.0757844385409636,0.241041787253906,-0.127110092322661,-0.286875978977933,-0.407664672208287
DELPUECH_FOXO3_TARGETS_DN,-0.230922841595746,0.0692035687385335,0.435165460031128,-0.0551631170468711,-0.334869976690928
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,-0.482376847789395,0.112667902171798,-0.256231052295814,0.476205130816138,-0.40247456432825
KASLER_HDAC7_TARGETS_1_UP,-0.28692407075886,0.246328601648929,0.0684128588268464,-0.278021944344434,-0.169414726164206
KASLER_HDAC7_TARGETS_2_DN,-0.271556070970288,0.132982002995268,-0.281699110882731,0.347549462598681,-0.211800345314386
LEE_BMP2_TARGETS_UP,-0.122119598311597,0.0867184508022581,0.0386806783533136,-0.145772856532048,-0.210925246854361
LEE_BMP2_TARGETS_DN,-0.0357530980373114,0.138646517143324,0.107297707454916,-0.463760577181932,-0.207355323799239
BILANGES_SERUM_SENSITIVE_GENES,0.151234652185406,0.283720255304177,-0.221220837216194,-0.147367846643741,-0.351367419651285
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,-0.148694190763321,-0.212734250644097,0.407133837427508,-0.477837802915061,-0.102181278726907
BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.205404624000088,-0.076129701114951,-0.180612296794188,-0.498577851359699,-0.198577358424637
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,0.244809700558804,0.111627817551578,-0.131232987563974,-0.473609547430669,-0.451443914725384
BILANGES_SERUM_SENSITIVE_VIA_TSC2,-0.733237711356205,-0.138925741854319,0.203013308141161,0.0295582778428072,-0.054388257438737
KIM_TIAL1_TARGETS,0.162561288893725,0.304514059951314,0.107253051702505,-0.352646775871338,-0.448201229246808
DUAN_PRDM5_TARGETS,-0.170187633028599,0.264362937151232,0.221369575544395,-0.406459916328805,-0.301118685384515
DALESSIO_TSA_RESPONSE,-0.294731435138001,0.292371336630025,-0.241459186366174,0.175840446739998,-0.286400759312899
FEVR_CTNNB1_TARGETS_UP,-0.0724504152374095,0.144225030597569,0.097819126269476,-0.238215945214034,-0.280381580596149
FEVR_CTNNB1_TARGETS_DN,-0.0238066730229037,0.183621632041908,0.15622217985496,-0.480762557245625,-0.0787821031627647
FARDIN_HYPOXIA_11,0.235373168428846,-0.0794134282958328,-0.0789181630814199,-0.187200252444345,-0.456972396606242
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.213120262816046,-0.0170978434112298,0.157026384523506,-0.284959111307203,-0.367130524945985
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,-0.529289776776014,-0.215777400743058,-0.0298957940045973,-0.175768109383034,0.134725216157731
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,-0.0686094977695909,-0.0215510239956983,0.282258503112848,-0.280691681182015,-0.288585866344385
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,-0.165261168406114,0.0759542494377253,0.153282950459924,-0.261504182313098,-0.15077452486463
WINZEN_DEGRADED_VIA_KHSRP,-0.266907943663074,0.187161472801662,-0.0434315153930223,-0.0183907373171457,-0.118218073891298
VANLOO_SP3_TARGETS_DN,-0.0678474573441586,0.27474628128088,0.160714491473311,-0.131450083226356,-0.309128350436992
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,-0.0126893261312318,0.104308498140523,-0.0623853461004453,-0.15467924553346,-0.389714894724416
TERAO_AOX4_TARGETS_HG_UP,-0.240709307171518,0.378574721766402,-0.0985150388768644,0.00105883370226398,-0.41749784661068
TERAO_AOX4_TARGETS_SKIN_UP,-0.110082561350329,0.260795855082312,0.217850770217574,-0.253904298510822,-0.447775140637917
TERAO_AOX4_TARGETS_SKIN_DN,-0.357471212235061,0.19265595052358,0.322250549158505,-0.494556209624543,0.0153272254586536
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,0.196476920600307,-0.0929431087256685,0.0641378838006835,-0.261176700316973,-0.196113963337099
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,0.0348738811395288,-0.0774391847125092,0.191588033818556,-0.17740408060911,-0.336121701753554
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,-0.119527312632954,0.312119829642185,0.079523775626789,-0.311118286851652,-0.277982333514096
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,-0.0813059862121386,0.190198729748246,0.129131823405729,-0.32641723673161,-0.163247972512879
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,-0.0582948024257816,0.287122198310482,0.0979846454473053,-0.433510703231003,-0.376395049637078
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,-0.234644731767594,0.103626505900581,0.0359916958596423,-0.363053676478332,0.0106901601027053
IKEDA_MIR1_TARGETS_UP,-0.490726000711688,-0.174699849661005,-0.339796108987327,-0.0217602660406773,0.223512460055919
IKEDA_MIR133_TARGETS_UP,-0.0233384217627765,0.264784363023231,-0.239725662166383,-0.421872987861454,-0.362485213954705
IKEDA_MIR30_TARGETS_UP,-0.278906893630289,0.0877320602994731,0.220134674682575,-0.334068536231824,-0.101263801580308
KATSANOU_ELAVL1_TARGETS_UP,-0.0811813555498949,0.0232273603062207,0.0878360268896341,-0.101382453237936,-0.0178748343603843
KATSANOU_ELAVL1_TARGETS_DN,-0.233750273895976,0.129431979794699,0.104080891155855,-0.160311839115602,-0.125959868640915
WANG_THOC1_TARGETS_DN,-0.140336643020574,-0.28155170331909,0.508923232727378,-0.195020610638692,-0.191304108838253
SERVITJA_ISLET_HNF1A_TARGETS_UP,-0.204689577724332,-0.112875991735488,-0.0773060540613972,0.0117529424303617,0.026399589428717
SERVITJA_ISLET_HNF1A_TARGETS_DN,-0.0183946078250486,0.0337137065281888,0.425905202206221,-0.475997598190258,-0.0516779361978104
SERVITJA_LIVER_HNF1A_TARGETS_UP,-0.0521478156395898,0.0952789859743934,0.100580662825024,-0.289044366350063,-0.23588497054815
SERVITJA_LIVER_HNF1A_TARGETS_DN,0.0130761877665338,-0.00852021632812108,0.307724566779458,-0.395635329295942,-0.0965233324001007
MADAN_DPPA4_TARGETS,-0.193538998469076,0.35023601202482,0.186970862355523,-0.26260112595902,-0.188643045338881
KOHOUTEK_CCNT1_TARGETS,-0.053906653993379,-0.190058765690521,0.289082264638867,-0.130803066463998,-0.305563662299008
KOHOUTEK_CCNT2_TARGETS,0.248683560836468,-0.0337426588895277,-0.0556576403729962,-0.0424437230195231,-0.404959041226725
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,-0.397736161006445,0.290916602066973,0.0903776492693066,-0.364038218511036,-0.0643407107215024
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,0.0618532218145733,-0.0566222131926099,0.0356720256190659,0.254384999979547,-0.514518308821908
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,-0.0818826831809364,0.193075284853698,-0.0104169451139811,-0.135108791294894,-0.191964184419313
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,-0.412571875101652,0.223008153621435,0.260193508588638,-0.116501609996098,-0.311365896667594
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,-0.112348811574309,0.145057036362772,0.0223622111855677,-0.182551430990489,-0.264451377142373
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,-0.040134222096228,0.260205333405619,0.111599787248986,0.00363035496320596,-0.479118641353356
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,0.181672568342685,-0.0579921677015831,-0.0859759506535399,-0.180549607507803,-0.235731416710756
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,-0.164896077684728,0.0712832349599277,0.576338972625232,-0.618957842885738,-0.25134043697616
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,-0.0101885059272765,-0.0533423824351328,0.0329562878029789,-0.251331132933057,-0.189651476566924
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,-0.0542492322347821,0.0738606364912599,0.0845122210566761,-0.28204768781642,-0.160845365492802
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,0.232343892017211,-0.361752498245454,-0.028261386405302,-0.174549585330087,-0.156877952113275
YANG_BCL3_TARGETS_UP,-0.0419668615650904,0.0989316647614347,0.0222334406042186,-0.230224967092721,-0.209081636036781
VERNOCHET_ADIPOGENESIS,-0.16899188407986,-0.293892729001195,0.303685334151739,0.0097931601106872,-0.150915173046394
GUO_TARGETS_OF_IRS1_AND_IRS2,0.141210830313072,-0.0419569477103002,-0.0138651252661681,-0.507590451412417,0.0335474511468117
HUANG_GATA2_TARGETS_UP,0.108502614795282,0.064040647841263,-0.145707455177548,-0.269152378918689,-0.123960681718511
HUANG_GATA2_TARGETS_DN,-0.0474319449816552,0.360324242215132,-0.0740608283329965,-0.424332495549996,-0.23339089670958
LE_NEURONAL_DIFFERENTIATION_UP,-0.480898670692475,0.235438035193337,0.0558263254883153,-0.399685664551431,0.146082918822583
LE_NEURONAL_DIFFERENTIATION_DN,0.141719171693417,0.0813634192854509,-0.312382165999689,-0.388884362634917,-0.0564939808391634
PLASARI_TGFB1_TARGETS_1HR_UP,0.0614153181949081,0.293513771859801,-0.425707026370578,-0.145204290756852,0.0363770390812546
PLASARI_TGFB1_TARGETS_10HR_UP,-0.166450219849653,0.338447922641347,-0.178580863674202,-0.0906472094466432,-0.175335493159749
PLASARI_TGFB1_TARGETS_10HR_DN,-0.347888133494402,0.0290605172234505,0.0675130071529431,-0.179687091259457,0.0521591732227455
PLASARI_NFIC_TARGETS_BASAL_UP,0.084670717737698,-0.159192574252725,-0.0936672098163617,-0.0633845117960689,-0.28395889729529
PLASARI_NFIC_TARGETS_BASAL_DN,-0.355469442274891,-0.0951411823499491,0.593164270534759,-0.256523898713257,-0.110783675970364
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,-0.43591977269696,0.282249775492391,0.425735171011354,-0.317720751193258,-0.114942548806571
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,-0.400205130022097,-0.144897443229995,0.101561157890136,0.0292382703056038,-0.0088390889839155
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,-0.221337275330347,-0.00248395590427072,0.250511277022634,-0.46916814361211,0.0271355918379548
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,-0.408966954182322,0.335816294773612,0.205057637619305,-0.195840892397807,-0.418887919828394
WANG_MLL_TARGETS,-0.227124594901528,0.142285393092296,0.114695729297687,-0.215485832161528,-0.118256737129186
KANG_GLIS3_TARGETS,-0.222412061093709,0.161273173473909,-0.21151647636741,-0.121648880366607,0.061561617517107
DELACROIX_RARG_BOUND_MEF,-0.177913260692916,0.09173089994758,-0.217822239546801,0.0374101910383698,-0.269237924271471
DELACROIX_RAR_TARGETS_UP,-0.124183155772602,0.321337029709568,-0.283079841285095,0.158076745552503,-0.255854469087178
DELACROIX_RAR_TARGETS_DN,-0.339332801488021,-0.311337779253381,-0.0838015737217759,0.522365013356219,-0.22236961841432
DELACROIX_RAR_BOUND_ES,-0.0737921434549081,0.166653131676217,0.10168526685744,-0.302092574500229,-0.213375410132536
KRIEG_HYPOXIA_VIA_KDM3A,-0.178278845534052,0.508779049864416,-0.18179145869662,-0.172307819754933,-0.358797092088354
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,0.0407148495002711,0.00243231808831007,0.0307374027995272,-0.233189654841746,-0.190620909519088
KRIEG_HYPOXIA_NOT_VIA_KDM3A,-0.0777039905284638,0.260678043863393,-0.0541054548331451,-0.190251320548211,-0.356958522699119
TIAN_BHLHA15_TARGETS,-0.111310704085568,0.0278075667852241,0.0675459044898112,-0.391022856566827,0.0583327805832689
ALFANO_MYC_TARGETS,-0.0330968604093287,-0.0102081545475813,0.0868159982228519,-0.181172613864348,-0.30834096751445
REICHERT_MITOSIS_LIN9_TARGETS,0.458635150767498,0.315941828694496,-0.0487453361691124,-0.592220826427061,-0.554426614574341
GUILLAUMOND_KLF10_TARGETS_UP,-0.359320647488117,-0.0693483048374612,0.260569866360113,-0.384063620830308,0.163362337812982
GUILLAUMOND_KLF10_TARGETS_DN,0.340979193569845,-0.228150180486591,0.111513988032916,-0.538008159949972,0.00456769788583161
FORTSCHEGGER_PHF8_TARGETS_UP,-0.0125488942647115,0.00448898559382652,0.09935441307613,-0.192346831960652,-0.113385605222188
FORTSCHEGGER_PHF8_TARGETS_DN,-0.0105701089960327,0.0602758786077499,-0.0477103463720237,-0.226002751875912,-0.212347130622952
BRIDEAU_IMPRINTED_GENES,-0.23795549635162,0.114104655209857,0.295665165160123,-0.231676533435036,-0.0601316131042537
PEDRIOLI_MIR31_TARGETS_UP,-0.144657062964243,0.112296968298668,0.208795379109076,-0.225690811959076,-0.174572277629956
PEDRIOLI_MIR31_TARGETS_DN,-0.0343716388134954,0.114690222889796,0.13800004139544,-0.383103971855766,-0.131225571282572
PHONG_TNF_TARGETS_UP,-0.142173003270994,0.369637281040171,-0.300406272459009,0.108871610093327,-0.375399555283367
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,-0.217093808581739,0.117934241838094,-0.0355004706578392,-0.113926625916542,-0.280975969012941
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,-0.176252162302707,0.0467327491170522,-0.0127094791720806,-0.049181830455264,-0.17560152001469
PHONG_TNF_RESPONSE_NOT_VIA_P38,-0.22556527645047,0.280106959446829,-0.10482106716872,-0.186461657329838,-0.1825867287508
RATTENBACHER_BOUND_BY_CELF1,-0.0573921035811658,0.0778753665097928,0.105377234571402,-0.36585260743028,-0.0755112702611569
KINNEY_DNMT1_METHYLATION_TARGETS,0.436722063894136,0.154354787528631,0.209191959394282,-0.538996230262163,-0.0396506321852227
FOSTER_KDM1A_TARGETS_UP,-0.127270097561802,0.1297766743868,0.244892797870927,-0.257091923457241,-0.247971110799859
FOSTER_KDM1A_TARGETS_DN,-0.0840973962876714,0.216352564373262,0.024719241611913,-0.248984216247369,-0.261983491429948
YU_BAP1_TARGETS,-0.364105657774234,0.456889906211815,-0.179299007084393,-0.303769381663858,-0.0790183652717853
RAO_BOUND_BY_SALL4_ISOFORM_A,-0.329810441280945,0.147134527270213,0.259541972467262,-0.290450491918013,0.122362594195326
RAO_BOUND_BY_SALL4_ISOFORM_B,-0.126750002285984,0.0469088221493276,0.256332545146446,-0.431155284001473,-0.0438517908703972
RAO_BOUND_BY_SALL4,-0.247010211126465,0.0905032142447953,0.137377921356811,-0.257968535124621,-0.134331409090553
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,0.0843004855016545,0.0243169304551067,0.0622318558856286,-0.311511698875412,-0.321274764179216
BOUDOUKHA_BOUND_BY_IGF2BP2,0.0112987588265684,-0.117061513878041,-0.175361286957109,0.00984332861053416,-0.250030826353794
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,-0.0689123329528879,-0.0094119075096103,0.267639802384265,-0.44494906741429,0.0336070304409048
BOSCO_TH1_CYTOTOXIC_MODULE,-0.120791542728974,0.138821800354559,0.428850204046307,-0.266201412160264,-0.161154660462227
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,-0.372491154132341,0.247698275546641,-0.0295734976119681,-0.0282744398386754,-0.276767072048716
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,-0.101173522456978,0.185538402018705,0.365004789572468,-0.329675922766698,-0.233097871431719
PECE_MAMMARY_STEM_CELL_UP,0.316774952388432,0.227721868047951,-0.187815499413702,-0.338651959404673,-0.426849529593336
PECE_MAMMARY_STEM_CELL_DN,-0.23937723677508,-0.101031504158948,0.193288598251532,-0.383227847618031,-0.079722426127375
ABRAMSON_INTERACT_WITH_AIRE,-0.193485119873526,-0.0110383686157303,0.0584556183324016,-0.339506875721767,-0.187252569707914
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,-0.123401719126653,0.11047877976302,0.275584078946898,-0.375387899483683,-0.170062251765611
KUMAR_AUTOPHAGY_NETWORK,-0.398314214187324,0.039629460978605,0.35978730066478,-0.168441888134563,-0.0541603048130504
GENTLES_LEUKEMIC_STEM_CELL_UP,-0.364756234818709,0.126179161049043,0.576806113699034,-0.470716198461607,0.158799860885924
GENTLES_LEUKEMIC_STEM_CELL_DN,-0.101649001254445,-0.0536262070824804,0.53241674825899,-0.470903598221499,0.14930913155104
ROESSLER_LIVER_CANCER_METASTASIS_UP,0.193043384508001,0.280661841129464,-0.12928998676144,-0.471232878380896,-0.253625624239446
ROESSLER_LIVER_CANCER_METASTASIS_DN,-0.13224057198571,0.120980509169216,0.229936639648881,-0.460386849714466,0.0642728142771429
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,-0.494123676331173,0.1555035517475,-0.109645777001568,-0.452224152099295,0.363485294967406
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,-0.230813059083768,0.389778486649449,0.273346259360635,-0.504337939468128,-0.174067230503995
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,0.24902726835041,-0.169381612513077,0.060730078088218,-0.663198078716806,0.134100274630511
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,-0.10257054752239,0.338810269909062,-0.193642918371297,-0.044109512778376,-0.209547490908393
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,-0.430944663584286,-0.00946463079109675,-0.0405709550447271,0.316570128204431,-0.438426547053175
LIM_MAMMARY_STEM_CELL_UP,-0.218636315087888,0.0780441370093349,-0.056737493826268,-0.0947543118446532,-0.168552898652272
LIM_MAMMARY_STEM_CELL_DN,0.110399332465916,0.126056650598527,0.161388439365049,-0.390633453369678,-0.297927698686891
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,-0.0418846657385569,0.304847568963821,-0.00283154278495218,-0.382397238443663,-0.174260147116501
LIM_MAMMARY_LUMINAL_MATURE_UP,-0.0558898884629239,0.298249223709995,0.0995495346197129,-0.217162439087286,-0.374261330189817
LIM_MAMMARY_LUMINAL_MATURE_DN,-0.337065519248379,-0.211968279826401,-0.0219735957787116,-0.01825594129475,0.103907557260878
DURAND_STROMA_S_UP,-0.199282157013349,0.0373201918083749,0.14263164006236,-0.122970270792232,-0.296906482212926
DURAND_STROMA_NS_UP,-0.231351882742102,0.15948318926689,0.123535308035611,-0.355798971661103,-0.0324414924085717
SMIRNOV_RESPONSE_TO_IR_2HR_UP,-0.251816859545019,0.31879789274663,-0.302265203259782,-0.0641428752772654,-0.151131818559047
SMIRNOV_RESPONSE_TO_IR_2HR_DN,-0.0239606657202822,-0.0512836099037335,0.103243220802357,-0.229485810279831,-0.0811022512579735
SMIRNOV_RESPONSE_TO_IR_6HR_UP,-0.110907449908005,0.174723341010177,-0.111917506069526,-0.312079005050165,-0.0981684299991077
SMIRNOV_RESPONSE_TO_IR_6HR_DN,-0.0774095561067671,0.251165508276231,0.0698034555109275,-0.138273985077808,-0.361279281321804
GHANDHI_DIRECT_IRRADIATION_UP,-0.0477091994430882,0.433368520995173,0.0382111329276029,-0.419664588819345,-0.288086903011751
GHANDHI_DIRECT_IRRADIATION_DN,0.125103625899369,0.125636310525916,-0.236005010299003,-0.0544458927661746,-0.428784170855293
GHANDHI_BYSTANDER_IRRADIATION_UP,-0.0467737543859974,0.366741452463141,0.32423452594071,-0.440449062155556,-0.257121149605039
WARTERS_RESPONSE_TO_IR_SKIN,0.144293150763413,0.248019356568651,-0.294625532841094,-0.228871458542114,-0.303269048000991
WARTERS_IR_RESPONSE_5GY,0.102080952688957,0.374644165304443,0.0155600993486655,-0.421880812682611,-0.281474276608336
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.0636308727552603,0.0804795048275987,0.191914691091239,-0.469413908935789,-0.310482379245183
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,0.137135831609285,0.0671289823923035,0.006189881157766,-0.457145206599669,-0.232780937871424
ZWANG_EGF_PERSISTENTLY_UP,-0.219503219540192,-0.243758932595175,0.410248243654109,-0.465235959224561,-0.128599997715716
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,-0.210730409515978,0.248017702609335,0.0559065284678239,-0.246012556506288,-0.232188685360456
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.0178364869938406,-0.0292005556051205,0.0508533340024672,0.0588199141502899,-0.226261552094901
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,-0.144632202670781,0.264437553421992,-0.0994068387584734,-0.183515689037667,-0.290636187673691
ZWANG_DOWN_BY_2ND_EGF_PULSE,-0.173669314239053,0.201448072946926,0.197134961858268,-0.343817592146783,-0.250759579631054
ZWANG_EGF_INTERVAL_UP,0.0546220499252652,0.0078608965429251,0.40044532764145,-0.442829584561825,-0.120649378600229
ZWANG_EGF_INTERVAL_DN,0.0104906078166716,0.193231004045466,0.063082989858553,-0.375993245650532,-0.368221576534678
ZWANG_EGF_PERSISTENTLY_DN,-0.0208505954291952,0.264634769796294,-0.167159796577402,-0.272021087055499,-0.114767102347359
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,-0.133364454946245,-0.100128739830604,0.199489835777269,0.0133009120886865,-0.397046083013893
HORTON_SREBF_TARGETS,0.478705099783388,-0.606381030848309,0.00396132583211786,-0.481982524912734,0.0273605949401722
HECKER_IFNB1_TARGETS,-0.143566406996101,0.303513993071824,0.013604077828093,-0.100849435610164,-0.299076321627761
FARMER_BREAST_CANCER_CLUSTER_4,-0.411039188981846,-0.375492993198056,-0.469480139943178,0.700903562505256,-0.573772645951007
EPPERT_LSC_R,-0.165440166579911,-0.22226197644272,0.193961385697883,-0.498738210603103,0.128471309589957
EPPERT_HSC_R,-0.156367632731845,0.154660267045722,0.139984750246474,-0.47741249693851,0.0108773027955103
EPPERT_PROGENITOR,-0.0240478042056507,-0.0649710692332247,0.155955199723282,-0.496091078449593,-0.289225675354507
EPPERT_CE_HSC_LSC,0.0571703902619786,0.184367365593742,0.460282789671687,-0.541409550580443,-0.256796467200409
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,-0.127772786048556,0.0977209030263762,-0.228117038349171,-0.27538299952753,0.027084189237626
MACAEVA_PBMC_RESPONSE_TO_IR,0.0193820629682709,0.256960272503072,-0.0763921387715515,-0.26551118089566,-0.2760211411799
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,-0.0456657509584929,0.284399904758621,-0.0532070830289238,-0.282964400073571,-0.210844433390983
FISCHER_G1_S_CELL_CYCLE,0.151590327265869,-0.00522591570742489,0.0458064260831331,-0.404622272932707,-0.212297096961325
FISCHER_G2_M_CELL_CYCLE,-0.191560046833072,0.289410475556139,0.130651887150311,-0.44672048166351,-0.375281455300226
FISCHER_DREAM_TARGETS,-0.0105554410062396,0.192736512258405,0.146590869282248,-0.485822173714619,-0.376144791630371
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,-0.222505425175156,-0.055483750955206,0.2060764044758,-0.310251011742425,-0.119533378472703
GRYDER_PAX3FOXO1_TOP_ENHANCERS,-0.187197074815052,0.0089191704884079,0.170682412339565,-0.348395195967753,-0.185098357500113
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,-0.163933321184108,-0.11999336764324,0.155123340927395,-0.302002797721578,-0.0588858610747596
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,-0.0901156230547809,0.336436385840918,0.196104001347741,-0.371000581362836,-0.265090867338519
ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,-0.246584860598261,0.302558616965312,-0.109918864778805,-0.162035491248105,0.138736641791597
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,-0.299442529584073,-0.0474424760539636,0.223020744476399,-0.273303394204678,-0.148548752471859
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,-0.219057667821247,0.191064015496846,0.0546820330354562,-0.201023668920908,-0.200656108264859
VILLANUEVA_LIVER_CANCER_KRT19_UP,-0.253703429500718,0.295847225816472,0.20347531737504,-0.455002065538561,-0.240110223279983
VILLANUEVA_LIVER_CANCER_KRT19_DN,0.240890521726264,0.292558543715425,-0.193443383967272,-0.252492910253156,-0.336677146383248
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,0.136449887882518,-0.321139495343959,-0.0768632453762449,-0.323062019771669,0.329997485610398
ANDERSEN_LIVER_CANCER_KRT19_DN,0.124228287783436,0.0341293705426721,-0.02432678316003,-0.220133167139907,-0.205230444082339
KIM_LIVER_CANCER_POOR_SURVIVAL_DN,-0.0235825851025853,0.089885090745749,0.401310338259255,-0.301911335552927,-0.269242833760637
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,-0.542000509285845,0.356079702972779,0.244446071440766,-0.397683225363581,0.306683803691306
HOLLERN_EMT_BREAST_TUMOR_UP,-0.239441184690395,-0.0740487891445181,-0.117043622236005,0.0444310673973132,-0.00513142765017446
HOLLERN_EMT_BREAST_TUMOR_DN,-0.00898914718400043,0.253870790801961,0.150222461149056,-0.331104279623978,-0.296867362019028
HOLLERN_SQUAMOUS_BREAST_TUMOR,0.11064121938343,0.0724056226670439,0.12349487350031,-0.185837118220027,-0.122346146094422
HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.10975362395975,0.161064589500608,0.0577071166426418,-0.494747290324061,-0.110541101794521
HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,-0.380916798733619,-0.0559683639444779,-0.0372194820341382,-0.144866278988617,0.181969243333319
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,-0.123099191891959,0.319333296952598,0.143291423105757,-0.472678840306763,-0.285422017722396
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,-0.20507321776484,0.287321454486425,0.286958830751544,-0.390086088396303,-0.0579062901148859
FLORIO_HUMAN_NEOCORTEX,-0.0218135718173407,0.439355255980245,0.313550413307715,-0.467636213722496,-0.154457038622819
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,-0.480131957054167,-0.104720089189252,0.283808788632848,-0.14286566606859,0.178452667818743
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,-0.276194659311622,-0.210107787881352,0.258390208443246,-0.429395224284895,0.190395189157545
